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1.1 INTRODUCTION 
 
Chronic kidney disease (CKD) is a common disease in cats. In veterinary practices or 
colleges of the United States, the overall prevalence of feline CKD varies between 1 and 3%. 
The prevalence increases to approximately 7.5% in cats over 10 years and reaches between 15 
and 30% in cats over 15 years of age (Lulich et al 1992, Lund et al 1999, Polzin 2010, 
Lefebvre 2011). Hence, feline CKD is frequently encountered by veterinarians, mainly in 
older cats.  
Establishing a correct diagnosis is mandatory for an adequate management of these 
patients, but diagnosing CKD may be challenging, particularly in early disease stages or in 
cats with concurrent diseases.  
This introduction gives an overview of necessary diagnostic tests, the classification 
system proposed by the International Renal Interest Society (IRIS; IRIS 2009, Polzin 2010) 
and the importance and possibilities to improve early detection of CKD.  
 
1.2 DIAGNOSIS 
 
Feline CKD is diagnosed based on the presence of combined renal azotemia and 
poorly concentrated urine (urine specific gravity (USG) ≤ 1.035), with compatible historical 
or physical examination findings (Grauer 1998, Bartges 2012). If the urinary bladder is 
palpable, urine can be collected easily by cystocentesis (Fig 1.1). 
 
Fig 1.1. 
Cystocentesis in an 
unsedated cat. The cat 
is restrained in dorsal 
recumbency and the 
bladder is palpated and 
immobilized during 
aspiration of urine. 
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1.2.1 Signalment, history and physical examination 
 
Idiopathic CKD may affect cats of all ages and obvious breed and sex predispositions 
have not been reported. This contrasts with the clear breed predispositions that have been 
recognized for other renal diseases such as polycystic kidney disease (PKD) and amyloidosis. 
However, the signalment might be helpful for diagnosing feline idiopathic CKD. 
Veterinarians should have an increased awareness for CKD in senior and geriatric cats as 
CKD typically is a disease of older cats. Some breeds have been overrepresented in some 
studies, such as Siamese, Persian, Abyssinian, Maine Coon, Russian Blue, and Burmese cats 
(DiBartola et al 1987, Lulich et al 1992, Elliott and Barber 1998, Boyd et al 2008). Websites 
of European Ragdoll breed clubs warn for an increased susceptibility of Ragdoll cats for renal 
problems (SRC 2012, RCB 2013). However, scientific literature does not support a 
predisposition of Ragdoll cats for CKD.  
Cats with CKD are presented to veterinarians in various stages of illness. Some are 
incidentally diagnosed during health screening, others demonstrate mild clinical signs, while 
others suffer from end-stage CKD with severe signs such as emaciation or dehydration 
(DiBartola et al 1987, Elliott and Barber 1998). The illness duration prior to admission is 
highly variable. Although feline CKD is typically chronic, an acute history of illness is not 
uncommon (DiBartola et al 1987). The most common clinical signs are nonspecific and 
include inappetence, polyuria, polydipsia, weight loss, lethargy, halitosis, and vomiting 
(DiBartola et al 1987, Lulich et al 1992, Elliott and Barber 1998, King et al 2006). Signs 
associated with nephrotic syndrome or hypertension are uncommon in cats with CKD 
(DiBartola et al 1987, Elliott and Barber 1998, King et al 2006).  
Physical examination findings depend on the disease stage and consist of thin body 
condition, dehydration, periodontal disease, unkempt hair coat, abnormal kidney palpation 
(small, irregular or enlarged) and pale mucous membranes (Fig 1.2). Physical examination 
can be unremarkable in the early disease stage (DiBartola et al 1987, Elliott and Barber 1998). 
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Fig 1.2. A cat presented with severe clinical signs due to acute-on-chronic kidney disease. A 
thin body condition (body condition score 3/9) and an unkempt haircoat with scaling are 
visible (left and upper right figure). The cat also had pale mucous membranes and was 
salivating because of uremic stomatitis and nausea (bottom right figure). After stabilization 
with infusion, supportive therapy (nasoesophageal tube feeding, antiemetics, antacids, 
analgesics) and antibiotics, the cat was discharged. Follow-up two weeks later revealed 
chronic kidney disease IRIS end-stage 3. 
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1.2.2 Minimum laboratory database 
 
As feline CKD is diagnosed based on the presence of compatible clinical signs and 
renal azotemia, the minimum laboratory database to confirm CKD consists of measuring 
serum creatinine and urea concentrations and USG. 
Renal azotemia is defined as increased serum creatinine and urea concentrations due to 
intrinsic renal pathology (Table 1.1) (Stockham and Scott 2008a). Creatinine is more reliable 
than urea as an indirect marker for glomerular filtration rate (GFR) because creatinine is less 
influenced by extrarenal factors (e.g. intestinal protein content, liver function) and only 
undergoes glomerular filtration without tubular reabsorption. The daily production rate of 
creatinine depends on muscle mass, which may be of clinical importance in geriatric cats with 
age-related muscle wasting or when muscle mass gradually declines during CKD progression 
(Lees 2004, Polzin 2010, DiBartola 2010). The (modified) Jaffe and enzymatic assays are 
currently the only used commercial creatinine assays. Both methods correlate well with a 
reference method. However, the Jaffe assay may overestimate low concentrations and 
underestimate high concentrations of feline serum creatinine. The enzymatic assay only 
slightly overestimates feline creatinine and appears to be the preferred method (Le Garreres et 
al 2007). Although the (modified) Jaffe assay is being replaced gradually by enzymatic 
assays, many diagnostic laboratories still use the (modified) Jaffe assay to measure serum 
creatinine concentrations. Reference intervals (RIs) for serum creatinine can widely differ 
between laboratories which may lead to misclassification of samples as normal or abnormal 
(Boozer et al 2002, Ulleberg et al 2011). Because assays and RIs often differ between 
laboratories, clinicians are encouraged to consistently determine serum creatinine in a 
laboratory with good quality control (Lees 2004).  
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Table 1.1. Characteristics of prerenal, renal and postrenal azotemia (Grauer 1998, Stockham 
and Scott 2008a, DiBartola 2010). 
PRERENAL AZOTEMIA RENAL AZOTEMIA POSTRENAL AZOTEMIA 
Due to decreased renal blood 
flow secondary to 
dehydration, hypovolemia, 
shock or cardiac failure 
Signs of dehydration, hypo-
volemia, shock or cardiac 
failure 
Usually mild azotemia 
(serum creatinine < 400 
µmol/L) 
USG > 1.030 – 1.040, unless 
primary disease interferes 
with urinary concentrating 
ability or prerenal azotemia 
complicates renal azotemia 
Rapid resolution of azotemia 
with correction of hypo-
volemia or dehydration 
Can evolve to renal azotemia 
if no timely management 
Due to intrinsic renal 
damage/pathology resulting 
in decreased glomerular 
filtration rate 
Usually no clinical signs of 
dehydration or hypo-
volemia, except if renal 
azotemia is complicated by 
prerenal azotemia 
Mild to severe azotemia 
USG < 1.030 – 1.040, often 
isosthenuria (1.007 – 1.015) 
Slower or only partial or no 
improvement with infusion 
therapy 
Due to urinary obstructive 
disease or urinary tract 
rupture leading to 
accumulation of urine in the 
body 
History often reveals dysuria, 
stranguria or oliguria if 
lower urinary tract 
obstruction 
Palpable renal asymmetry if 
upper urinary tract 
obstruction 
Distended abdomen and 
positive undulation if uro-
abdomen 
Mild to severe azotemia 
Variable USG 
Resolution of azotemia with 
correction of underlying 
disease 
Can evolve to renal azotemia 
if no timely management 
(USG = Urine specific gravity) 
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In veterinary medicine, USG is routinely measured by refractometry. Human hand-
held optical refractometers can overestimate feline USG (George 2001). However, these 
errors are not clinically relevant and are unlikely to change clinical decision making (Bennett 
et al 2011). Veterinary refractometers with a separate feline USG scale avoid these errors 
(George 2001). Alternatively, a conversion calculation is available: feline USG = (0.846 x SG 
of human refractometer) + 0.154, a formula that is dating from 1956 (George 2001, Bennett 
et al 2011). Most CKD cats have isosthenuric urine (USG 1.007 – 1.015) (Fig 1.3) (DiBartola 
et al 1987, Elliott and Barber 1998), but this is less consistent in cats compared with dogs 
(Finco 1995). Some cats, with spontaneous as well as with experimentally induced CKD, can 
retain their urine concentrating ability despite being azotemic, particularly in early disease 
stages (Ross and Finco 1981, DiBartola et al 1987, Elliott and Barber 1998). With disease 
progression, USG usually gradually declines (Elliott and Barber 1998, Elliott et al 2003). 
 
 
 
  
Fig 1.3. Urine samples taken by cystocentesis of a cat 
with chronic kidney disease IRIS stage 3 (left) and a 
healthy geriatric cat (right). The CKD cat had poorly 
concentrated urine with urine specific gravity (USG) 
1.014, the healthy cat concentrated urine with USG 
1.045. In the absence of bilirubinuria, the difference in 
urinary concentration is macroscopically visible. 
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1.2.3 Proteinuria 
 
Although severe proteinuria is uncommon, low-level proteinuria (urinary protein: 
creatinine ratio (UPC) < 1) commonly affects feline CKD patients and is an important 
prognostic factor and therapeutic target (King et al 2006, Kuwahara et al 2006, Syme et al 
2006, King et al 2007). Therefore, quantifying and longitudinal monitoring of proteinuria is 
very important in all cats with CKD. 
Proteinuria may be of prerenal, renal or postrenal origin and persistent renal 
proteinuria indicates CKD. A step-wise diagnostic approach (Fig 1.4) must be followed to 
eliminate prerenal (e.g. hemoglobinuria, myoglobinuria, Bence-Jones proteinuria), postrenal 
urinary (e.g. urolithiasis, cystitis, ureteritis, bladder or urethral neoplasia) and postrenal 
extraurinary (e.g. genital tract inflammation) proteinuria. The severity of proteinuria may help 
to localize renal proteinuria: UPC values above 2 are likely glomerular, but lower values 
might be glomerular, tubular or interstitial in origin (Lees et al 2005, Segev 2010).  
Several methods exist to evaluate whether CKD cats are proteinuric. However, the 
UPC, that provides an index of total urinary protein loss and correlates closely with the gold 
standard of 24-hour urinary protein excretion, is the only reliable method to determine its 
clinical implications (Adams et al 1992, Lees et al 2005). Because UPC can vary depending 
on the methodology used, monitoring of UPC requires the same laboratory assay (Fernandes 
et al 2005). In practice, dipstick tests are often used as a measure of urinary protein. Urine 
dipstick tests primarily measure albumin; are easy, rapid, in-house tests; and provide 
semiquantitative assessment of proteinuria. Unfortunately, urine dipsticks only reliably detect 
severe feline proteinuria. In cats with low-level proteinuria, false positive and false negative 
results are common (Syme 2009, Lyon et al 2010). A positive dipstick test can be confirmed 
by the more sensitive and specific semiquantitative sulfosalicylic acid turbidity (SSA) test that 
has a lower detection limit (5 mg/dL) compared with dipstick tests (30 mg/dL). Interpretation 
of dipstick and SSA results must be done in light of USG, because positive results in 
concentrated urine reflect less severe protein loss than in diluted urine (Lees 2004, Segev 
2010). If a false negative dipstick result is suspected, the SSA test or a species-specific 
microalbuminuria test (see below) can be employed (Grauer 2007, Segev 2010). Nevertheless, 
measurement of UPC is recommended in all animals with positive semiquantitative 
proteinuria tests (Lees 2004, Lees et al 2005, Grauer 2007).  
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Fig 1.4. Flow-chart to assess the origin of proteinuria in cats, based on Lees et al (2005). 
*To evaluate for persistence of proteinuria: testing on 3 or more occasions, 2 or more 
weeks apart is recommended. 
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1.2.4 Additional diagnostic tests 
 
1.2.4.1 Blood and urine examination 
 Additional blood and urine parameters need to be monitored carefully in CKD cats, 
mainly to improve early recognition and treatment of complications.  
Because 30 – 65% of CKD cats develop anemia during their disease course and 
chronic anemia implies decreased quality of life, timely diagnosis of anemia of renal disease 
is important (DiBartola et al 1987, Lulich et al 1992, Elliott and Barber 1998, Boyd et al 
2008, Chalhoub et al 2011). The anemia of CKD, usually non-regenerative, worsens with 
increasing disease severity (Elliott and Barber 1998, Elliott et al 2003, King et al 2006). 
Although not consistently found, anemia at diagnosis might be associated with more rapid 
disease progression and shorter survival (Kuwahara et al 2006, King et al 2007, Chakrabarti 
et al 2012). 
 Renal secondary hyperparathyroidism commonly complicates feline CKD, being 
more common and more severe with higher degrees of renal dysfunction (Barber and Elliott 
1998). Higher phosphate concentration at diagnosis has been associated with shorter survival 
times and disease progression (King et al 2007, Boyd et al 2008, Chakrabarti et al 2012). 
Thus, phosphate and – preferably ionized – calcium concentrations should be assessed in 
CKD cats, though, these are relatively insensitive tests to detect renal secondary 
hyperparathyroidism. Measuring parathyroid hormone would provide more information 
regarding parathyroid status, but parathyroid hormone assays are expensive, not widely 
available and correct sample handling is difficult (Barber and Elliott 1998, Finch et al 2012, 
Geddes et al 2013a). Both parathyroid hormone and fibroblast growth factor 23, a 
phosphaturic hormone secreted in response to hyperphosphatemia, progressively increase 
with more advanced CKD and may be increased before azotemia develops (Finch et al 2012, 
Finch et al 2013a, Geddes et al 2013b). Also, fibroblast growth factor 23 was higher in 
hyperphosphatemic azotemic cats compared with normophosphatemic azotemic cats of the 
same IRIS stage (Geddes et al 2013b). Further studies looking at the potential value of 
fibroblast growth factor 23 for early diagnosis of renal secondary hyperparathyroidism are 
warranted (Finch et al 2013a). Approximately 15% of cats with mild CKD (IRIS stage 2) and 
up to 100% of end-stage CKD cats have hyperphosphatemia (DiBartola et al 1987, Lulich et 
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al 1992, Barber and Elliott 1998, King et al 2006). Total and ionized calcium concentrations 
in CKD cats vary from increased, normal to decreased (Barber and Elliott 1998, Elliott et al 
2003, Schenck and Chew 2010). Ionized calcium concentrations tend to decline with 
increasing severity of CKD (Barber and Elliott 1998, Elliott et al 2003). Because total 
calcium poorly predicts ionized calcium concentration, particularly in CKD cats, 
measurement of total calcium is of little value and ionized calcium determination is required 
to assess calcium status in CKD cats (Barber and Elliott 1998, Schenck and Chew 2010).  
 Hypokalemia affects 15 to 30% of CKD cats, especially IRIS stage 2 and 3 cats. 
Hypokalemia is less common in cats with more severe CKD and cats with end-stage CKD 
(IRIS stage 4) may develop hyperkalemia (12 – 22%) due to reduced potassium excretion 
(DiBartola et al 1987, Lulich et al 1992, Elliott and Barber 1998, Elliott et al 2003, King et al 
2006). Monitoring potassium concentrations is recommended for CKD cats of all stages.  
Metabolic acidosis characterized by decreased pH, low bicarbonate concentration, 
increased anion gap and/or decreased to normal chloride concentration, occurs frequently in 
feline CKD patients, especially in cats with advanced CKD (DiBartola et al 1987, Lulich et al 
1992, Elliott et al 2003). Cats with mild to moderate CKD usually maintain their acid-base 
balance (Elliott et al 2003). Determining the acid-base status and appropriate treatment of 
acid-base disturbances is recommended in cats with advanced CKD (IRIS end stage 3 and 4). 
Blood gas testing in cats with CKD can be performed on venous samples drawn into syringes 
that are coated with 1:1000 heparin or into specialized blood gas syringes containing pelleted 
heparin (Kerl 2010). The amount of heparin in the syringe must be minimized by an 
evacuation technique to avoid preanalytical errors due to dilution of the sample (Hopper et al 
2005). After sampling, the syringe must be made airtight immediately and sample analysis 
must be done within 15 minutes on a bench-top analyzer that is developed or validated to 
perform blood gas analysis in veterinary patients (Kerl 2010). As an alternative to blood gas 
testing, the bicarbonate concentration may be determined as decreased bicarbonate 
concentrations are usually associated with metabolic acidosis (Stockham and Scott 2008b).  
 Routine urine bacterial culture, at diagnosis of CKD and during follow-up, is 
recommended because bacterial urinary tract infections (UTIs), commonly affect CKD cats, 
independently of the severity of CKD (Mayer-Roenne et al 2007, Bailiff et al 2008, Martinez-
Ruzafa et al 2012, White et al 2013). During a 3-year follow-up study in which urine cultures 
were routinely performed in cats with CKD, 30% developed a positive urine culture (White et 
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al 2013). Many CKD cats with UTI have an occult UTI, which means that they do not show 
lower urinary tract signs (up to 72%) and/or urinary sediment abnormalities (up to 25%). 
Therefore, UTI may be overlooked based on history, physical examination and routine 
urinalysis (Mayer-Roenne et al 2007, Bailiff et al 2008, Martinez-Ruzafa et al 2012, White et 
al 2013).  
 A significant relationship has been shown between feline immunodeficiency virus 
(FIV) and CKD and between FIV and azotemia. Also, proteinuria is common in FIV-infected 
cats (Thomas et al 1993, Avila et al 2010, White et al 2010, Baxter et al 2012). In contrast, a 
relationship between feline leukemia virus (FeLV) and CKD has not yet been shown, but 
FeLV can cause serious clinical syndromes leading to considerable negative effects on quality 
and quantity of life (Hartmann 2012). Determination of the FIV- and FeLV-status is therefore 
recommended in cats with CKD. 
 
1.2.4.2 Blood pressure (BP) 
Hypertension frequently complicates CKD (20 – 65%) (Kobayashi et al 1990, Stiles et 
al 1994, Syme et al 2002) and renal dysfunction is the most common underlying cause of 
feline hypertension (31.9 – 87%) (Littman 1994, Maggio et al 2000, Elliott et al 2001, Jepson 
et al 2007). In humans, hypertension is considered to be both cause and consequence of CKD 
and contributes to progressive CKD (Tedla et al 2011). Similarly, regardless of the underlying 
cause for hypertension, azotemia is observed in many hypertensive cats (Littman 1994, 
Maggio et al 2000, Chetboul et al 2003, Jepson et al 2007). Idiopathic hypertension is 
diagnosed in 13 – 20% of hypertensive cats, however, whether these non-azotemic and non-
hyperthyroid cats have primary hypertension or hypertension secondary to early, subclinical, 
non-azotemic CKD is uncertain (Maggio et al 2000, Elliott et al 2001, Jepson et al 2007, 
Syme 2011). Although an association between hypertension and progressive kidney disease is 
generally presumed, it remains uncertain whether feline systemic hypertension might cause 
CKD and which role it plays in CKD progression (Syme 2011). Nevertheless, BP should be 
measured in all cats with kidney disease and renal function should be assessed in all 
hypertensive cats (Maggio et al 2000, Chetboul et al 2003, Stepien 2011). 
Techniques for BP measurement are reviewed in detail elsewhere (Brown et al 2007, 
Stepien 2011). Because it is inexpensive, easy and accurate, the Doppler ultrasonic technique 
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(Fig 1.5) is the most suitable method for indirect systolic blood pressure (SBP) measurement 
in practice. Oscillometric techniques are less accurate in cats, but may be advantageous in cats 
that prefer minimal restraint (Stepien 2010, Stepien 2011). Hypertension is considered and 
further diagnostic tests are advised if SBP, measured with Doppler device, exceeds 160 
mmHg on repeated occasions or on a single occasion with clinical manifestations of 
hypertension (Lin et al 2006, Brown et al 2007, Stepien 2011). Uncontrolled hypertension 
leads to end-organ damage at the level of the kidneys, heart, brain and eyes and the majority 
of hypertensive cats have ocular or cardiac abnormalities on physical examination (Littman 
1994, Maggio et al 2000, Elliott et al 2001, Syme et al 2002, Chetboul et al 2003, Brown et al 
2007). 
 
 
 
 
 
  
Fig 1.5. Systolic blood pressure measurement in a cat using the Doppler ultrasonic 
technique, in sitting position (A), in lateral (B) and sternal recumbency (C). Points of 
attention are to restrain the cat gently in a comfortable position and to held the cuff at the 
level of the heart base. In cats, we always use headphones to avoid stress hypertension due 
to the sounds of the Doppler machine and to improve hearing of the Doppler sounds by the 
clinician. 
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1.2.4.3 Medical imaging 
Once CKD is diagnosed, medical imaging studies may reveal an underlying cause, 
particularly in cats with unilateral or bilateral renomegaly or obvious asymmetry in kidney 
size. Causes that may be detected are PKD, nephrocalcinosis, urinary obstructive disease and 
renal neoplasia (Fig 1.6 – 1.8). Additionally, signs of feline infectious peritonitis or 
pyelonephritis may be identified (Polzin 2010, Bartges 2012). Abdominal radiography allows 
assessment of kidney size and presence of radiopaque uroliths (Fig 1.9). Contrast radiography 
may improve urolith detection and localization. More detailed information regarding internal 
renal architecture can be obtained with ultrasonography (DiBartola 2010). Typical renal 
ultrasonographic findings in CKD cats are small (< 3.2 cm) and irregularly outlined kidneys, 
heterogenous renal parenchyma, focally or diffusely increased cortical and/or medullar 
echogenicity, loss of corticomedullary demarcation, areas of mineralization and poor 
visualization of internal architecture (Fig 1.10) (Grooters and Biller 1995, Widmer et al 2004, 
d’Anjou 2008, Debruyn et al 2012). However, there is no correlation between 
ultrasonographic findings and the degree of renal dysfunction (Grooters and Biller 1995). 
Furthermore, the frequency of renal ultrasonographic abnormalities in healthy cats is 
unknown.  
 
 
 
Fig 1.6. Ultrasonographic 
dorsal plane of the right 
kidney of a 13-year-old 
Persian cat with polycystic 
kidney disease. The kidney is 
severely enlarged (length > 6 
cm) (normal 3.2-4.2 cm; 
Widmer et al 2004) and 
contains multiple, well-
defined cysts of different 
sizes. The presence of the 
multiple cysts in the cortex 
and medulla results in 
complete distortion of the 
normal kidney structure. 
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Fig 1.7. Sagittal and transverse ultrasound images of the left kidney of a 1-year-old 
domestic shorthair cat with ureteral obstruction due to ligation. Note the moderate 
pyelectasia (3.6 mm) and dilation of the proximal ureter (1.8 mm). The size of the kidney 
(4.6 cm) was mildly enlarged. 
Fig 1.8. Dorsal and transverse ultrasound images of the right kidney of a 9-year-old 
domestic shorthair cat with renal lymphoma. The hyperechoic cortex is surrounded by a 
thick hypoechoic subcapsular halo. The kidney was severely enlarged (6.5 cm). 
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Fig 1.9. Left-right lateral and ventrodorsal projections of the abdomen of a 4-year-old 
domestic shorthair cat with acute-on-chronic renal failure and nephrolithiasis. Both 
kidneys are small and markedly irregularly outlined. An asymmetry in kidney size is 
visible. Both kidneys contain radiopaque, well-defined, mineralized elements (nephroliths) 
in the pelvic area. 
Fig 1.10. 
Dorsal ultrasound image of 
the left kidney of a 7- year-
old British shorthair cat 
with chronic kidney 
disease (IRIS stage 3). The 
kidney is decreased in size 
(2.9 cm), irregularly 
outlined and has a 
hyperechoic cortex.  
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1.2.4.4 (Micro)albuminuria 
 Microalbuminuria is defined as the presence of a small amount (1 – 30 mg/dL) of 
albumin in the urine, beneath the limit of detection of urinary dipstick tests (Langston 2004, 
Grauer 2007). Microalbuminuria may also remain undetected by UPC determination (Lyon et 
al 2010). Higher urinary albumin concentrations (> 30 mg/dL) are termed (overt) albuminuria 
and are usually detected using urinary dipstick tests or UPC (Langston 2004, Grauer 2007). 
Persistent renal (micro)albuminuria may be indicative for renal disease (Langston 2004, Lees 
et al 2005), however, (micro)albuminuria has been observed in healthy cats and in cats with a 
wide variety of non-renal diseases (e.g. infectious, inflammatory, endocrine, neoplastic, 
urinary tract disease) (Langston 2004, Mardell and Sparkes 2006, Whittemore et al 2007, 
Vaden et al 2010, Al-Ghazlat et al 2011). It is currently unknown whether microalbuminuria 
serves as negative prognostic marker in cats as in humans (Langston 2004, Vaden et al 2010). 
 (Micro)albuminuria can be measured with the urinary albumin: creatinine ratio (UAC) 
(Langston 2004), but an apparent benefit for UAC measurement over UPC has not yet been 
found (Syme and Elliott 2005a, Syme et al 2006, Jepson et al 2009). Alternatively, feline 
microalbuminuria can be detected with a commercial in-house semi-quantitative enzyme-
linked immunosorbent assay (ELISA)-based dipstick test (E.R.D-Health Screen, Heska 
Corporation, Fort Collins, Colorado, United States) (Langston 2004, Syme and Elliott 2005b, 
Mardell and Sparkes 2006). Although, most cats with negative microalbuminuria dipstick test 
have UPC < 0.4 (Syme and Elliott 2005b, Mardell and Sparkes 2006, Hanzlicek et al 2012), a 
negative microalbuminuria dipstick does not preclude elevated UPC (Mardell and Sparkes 
2006, Al-Ghazlat et al 2011). On the other hand, microalbuminuria is unlikely in CKD cats 
with UPC < 0.2. Nevertheless, quantification of UPC or UAC is recommended in cats with a 
positive microalbuminuria test (Hanzlicek et al 2012). 
 Routine evaluation for presence of (micro)albuminuria in cats is not warranted 
because (micro)albuminuria occurs with various diseases, UAC measurement is not widely 
commercially available, UAC lacks benefit over UPC, semiquantitative test interpretation 
might be difficult and negative microalbuminuria tests do not rule out proteinuria (Lees 2004, 
Syme 2009). However, there are some indications to assess for (micro)albuminuria, 
particularly in cats at risk for renal disease without overt proteinuria (Lees 2004, Grauer 
2007). It is important to remember that (micro)albuminuria is not necessarily associated with 
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CKD and diagnostic tests to define the underlying cause are recommended (Langston 2004, 
Whittemore et al 2007).  
 
1.2.4.5 Glomerular filtration rate 
Determination of GFR – i.e. the volume of ultrafiltrate produced per unit of time – is 
considered to be the gold standard to evaluate kidney function (Braun and Lefebvre 2008). 
Glomerular filtration rate is mostly determined by plasma clearance of a filtration marker. 
Appropriate filtration markers are freely filtered through the glomerulus, not protein-bound, 
not toxic, do not undergo tubular secretion or absorption, and do not alter GFR (Heiene and 
Moe 1998, DiBartola 2010, Von Hendy-Willson and Pressler 2011, Sandilands et al 2013).  
For research purposes, plasma clearance of iohexol or creatinine administered by 
single intravenous injection is frequently used in cats to estimate GFR (Brown et al 1996, 
Miyamoto 1998, Miyamoto 2001a, Miyamoto 2001b, Goy-Thollot et al 2006a, Goy-Thollot 
et al 2006b, Le Garreres et al 2007, van Hoek et al 2007, van Hoek et al 2008a, Heiene et al 
2009, van Hoek et al 2009a, van Hoek et al 2009b, Miyagawa et al 2010a, Miyagawa et al 
2010b, Finch et al 2011, Finch et al 2013b). Unfortunately, iohexol assays and injectable 
creatinine are not commercially available. Also inulin and radioisotopes have been used as 
clearance markers but inulin assays are technically challenging and not widely available, 
while radioisotopes require specialized equipment and carry the risk of radiation exposure 
(DiBartola 2010, Von Hendy-Willson and Pressler 2011). Multi-sample techniques for GFR 
estimation are labor-intensive, time-consuming and may be stressful or painful for the patient, 
which limits their practical use in cats (Finch et al 2013b). However, GFR determination 
might be valuable for cats with doubtful renal function (e.g. unexplained weight loss or 
polyuria/polydipsia; CKD IRIS stage 1 patients; idiopathic hypertension; azotemia, poorly 
concentrated urine or pathologic renal proteinuria as a single laboratory abnormality). 
Determination of GFR is also recommended for dosage adjustment in companion animals 
receiving potentially toxic drugs that primarily undergo renal excretion (Lees 2004, Polzin 
2010). 
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In human medicine, GFR is usually estimated using equations based on serum 
creatinine concentration and demographic variables. Yet, these equations do not provide an 
accurate GFR estimate in certain patient groups, namely patients at extremes of ages and body 
size, patients with unusual diet, patients without CKD and patients with rapidly changing 
kidney function (de Jong and Gansevoort 2005, Stevens et al 2006, Stevens and Levey 2009, 
Salgado et al 2010). Trends in kidney function are often more important than the true GFR 
value, limiting the impact of these inaccuracies in the clinical setting. Nevertheless, the 
implications of this imprecision might be important in some clinical situations (e.g. GFR 
based dose adjustment for nephrotoxic drugs) and, particularly, in research trials (Munar and 
Singh 2007, Sandilands et al 2013). Measuring GFR using exogenous markers is 
recommended to assess kidney function in these patient groups (Stevens et al 2006, Stevens 
and Levey 2009, Salgado et al 2010).  
Because GFR determination is cumbersome, time-consuming and consequently 
expensive and potentially stressful or painful for the patient (de Jong and Gansevoort 2005, 
Finch et al 2013b), efforts have been taken to simplify GFR determination in humans by 
using the least number of possible blood samples, particularly in children (Schwartz and 
Work 2009). Limited sampling strategies (LSS) – i.e. clearance techniques based on a reduced 
number of blood samples – are a suitable compromise between practical convenience and 
clinical accuracy for GFR determination (Swinkels et al 2000). In comparison, several LSS 
have been described to estimate feline GFR. Unfortunately, in most veterinary studies 
reported to date, no or only few renal-impaired cats were evaluated and none of these methods 
is sufficiently validated in CKD cats to be used in practice (Barthez et al 2000, Barthez et al 
2001, Goy-Thollot et al 2006b, Vandermeulen et al 2008, Heiene et al 2009, Miyagawa et al 
2010a, Vandermeulen et al 2010, Finch et al 2011, Katayama et al 2012, Katayama et al 
2013). One group recently developed a single sample method for estimating feline GFR in 
both nonazotemic and azotemic cats (Finch et al 2013b), using a modification of the 
Jacobsson method that was originally developed for human patients (Jacobsson 1983). Yet, it 
is unknown whether the assumptions that are inherent to this Jacobsson method are applicable 
to cats as well. The limitations of current feline LSS underline the need for further research on 
simplified methods to estimate GFR in cats.  
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1.2.4.6 Renal biopsies 
Kidney histology of CKD cats often cannot reveal the underlying cause. However, 
some primary causes such as renal lymphoma, amyloidosis, and feline infectious peritonitis 
usually can be identified on renal biopsies, regardless of the disease stage (DiBartola et al 
1987). Renal biopsies should be considered when knowledge of morphologic alterations in 
renal structure will substantially influence patient management, for example in cats with renal 
lymphoma that could not be identified with fine-needle aspiration, amyloidosis or 
glomerulonephritis. However, this is not true for the majority of CKD cats that suffer from 
chronic generalized tubulointerstitial nephritis, glomerulosclerosis, tubular necrosis, or PKD 
nor for cats with significant azotemia or end-stage CKD regardless of the underlying cause 
(Lulich et al 1992, Polzin 2010). Maximal information will be obtained by evaluating kidney 
biopsies with light, electron and immunofluorescent microscopy, which is particularly 
recommended in patients with persistent severe proteinuria (UPC ≥ 2) without severe 
azotemia (IRIS stages 1 to early 3). Potential underlying diseases leading to proteinuria 
should be ruled out before taking kidney biopsies (Segev 2010, Vaden 2010).   
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1.3 STAGING 
 
Analogous to the situation in human medicine, a classification system to stage dogs 
and cats with CKD has been developed by the International Renal Interest Society and 
accepted by American and European Societies of Veterinary Nephrology and Urology (IRIS 
2009, Polzin 2010). Goals of staging are to standardize and simplify nomenclature, to 
facilitate treatment and monitoring by providing therapeutic recommendations adapted for 
each disease stage, and to facilitate estimating the prognosis of CKD patients (NKF 2002, 
IRIS 2009, Polzin 2010). 
In human medicine, five CKD stages were developed according to the level of GFR of 
the patient, mostly estimated using creatinine-based equations (NKF 2002). In veterinary 
medicine, the CKD stage is based on serum creatinine concentration, assessed on at least two 
occasions, and further substaging is based on proteinuria, assessed by UPC, and SBP (Fig 
1.11). Only stable patients can be staged (i.e. well-hydrated, normal eating/drinking behavior), 
preferably after 12-hour fasting with free access to water. Prerenal or postrenal azotemia 
needs to be corrected prior to staging to prevent allocating cats incorrectly to a higher disease 
stage and worsened prognosis (Boyd et al 2008, IRIS 2009). For proteinuria substaging, only 
persistent renal proteinuria is of importance. The SBP substaging system reflects the risk that 
end-organ injury arises in the eyes, brain, kidneys or heart. Efforts must be taken to minimize 
white-coat hypertension and SBP must be determined 2 to 3 times over several weeks (IRIS 
2009, Brown et al 2007, Polzin 2010, Polzin 2011). 
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Fig 1.11. Overview of the International Renal Interest Society (IRIS) staging for feline 
patients with chronic kidney disease (IRIS 2009, Polzin 2010, Polzin 2011). The serum 
creatinine concentration (sCreat) determines the IRIS stage. Further substaging is based on 
the degree of proteinuria, assessed by the urinary protein :creatinine ratio (UPC) and the 
systolic blood pressure (SBP). The SBP substaging system reflects the risk for target organ 
damage (TOD).  
* Persistence of elevation should be judged on multiple blood pressure measurements over 
a period of 2 months.  
** Persistence of elevation should be judged on multiple blood pressure measurements over 
a period of 1 to 2 weeks. 
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1.4 SCREENING FOR EARLY CHRONIC KIDNEY DISEASE 
 
1.4.1 Importance of early detection of chronic kidney disease 
 
Survival rates for CKD cats are significantly associated with azotemia and proteinuria 
and cats diagnosed early in the disease live longer than cats diagnosed with more severe 
azotemia (Syme et al 2006, Boyd et al 2008). Consequently, an even better prognosis can be 
expected for cats diagnosed in the non-azotemic disease stage (IRIS stage 1) because timely 
therapeutic intervention might prevent or delay disease progression and complications (Fig 
1.12) (Lees 2004, Grauer 2005). Similarly, in humans, many adverse events of CKD such as 
progressive deterioration of kidney function, complications of decreased kidney function, and 
cardiovascular disease can be prevented or delayed by early detection and treatment (Maschio 
et al 1996, NKF 2002, Remuzzi et al 2002, Levey et al 2003, Levin and Stevens 2011). 
Hence, screening is regarded to be an important public health tool for early detection of CKD 
in people. Screening is strongly recommended in patient groups at-risk for CKD such as 
patients diagnosed with hypertension or diabetes and close relatives of patients with 
nephropathy (Li et al 2005, Narva 2007). 
 
 
 
Fig 1.12. Hypothetic effects of altering the rate of disease progression at early (point A) or 
later (point B) time in the course of renal disease. Equally effective treatments to slow 
progression of renal dysfunction result in a longer prolongation of survival if early 
intervention (at point A) compared to later intervention (point B). (Based on Lees 2004) 
Chapter 1. General introduction 
36 
 
1.4.2 Screening for chronic kidney disease based on routine diagnostic tests 
 
Unfortunately, diagnosing early feline CKD is challenging. It is assumed that over 
two-thirds of functional renal mass must be lost before kidneys lose their urinary 
concentrating ability and over three-quarters must be lost before azotemia develops. Thus, 
serum creatinine and urea concentrations and USG are often within RIs in cats with early 
CKD, particularly because some cats may maintain their urinary concentrating ability (Braun 
and Lefebvre 2008, Stockham and Scott 2008a, DiBartola 2010). Practical, inexpensive and 
accurate methods to detect early feline CKD are urgently needed. Also, veterinarians should 
improve owner awareness for early signs of CKD because poor body condition, weight loss 
and polyuria/polydipsia are not always recognized by cat owners (Hughes et al 2002, Pittari et 
al 2009, Bartlett et al 2010). 
The minimum laboratory database for CKD screening consists of measuring serum 
creatinine, USG and proteinuria or eventually (micro)albuminuria (FAB 2008, Vogt et al 
2010). In comparison, a spot urine sample for protein and an estimate of GFR based on serum 
creatinine concentration are the recommended tests to screen human patients for CKD (NKF 
2002). Physical and laboratory parameters should be compared with values of previous health 
screenings to detect clinically relevant changes. Increasing serum creatinine concentrations, 
even within RI, may indicate early kidney dysfunction, particularly in cats with weight loss or 
muscle wasting or USG consistently below 1.035 (Lees 2004, Grauer 2005, Pittari et al 2009). 
However, many factors influence USG and daily USG fluctuations can be seen in healthy 
animals. Thus, low USG without other indications for CKD does not necessarily suggest 
kidney dysfunction (Lees 2004, Stockham and Scott 2008a). In healthy non-azotemic geriatric 
cats, plasma creatinine concentration combined with UPC were predictive of azotemia 
developing, indicating that high-normal creatinine concentrations and/or UPC values 
consistent with borderline or overt proteinuria might indicate early kidney dysfunction 
(Jepson et al 2009). 
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1.4.3 Advanced diagnostic tests for detection of early chronic kidney disease 
 
More advanced tests to evaluate kidney function might be considered in cats with 
doubtful routine blood and urine tests. As discussed above, GFR estimation would be ideal 
but has important practical limitations. Some of these limitations might be avoided by LSS, 
but further research is needed.  
Also, the value of serum Cystatin C (sCysC) as indirect GFR marker in cats is under 
investigation. Cystatin C, a low-molecular-weight protein produced at constant rate by all 
nucleated cells, meets criteria required for endogenous GFR markers (Dharnidharka et al 
2002). Serum CysC is superior to serum creatinine to detect renal dysfunction in humans 
(Dharnidharka et al 2002) and also has some advantages over serum creatinine in dogs 
(Wehner et al 2008). Cats with CKD have higher sCysC concentrations compared with 
healthy cats (Poświatowska-Kaszczyszyn 2012, Ghys et al In Press), but evidence showing 
advantages of sCysC over serum creatinine to detect early feline CKD is currently not 
available.  
Another pathway to identify kidney disease is by urinary biomarkers for tubular or 
glomerular damage (Price 2002, Cobrin et al 2013, De Loor et al 2013). Retinol-binding 
protein (RBP), N-acetyl-β-glucosaminidase activity (NAG), urinary Cystatin C (uCysC), 
transforming growth factor-β1, interleukin-8 and (micro)albuminuria (see above) are 
promising candidate urinary biomarkers for cats (Langston 2004, Arata et al 2005, Syme and 
Elliott 2005a, Mardell and Sparkes 2006, van Hoek et al 2008b, van Hoek et al 2009c, Jepson 
et al 2010, De Loor et al 2013, Habenicht et al 2013, Ghys et al In Press). Low-molecular-
weight proteins (NAG, uCysC, RBP) and tubular enzymes (NAG) are not present in the urine 
of healthy animals. Secondary to tubulointerstitial damage or inflammation, patients with 
CKD might have detectable urinary concentrations. Also, tubulointerstitial inflammation or 
fibrosis might result in overexpression and increased urinary concentrations of inflammatory 
cytokines (transforming growth factor-β1, interleukin-8) (Price 2002, De Loor et al 2013). In 
humans, careful selection of biomarkers allows detection of site specific changes (glomerular 
versus tubular) (Price 2002). Whether the latter is true in cats and whether these urinary 
biomarkers have benefit over routine parameters to detect early feline CKD is currently 
unknown.  
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1.4.4 Cat populations to consider screening for chronic kidney disease  
 
1.4.4.1 Healthy aged cats 
Because old cats are susceptible to many chronic diseases, routine health screening of 
aged cats is important for early detection of these conditions, such as CKD (FAB 2008, Vogt 
et al 2010). According to the senior and geriatric care guidelines developed by the American 
Association of Feline Practitioners, American Animal Hospital Association and Feline 
Advisory Bureau, ‘geriatric health care packages’ should consist of a thorough history 
(preferably by detailed owner questionnaire), physical examination (including oral cavity 
examination and thyroid palpation), BP measurement, ophthalmic examination and laboratory 
tests (FAB 2008, Pittari et al 2009, Vogt et al 2010). Unfortunately, the interpretation of 
results is difficult because scientific information regarding clinical and laboratory 
abnormalities in older animals is scarce. One study demonstrated significant but minor age 
effects on biochemistry values in a purebred cat population with wide age range (0.5 – 15.6 
years). These authors found mildly increasing values for urea, creatinine and total protein 
concentrations with increasing age (Reynolds et al 2010). Also, specific RIs to interpret 
laboratory parameters of senior or geriatric animals may be warranted (Gunn and Alleman 
2005). Several physiological changes can be expected with aging, resulting in age-related but 
clinically insignificant changes (Fig 1.13) (Dowling 2005). As the creatinine concentration 
depends on muscle mass and as muscle wasting is common in aged cats, this might be 
particularly true for serum creatinine. Finally, the age at which cats are defined as geriatric 
varies widely in scientific literature, from 8 years and older (Simpson et al 2009), to 14 years 
(Metzger 2005) or even 15 years and older (FAB 2008, Pittari et al 2009, Vogt et al 2010). As 
geriatric medicine is forming an increasing part of the case load of first opinion and referral 
practices (Caney 2009), improved scientific data on this age group would help veterinarians to 
manage and treat senior or geriatric cats.  
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1.4.4.2 Ragdoll cats 
Several Ragdoll breeder organizations such as the Scandinavian Ragdoll Club (SRC) 
and the Ragdoll Club Benelux (RCB) forewarn owners that renal problems may develop due 
to PKD, chronic interstitial nephritis (CIN), familial renal dysplasia or nephrocalcinosis (SRC 
2012, RCB 2013). Based on recommendations of these breed clubs, Ragdoll cats are screened 
for PKD and CIN prior to breeding in several European countries such as Belgium, the 
Netherlands, Sweden and Finland (SRC 2012, RCB 2013). Several tests are part of this 
screening program, including abdominal ultrasonography to identify renal and/or hepatic cysts 
and evidence of CIN, measurement of serum urea and creatinine concentrations, and genetic 
testing for the PKD-1 mutation.  
Polycystic kidney disease is an inherited condition that results in the formation of 
fluid-filled renal and, occasionally, hepatic cysts. This condition mainly affects Persian and 
Fig 1.13. A 20-year-old cat that was 
presented because of constipation. 
The cat was otherwise healthy and 
had normal blood (including serum 
total thyroxine) and urine 
examinations.  
Some age-related changes such as 
muscle atrophy and unkempt haircoat 
are visible on the pictures. 
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Persian-related cats and recent European studies report a prevalence between 31 and 42% for 
these breeds (Biller and DiBartola 1995, Barthez et al 2003, Bonazzi et al 2007, Domanjko-
Petrič et al 2008, Wills et al 2009). Because the Ragdoll is one of the breeds that have been 
outcrossed with Persians, Ragdoll cats could be at risk for PKD (Beck and Lavelle 2001). 
Affected cats are heterozygous for a stop mutation in the PKD-1 gene that is inherited in an 
autosomal dominant manner (Biller et al 1996, Lyons et al 2004, Helps et al 2007). In total, 
scientific literature describes PKD testing of 9 Ragdolls (Beck and Lavelle 2001, Lyons et al 
2004, Lee et al 2010): 4 were only evaluated by ultrasonography and 5 solely by genetic 
testing. One of the genetically tested Ragdolls had the mutant PKD-1 allele (Lyons et al 
2004), the others were PKD negative. This indicates that the PKD-1 mutation does occur in 
Ragdolls, but the PKD prevalence in this breed is unknown.  
Chronic interstitial nephritis is a nonspecific inflammatory condition that is classified 
among the tubulointerstitial renal diseases. It can be primary or secondary to glomerular or 
systemic diseases, but the underlying cause is often unclear. It results in fibrosis, tubular 
atrophy and loss of healthy renal tissue. The consequence is progressive renal disease and it is 
considered to be a common cause of azotemic CKD in cats (DiBartola et al 1987, Lulich et al 
1992, Minkus et al 1994, Maxie and Newman 2007). The definitive diagnosis of CIN can 
only be made on kidney biopsies, but renal histology often does not reveal the underlying 
cause of the nephritis (DiBartola et al 1987, Lulich et al 1992, Polzin 2010). 
Although screening of Ragdoll cats for PKD and CIN has been performed for many 
years, there is only minimal scientific evidence about the occurrence of kidney disease within 
this breed. In addition, the criteria that give rise to a diagnosis of PKD or CIN are not 
specified on the Ragdoll breeder websites. For these reasons, it is important to elucidate 
whether the concerns of the breed organizations are justified or not. If Ragdoll cats are indeed 
at risk for renal disease, adequate and regular monitoring of the renal function may allow 
early disease detection and intervention.   
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1.4.4.3 Cats with endocrine disease 
 Feline endocrine diseases such as hyperthyroidism and diabetes mellitus (DM) might 
affect kidney function. These endocrine diseases as well as CKD are common in older cats 
and they may exist concurrently (Mooney and Peterson 2004, Bloom and Rand 2013).  
An extensive linkage exists between thyroid and kidney function which becomes 
mainly important in cats if hyperthyroidism develops. The importance and difficulties to 
closely evaluate kidney function before, during (e.g. medical treatment) or after treatment 
(e.g. surgery, radioiodine treatment) have been extensively studied in veterinary medicine and 
summarized by van Hoek and Daminet (2009) and Daminet et al (2014). 
In contrast, whether or not feline DM causes renal lesions or dysfunction has not yet 
been studied in detail.  
Diabetic kidney disease (DKD) or diabetic nephropathy is a very common and serious 
complication in human diabetics, particularly in type 2 DM. Diabetic nephropathy in humans 
is characterized by glomerular alterations, resulting in altered GFR and micro- or 
macroalbuminuria, tubular damage and hypertension (Reutens 2013, Ritz 2013, van Buren 
and Toto 2013).  
As feline diabetic patients mostly suffer from type 2 DM, cats might be susceptible to 
develop DKD (Bloom and Rand 2013, Rand 2013) and regular screening of diabetic cats for 
kidney disease might be required. However, scientific evidence whether or not feline diabetics 
are at risk for kidney disease is currently scarce and insufficient to recommend more intensive 
monitoring of renal function in diabetic cats compared with non-diabetic cats of the same age. 
Also, CKD and DM may be concurrently present in cats as both CKD and DM are frequent 
diseases in cats with growing prevalence (Reynolds and Lefebvre 2013, Osto et al 2013). 
Concurrent CKD is reported in 13 to 31% of diabetic cats (Bloom and Rand 2013). For those 
cats with concurrent DM and CKD, the question whether DM (partially) causes CKD or 
whether both diseases are unrelated cannot be answered yet. 
 An additional problem is that the hyperglycemic state of cats with DM may hamper 
the diagnosis of CKD. Weight loss, polyuria, polydipsia and lethargy – common signs of 
feline CKD – are also frequent in cats with poorly controlled DM (Feldman and Nelson 
2004). Additionally, osmotic diuresis due to hyperglycemia that exceeds the renal threshold 
and leads to glucosuria might influence the interpretation of routine tests to evaluate kidney 
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function. The glucosuria itself may falsely elevate USG and an increase of 0.004 – 0.005 for 
every 1 g/dL of glucose in urine is reported (Stockham and Scott 2008a). On the other hand, 
osmotic diuresis results in unconcentrated urine (USG < 1.035) and, if severe, may also lead 
to mild dehydration and mild prerenal azotemia (Feldman and Nelson 2004). So, diagnosing 
early CKD in a poorly controlled diabetic cat is challenging. 
 
1.4.4.4 Other cat populations to consider screening for chronic kidney disease 
 Next to the cat groups mentioned above, screening for CKD is also recommended in 
cats with diseases that might lead to CKD such as infectious diseases (e.g. pyelonephritis, 
FIV, FeLV), metabolic conditions (e.g. hypercalcemia, hypokalemia), renal neoplasia (e.g. 
lymphoma, carcinoma), urolithiasis (e.g. ureterolithiasis, nephrolithiasis), conditions that may 
be associated with renal ischemia (e.g. dehydration, cardiovascular disease) and diseases that 
may be associated with glomerulopathy (e.g. feline infectious peritonitis, pancreatitis, 
cholangiohepatitis, neoplasia). Further, screening for CKD must also be considered in cats 
that need treatment with potentially nephrotoxic agents (e.g. non steroidal anti-inflammatory 
drugs, doxorubicine). Also, cats that have been treated for acute kidney injury must be 
monitored carefully for persistent CKD (Polzin 2010, Vaden 2010). Finally, pre-breeding 
screening is advised for other breeds predisposed for PKD, namely Persian and related breeds, 
and might be warranted for other familial renal diseases such as amyloidosis in Abyssinian, 
Siamese and Oriental shorthair cats (Biller and DiBartola 1995).   
Chapter 1. General introduction 
 
43 
 
1.5 CONCLUSION 
 
 Feline CKD is typically diagnosed based upon compatible clinical signs, azotemia and 
poorly concentrated urine (USG ≤ 1.035). The diagnosis of advanced feline CKD and 
associated complications is usually straightforward based on complete blood and urine 
examinations. Medical imaging may identify specific underlying causes for CKD.  
To facilitate communication, treatment, monitoring and prognosis estimation, all CKD 
patients must be classified according to the IRIS system, using creatinine for staging and 
proteinuria and SBP for substaging.  
In contrast, early or non-azotemic CKD is more challenging to diagnose. Because 
early CKD diagnosis might improve the prognosis, screening of at-risk populations is 
recommended. A scientific basis for geriatric screening of cats in daily practice is required 
and studies evaluating whether Ragdoll cats and diabetic cats should be routinely screened for 
kidney disease are needed. Additionally, research regarding feline CKD should focus on 
development of simple, inexpensive and accurate methods for early disease diagnosis. 
Possible future techniques are LSS to estimate GFR, methods to identify cats with low GFR, 
new indirect GFR markers and urinary biomarkers.  
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Chronic kidney disease (CKD) is a common condition in companion animals, 
particularly in cats. Advanced feline CKD is usually straightforward to diagnose based on 
compatible clinical signs and renal azotemia. Since feline CKD is a progressive disease, the 
main therapeutic goal is slowing down further decline in kidney function and postponing 
disease complications (Polzin 2010).  
As the median survival time shortens with more severe azotemia and proteinuria 
(Syme et al 2006, Boyd et al 2008), a better prognosis is expected for cats diagnosed in early 
disease stages (e.g. non-azotemic or International Renal Interest Society (IRIS) stage 1 CKD) 
(Lees 2004, Grauer 2005). Unfortunately, confirming early CKD is challenging, because 
azotemia and impaired urine concentrating ability may be absent (Braun and Lefebvre 2008, 
Stockham and Scott 2008, DiBartola 2010). Therefore, screening of high-risk patients for 
CKD is highly recommended (FAB 2008, Vogt et al 2010, Taylor and Sparkes 2013). 
Although such screening nowadays is common practice in geriatric cats and – in some 
countries – in Ragdoll cats, the scientific basis for screening for early CKD is limited.  
Therefore, the final goal of this thesis was to evaluate the results and limitations of 
currently performed screening practices for feline CKD and to develop possible solutions to 
improve early CKD detection. 
 
Specific objectives of this thesis were:  
1. To evaluate results and limitations of routinely used tests for health screening – 
including screening for early feline CKD – in apparently healthy middle-aged and old 
cats 
 
2. To evaluate results and limitations of routinely used tests to screen Ragdoll cats for 
CKD prior to breeding 
 
3. To evaluate if cats with diabetes mellitus are susceptible for diabetic kidney disease 
and whether routine monitoring of diabetic cats for CKD is required 
 
4. To develop simple and cost-effective methods to estimate glomerular filtration rate 
(GFR) in cats and to identify cats with low or borderline GFR 
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Summary 
 
Veterinary practitioners often perform geriatric health screening in cats. 
Unfortunately, scientific information regarding clinical and laboratory abnormalities and 
normal blood pressure (BP) values in elderly cats is scarce.  
This prospective study evaluated routine health screening tests in apparently healthy 
middle-aged and old cats. One hundred cats of 6 years and older underwent BP measurement; 
physical, blood and urine examinations; indirect fundoscopy; and bilateral Schirmer tear tests 
(STT).  
The mean systolic blood pressure (SBP) was 133.6 ± 21.5 mmHg. Increased SBP (> 
160 mmHg) was observed in eight, submandibular lymphadenopathy in 32, gingivitis in 72, 
heart murmur in 11, thyroid goiter in 20, increased creatinine in 29, hyperglycemia in 25, 
increased total thyroxine in three, feline immunodeficiency virus (FIV) seropositivity in 14, 
crystalluria in 41, borderline proteinuria in 25 and overt proteinuria in two cats. The mean tear 
production was very similar for both eyes and none of the cats had ocular lesions secondary to 
hypertension. 
Old cats (> 10 years) had a significantly higher SBP, heart rate, murmur frequency, 
thrombocyte count, urinary protein: creatinine ratio (UPC) and serum urea and bilirubin 
concentrations in addition with significantly lower body condition score (BCS), hematocrit 
and albumin and total calcium concentrations than middle-age cats (6 – 10 years).  
In conclusion, physical examination as well as laboratory abnormalities are common 
in apparently healthy old cats underlining the need for regular health checks and development 
of age dependent laboratory reference intervals (RIs).  
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Introduction 
 
In the last few decades, the expected lifespan of pet cats in Europe and the United 
States has increased and the population of senior and geriatric cats has grown concurrently 
(Gunn-Moore 2006). Old cats are susceptible to many chronic diseases and senior care 
guidelines have been developed to improve early disease detection and promote longevity and 
quality of life. These “geriatric health care packages” should consist of a thorough history – 
preferably by detailed owner questionnaire –, physical examination – including oral cavity 
examination and thyroid palpation –, BP measurement, ophthalmic examination and 
laboratory tests (Epstein et al 2005, FAB 2008, Pittari et al 2009). Unfortunately, the 
interpretation of these results is difficult because scientific information regarding clinical and 
laboratory abnormalities in older animals is scarce. With aging, several physiologic changes 
can be expected, resulting in age-related but clinically insignificant changes (Dowling 2005). 
Therefore, specific RIs for senior or geriatric animals may be warranted (Gunn and Alleman 
2005). Although routine BP screening in middle-aged to old cats is advised (Stepien 2011), 
normal BP values in elderly cats have not been reported. Several studies evaluated indirect BP 
measurements in healthy adult cats (Bodey and Sansom 1998, Sparkes et al 1999, Sansom et 
al 2004, Lin et al 2006). However, only small numbers of old cats were included and these 
studies yielded conflicting results regarding the association between age and SBP. The STT to 
evaluate tear production can also be part of the minimum database for senior pets (Epstein et 
al 2005). STT-results are poorly documented in older cats. Several reports described STT-
results in healthy cats, but mostly included young or middle-aged cats (Margadant et al 2003, 
Cullen et al 2005, Ghaffari et al 2010). In normal dogs tear production decreases with age 
(Hartley et al 2006), but a similar age effect has not been examined in cats. 
Also, the age at which cats are defined as geriatric varies widely, from 8 years and 
older (Simpson et al 2009), to 14 years (Metzger 2005) or even 15 years (FAB 2008, Pittari et 
al 2009, Vogt et al 2010) and older. In general, it is accepted that a geriatric animal is one that 
has reached 75% of its expected life span, which obviously depends on species and breed 
(Carpenter 2005).  
All these questions make interpretation of clinical and laboratory parameters of 
healthy and diseased old cats complex. Because geriatric medicine is forming an increasing 
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part of the case load of first opinion and referral practices (Caney 2009), improved scientific 
data on this age group would help veterinarians to manage and treat senior or geriatric cats.  
 
 Therefore, this study aimed to evaluate the presence of abnormal findings on SBP 
measurement, physical examination, ophthalmic examination and routine blood and urine 
examinations prospectively in middle-aged and old cats that were apparently healthy 
according to their owners. 
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Materials and methods 
 
Study population 
 One hundred healthy cats of 6 years and older were included. To evaluate an age 
effect, the cats were allocated to two groups, namely group 1 (middle-aged cats) between 6 
and 10 years and group 2 (old cats) older than 10 years. We aimed to include an equal number 
of cats in both groups. All cats were fasted for 12 hours, water was offered ad libitum. 
 Health was defined as ‘being healthy for the owner’, namely no changes in general 
behavior or habits, normal eating and drinking behavior, stable body weight and absence of 
clinical signs. Cats needed to be free of medication (except preventive medication) for at least 
two months before inclusion. Preventive medication was allowed except during the week 
before inclusion. To check the health status, owners completed a questionnaire with questions 
related to their cat’s health, living environment, daily activity, feeding practices, vaccination 
status, parasite control and disease history.  
 The study was completed at the Department of Medicine and Clinical Biology of 
Small Animals, Ghent University between May and October 2010. All cats were privately 
owned, the owners signed an informed consent and the study was approved by the local and 
national ethical committees (EC2010/27). 
 
Procedures 
 All procedures were performed in the same order by the same author (GV) without 
using sedation or anesthesia.  
 First, SBP was measured using the Doppler ultrasonic technique and standardized 
procedure following the consensus statement of the American College of Veterinary Internal 
Medicine (ACVIM) (Brown et al 2007). Hypertension was defined as SBP > 160 mmHg and 
hypotension as SBP < 80 mmHg (Brown et al 2007, Stepien 2010, Waddell 2010). 
A standard physical examination was performed to evaluate the general demeanor, 
BCS on a 9-point scale (Laflamme 1997), rectal temperature, color and capillary refill time of 
the mucous membranes, visual oral inspection, peripheral lymph node palpation, respiratory 
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rate, heart rate, cardiac and pulmonary auscultation (Fig 3.1), abdominal palpation and thyroid 
gland palpation. The thyroid glands were palpated as previously described (Fig 3.2; Paepe et 
al 2008, Boretti et al 2009), using the classic technique (Feldman and Nelson 2004)
 
and semi-
quantitative scoring system initially proposed by Norsworthy et al (2002). 
 
 
 
 
 
 
Fig 3.1. Auscultation of the right 
ventral thorax in a cat. Standing 
behind the cat to restrain the cat 
gently in a comfortable position 
allows auscultation in almost all 
cats. 
Fig 3.2. Thyroid gland palpation 
in a cat using the classic thyroid 
palpation technique. The cat is 
restrained in sitting position. The 
neck of the cat is extended and the 
clinicians’ thumb and forefinger 
are placed on each side of the 
trachea and swept downwards 
from the larynx to the sternal 
manubrium. 
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All cats underwent an ophthalmic examination. The tear production was evaluated by 
placing a STT test-strip in the ventral conjunctival sac for 60 seconds and was recorded in 
mm/minute for both eyes (Fig 3.3). Afterwards, indirect fundoscopy was performed, paying 
special attention for signs secondary to systemic hypertension, such as retinal edema, vascular 
tortuosity, hemorrhage or detachment and papilledema.  
 
 
 
 
 
Five mL of blood was taken from the jugular vein (Fig 3.4) and 10 mL of urine was 
collected by cystocentesis. To obtain serum, the coagulated tubes were centrifuged within 30 
minutes at 2431 x g. All samples were preserved at 4°C and analyzed on the day of 
collection
a
.  
A complete blood count
b
 and serum biochemistry profile
c
 were performed and the 
total thyroxine (TT4) concentration was measured using a previously validated immunoassay
d
 
(Singh et al 1997). All cats were screened for infection with FIV and feline leukemia virus 
(FeLV) using an in-house enzyme-linked immunosorbent assay (ELISA) test
e
. 
 
Fig 3.3. One of the study cats just after the placement of the Schirmer tear test strip in 
ventral conjunctival sac of the left eye (a) and 60 seconds after placement of the Schirmer 
tear test strip (b). The tear production for the left eye is 9 mm/minute. 
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Urinalysis consisted of a urinary dipstick test; measurement of urine specific gravity 
(USG) with a manual refractometer, urinary pH and UPC
f
; sediment examination and urine 
bacterial culture
g
. The sediment was prepared by centrifugation of 5 mL of urine in a conical-
tipped tube for 3 minutes at 447 x g and decanting the supernatant to leave an equal amount of 
sediment and urine. This sediment was resuspended by flicking the tube several times and one 
unstained drop was placed on a clean glass slide and covered with a coverslip (Meyer 2001). 
The sediment (cells, casts, crystals) was evaluated under the microscope within 30 minutes of 
collection. Crystalluria was evaluated semi-quantitatively and expressed per low-power field 
(LPF, 10x objective) as mild (< 1/LPF), moderate (1 – 3/LPF), or severe (> 3/LPF).  
 
Statistical methods 
All statistical analyses were performed with the statistical software package SAS
h
. 
Different response variables were compared between two groups (FIV+ versus FIV-, middle-
aged versus old cats, normal versus abnormal UPC). The response variables that were 
normally distributed were analyzed by the t-test. For binary response variables, such as UPC 
(normal = UPC < 0.2 and abnormal = UPC ≥ 0.2), Fisher’s exact test was used. For discrete 
response variables with more than two outcomes, such as BCS ((underweight (BCS < 5), ideal 
(BCS = 5) and overweight (BCS > 5)), the Wilcoxon rank sum test was used. The Pearson’s 
correlation coefficient was used to evaluate the correlation between continuous variables. The 
significance level was set at 0.05.   
Fig 3.4. Blood sampling from the jugular vein 
of a cat. By keeping the neck and front legs 
extended, the jugular vein becomes visible or 
easily palpable in most cats. 
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Results 
 
Study population 
One hundred cats, 56 middle-aged and 44 old cats, were included. The population 
consisted of 44 males (five intact, 39 neutered) and 56 females (seven intact, 49 neutered). 
Most (n = 93) were domestic short- or long-haired cats, seven were pure breed cats (two 
British shorthairs, two Ragdolls, one Norwegian Forest cat, one Maine coon, one Persian cat). 
The majority of cats had both in- and outdoor access (n = 61), some were strictly indoor (n = 
19) or strictly outdoor (n = 20) cats. The age and body weight of the complete population and 
age groups are presented in Table 3.1.  
 
Blood pressure measurement, physical and ophthalmic examination 
The descriptive statistics for the SBP measurements and physical examination findings 
for the total population and age groups are summarized in Table 3.1. 
 
Eight cats had a mean SBP exceeding 160 mmHg. One of these cats had tachypnea, 
which was thought to be stress-related, one had mild leukocytosis, but none of these cats had 
hyperglycemia or glucosuria. No significant correlation between SBP and parameters that 
could be influenced by stress, namely respiratory rate (r = -0.144), heart rate (r = -0.118), 
serum glucose concentration (r = -0.127) and total leukocyte count (r = -0.033) was found. 
SBP ranged from 160 to 170 mmHg in four cats (two middle-aged, two old cats) and one of 
these was borderline proteinuric and had a serum creatinine concentration at the upper limit of 
the RI but with hypersthenuric urine. SBP exceeded 180 mmHg (with a maximum of 237 
mmHg) in the other four cats (one middle- aged, three old cats). The middle-aged cat had a 
grade 3/6 systolic heart murmur and the three old cats were borderline proteinuric (one with 
USG 1.051 and normal serum creatinine; one with USG 1.020 and normal serum creatinine; 
one with USG 1.027 and mildly increased serum creatinine). In the other hypertensive cats 
target organ abnormalities or an underlying cause for the hypertension were not found based 
on the diagnostic tests carried out in this study.  
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Table 3.1. Descriptive statistics for all included cats and for the two age groups. All 
parameters are expressed as mean ± standard deviation.  
 Global 
population 
(n = 100) 
Group 1 
(n = 56) 
Group 2 
(n = 44) 
Unit 
Age  9.9  ± 2.7 7.9 ± 1.4 12.5  ± 1.5 years 
Body weight 4.6  ± 1.2 4.7 ± 1.2 4.4  ± 1.2 kg  
SBP 133.6 ± 21.5 128.3 ± 16.7 140.4  ± 25.0 mmHg 
Heart rate 191.4 ± 17.4 187.6 ± 18.4 196.2  ± 14.8 bpm 
Respiratory rate 49.6 ± 16.2 48.0  ± 15.9 51.6  ± 16.6 /min 
Body temperature 38.2 ± 0.5 38.3 ± 0.5 38.1  ± 0.5 °C 
STT left eye 13.4 ± 5.5 12.8 ± 5.1 14.2  ± 6.0 mm/min 
STT right eye 14.0 ± 5.7 14.1 ± 5.7 14.0 ± 5.9 mm/min 
Hematocrit 36.8 ± 4.6 37.9 ± 4.7 35.5 ± 4.2 % 
Leukocytes 9,828 ± 4,575 9,162 ± 4,048 10,677  ± 5,091 /µL 
Thrombocytes 293,140 ± 144,685 266,179 ± 120,856 327,455 ± 165,416 /µL 
Sodium 152.9 ± 1.9 153.0 ± 1.8 152.8  ± 2.0 mmol/L 
Potassium 4.4 ± 0.5 4.4 ± 0.4 4.5 ± 0.5 mmol/L 
Total calcium 2.4 ± 0.1 2.4 ± 0.1 2.4  ± 0.1 mmol/L 
Phosphate 1.4 ± 0.3 1.4 ± 0.2 1.5 ± 0.3 mmol/L 
Urea 9.2 ± 2.4 9.1 ± 1.7 10.0 ± 2.9 mmol/L 
Creatinine 122.7 ± 30.8 126.0 ± 26.0 118.5 ± 35.9 µmol/L 
Total protein 73.7 ± 6.1 73.2 ± 5.8 74.4  ± 6.4 g/L 
Albumin 37.5 ± 3.5 38.4 ± 3.3 36.3  ± 3.4 g/L 
Glucose 5.4 ± 2.1 5.4 ± 2.1 5.4 ± 2.2 mmol/L 
ALT 40.2 ± 33.9 36.0 ± 14.6 45.5 ± 48.2 U/L 
AST 19.7 ± 10.5 18.3 ± 8.3 21.4 ± 12.7 U/L 
Total thyroxine 29.1 ± 18.4 28.0 ± 8.0 30.6 ± 27.3 nmol/L 
Urinary pH 6.7 ± 0.6 6.8 ± 0.6 6.6 ± 0.4  
USG 1.046 ± 0.010 1.047 ± 0.010 1.044 ± 0.012  
UPC 0.18 ± 0.11 0.13 ± 0.05 0.21 ± 0.15  
(Group 1 = Middle-aged cats (6 to 10 years); Group 2 = Old cats (older than 10 years); n = 
Number of cats; SBP = Systolic blood pressure; bpm = Beats per minute; STT = Schirmer 
tear test; ALT = Alanine aminotransferase activity; AST = Aspartate aminotransferase 
activity; USG = Urine specific gravity; UPC = Urinary protein: creatinine ratio) 
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Forty-nine cats had an ideal BCS, 11 cats (two middle-aged, nine old cats) were too 
thin (BCS < 5) and 40 cats (24 middle-aged, 16 old cats) too heavy (BCS > 5). Most cats (n = 
96) had a body temperature between 37.5 and 39.3°C. Four old cats had a body temperature 
below 37.5°C (minimum 37°C). The mucous membranes were moist and pink with normal 
capillary refill time in all cats. Mild local lymphadenopathy was detected in 34 cats: 32/34 
had submandibular and 2/34 popliteal lymphadenopathy. Thirty cats with submandibular 
lymphadenopathy had gingivitis. In total, 72 out of 100 cats had gingivitis. Pathological 
tachycardia (heart rate > 240 beats per minute (bpm)) or bradycardia (heart rate < 140 bpm) 
was not observed, but 11 cats had stress-related tachypnea. One cat even exhibited open-
mouth breathing initially, but calmed down after a prolonged acclimatization period, allowing 
further examinations. Auscultation revealed a cardiac murmur in 11 cats (two middle-aged, 
nine old cats), all systolic and with following murmur intensity: grade 1/6 (n = 3), 2/6 (n = 4), 
3/6 (n = 2), 4/6 (n = 2). These eleven cats were normotensive, normothermic and had a normal 
hematocrit, but one was hyperthyroid. Cardiac arrhythmias or gallop sounds were not heard. 
Lung auscultation was normal in 98 cats; two cats had a diffuse mild increase in lung sounds. 
Abdominal palpation did not reveal significant abnormalities in any of the cats. The majority 
(n = 92) had a soft abdomen, the others had a tensed but not painful abdomen. A thyroid 
goiter (score > 0) was palpated in 20 cats with a maximum score of 3: score 1 in 13/20, score 
2 in 4/20, score 3 in 3/20. 
 
The mean tear production was 14.0 ± 5.7 mm/min for the right eye and 13.5 ± 5.7 
mm/min for the left eye. A STT result < 5 mm/minute was found in both eyes of one cat and 
in the left eye of another cat. One cat showed mild corneal edema and one had papillary 
membrane remnants in both eyes. Fundoscopic abnormalities secondary to systemic 
hypertension were not found in any of the cats.  
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Laboratory parameters 
The descriptive statistics for the laboratory parameters are presented in Table 3.1 and 
the number of animals having laboratory parameters within, below or above the RI in Table 
3.2. The distribution of the serum phosphorus concentration of the cats across different 
categories based on the ‘2006 Phosphate Roundtable Guidelines’ (Elliott 2007) is shown in 
Table 3.3. 
 
Table 3.2. Distribution of the 100 included cats below, within and above the reference 
interval for certain laboratory parameters.  
Parameter 
Reference 
interval 
Below RI Within RI Above RI 
n Min n n Max 
Hematocrit (%) 24 – 45 1 20.5 95 4 51.8 
Leukocytes (/µL) 5,000 – 15,000 5 3,950 82 13 26,990 
Platelets (/µL) 175,000 – 500,000 26 22,000 67 8 909,000 
Urea (mmol/L) 6.2 – 11.0 1 6.0 84 15 25.6 
Creatinine (µmol/L) 44.2 – 132.6 0 / 71 29 280.2 
Total protein (g/L) 53 – 76 1 51 69 30 94 
Albumin (g/L) 25 – 4 0 / 98 2 45.8 
Glucose (mmol/L) 3.1 – 5.6 0 / 75 25 18.6 
Sodium (mmol/L) 146 – 154 0 / 80 20 159 
Potassium (mmol/L) 3.6 – 5.3 1 3.3 96 3 6.3 
Total calcium (mmol/L) 2.2 – 2.7 2 2.1 97 1 2.7 
Phosphorus (mmol/L) 1.4 – 3.0 40 0.87 60 0 / 
TT4 (nmol/L) 14.2 – 45.2 4 6.5 93 3 > 193.5 
ALT (U/L) < 70 0 / 94 6 333 
AST (U/L) < 42 0 / 98 2 88 
GGT (U/L) < 4 0 / 100 0 / 
Bilirubin (µmol/L) < 6.8 0 / 99 1 14.1 
(RI = Reference interval; n = Number of cats; Min = Minimum value observed for this 
laboratory parameter; Max = Maximum value observed for this laboratory parameter; 
TT4 = Total thyroxine concentration; ALT = Alanine aminotransferase activity; AST = 
Aspartate aminotransferase activity; GGT = γ-glutamyl transpeptidase activity)  
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Table 3.3. Distribution of the complete population and age groups for the serum phosphorus 
concentration across four different categories. These categories were defined based on the 
2006 Phosphate Roundtable Guidelines for dogs and cats with chronic kidney disease (Elliott 
2007). 
 Global population 
(n = 100) 
Group 1 
(n = 56) 
Group 2 
(n = 44) 
Phosphorus 0.81 – 1.45 mmol/L 56 33 (58.9%) 23  (52.3%) 
Phosphorus 1.45 – 1.61 mmol/L 24 14  (25%) 10  (22.7%) 
Phosphorus 1.61 – 1.94 mmol/L 18 9  (16.1%) 9  (20.5%) 
Phosphorus > 1.94 mmol/L 2 0  (0%) 2  (4.5%) 
(Group 1 = Middle-aged cats (6 to 10 years); Group 2 = Old cats (older than 10 years); n 
= Number of cats) 
 
The differential leukocyte count of all five leukopenic cats revealed a decrease in 
mature neutrophils only. Of the 13 cats with a leukocytosis, none had a left shift or a total 
leukocyte count exceeding the expected value for cats with steroid leukograms (< 30,000/µl) 
(Stockham and Scott 2008). The majority of cats with thrombocytopenia (18/26) showed 
platelet aggregates on their blood smear, suggesting pseudothrombocytopenia. Of the 29 cats 
with serum creatinine concentration above the RI, two had isosthenuric urine and six a USG 
between 1.015 – 1.035, six were borderline proteinuric (UPC 0.2 – 0.4), two were 
hypertensive, seven had an increased serum urea concentration and one a decreased TT4 
concentration. The others had a USG above 1.035, were nonproteinuric (UPC < 0.2) and 
normotensive and had serum urea and TT4 concentrations within RI. Both cats with 
isosthenuric urine were old cats (9 and 13 years) and nonproteinuric. They were diagnosed 
with chronic kidney disease (CKD) IRIS stage 2 and stage 3, respectively. Serum glucose 
exceeded 10 mmol/L in 3/25 cats with hyperglycemia. Two of these and one other cat 
(glucose 9.6 mmol/L) also had glucosuria. The increase in alanine aminotransferase activity 
(ALT) was mild (< 1.5 times the upper limit of the RI) in 5/6 cats, but serious in one cat 
(almost five times the upper limit of the RI). This cat (13 years old) was hyperthyroid and also 
the only cat with a significant elevation of aspartate aminotransferase activity (AST; twice the 
upper limit of the RI). The bilirubin concentration was increased in only one cat (11 years). 
This cat also had a very mildly increased ALT without increase of other liver enzymes and a 
decreased hematocrit. Of the three cats with an increased TT4 concentration, the TT4 was 
seriously elevated in one old and just above the upper limit of the RI in two middle-aged cats 
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(6 and 9 years). The hyperthyroid cat and one out of 2 cats with a mildly increased TT4 had a 
palpable thyroid gland (score 1).  
Fourteen cats were FIV seropositive (eight middle-aged, six old cats), no cats tested 
positive for FeLV antigen. Three FIV infected cats were hypertensive and, additionally, all 
FIV seropositive cats had a significantly higher SBP (mean 145.9 ± 29.8 mmHg) than FIV 
seronegative cats (mean 131.6 ± 19.4 mmHg; P = 0.02). Three of five cats with leukopenia 
were FIV seropositive and FIV seropositive cats had significantly lower total leukocyte 
counts (mean 6,899 ± 2,068 cells/µL) than FIV seronegative cats (mean 10,305 ± 4,699 
cells/µL; P = 0.009). 
 
Urinalysis was performed in all cats except one, which had an empty bladder. Fifteen 
cats had a USG below 1.035, with isosthenuria detected in three of them (one middle-aged, 
two old cats). More detailed information regarding USG is given in Table 3.4. Urinary pH 
ranged from 5.1 to 7.5 in 91/99 cats. The remaining eight had a pH > 7.5 (maximum 9) with a 
positive urine culture in one of these. The distribution of cats in proteinuria categories 
according to the ACVIM consensus statement (Lees et al 2005) is shown in Table 3.5. Of the 
27 cats with an abnormal UPC (UPC > 0.2) none had overt renal failure, isosthenuria or 
macroscopic hematuria; four were hypertensive; five had USG below 1.035; six an increased 
serum creatinine concentration; and the amount of urinary crystals did not differ significantly 
from cats with UPC < 0.2. Of the 25 cats with borderline proteinuria, three had microscopic 
hematuria and one a positive urine culture. Both cats with UPC > 0.4 had normal SBP and 
normal serum urea and creatinine concentrations. One had microscopic hematuria and the 
other was hyperthyroid. Casts were not detected on urinary sediment analysis. Crystalluria 
was present in 41/99 cats and was mild in 28/41, moderate in 8/41 and severe in 5/41 cats. 
Amorphous crystals were mostly (33/41) detected, struvite crystals in 5/41 and calcium 
oxalate crystals in 3/41 cats. For cats with crystalluria, 17/41 cats mainly received dry food, 
1/41 mainly canned food, 15/41 a combination of dry and canned food and for 8/41 the 
owners did not specify the diet type. For cats without crystalluria, 20/58 mainly received dry 
food, 2/58 mainly canned food, 20/58 a combination of dry and canned food, 2/58 a 
combination of dry and table food and for 12/58 the owner did not specify the diet type. The 
distribution of the diet type did not significantly differ between cats with and without 
crystalluria and between cats with different types of urinary crystals. On urinary dipstick 
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examination a trace of ketonuria, glucose positivity and a trace of urobilinogen was each 
present in 3/99 cats, 28/99 cats were hemoglobin positive, 98/99 cats were leukocyte-esterase 
positive, and no cats were bilirubin or nitrites positive. Only one cat had a positive urine 
bacterial culture with an Enterococcus species. This was a 9-year-old, intact female, mixed-
breed cat that had serum glucose, TT4, urea and creatinine concentrations within the RIs. It 
had alkaline urine, mild pyuria, and moderately concentrated urine (USG 1.020). 
 
 
Table 3.4. Distribution of the complete population and age groups for the urine specific 
gravity (USG) across three categories: USG below 1.035, USG 1.035 – 1.040 and USG above 
1.040.  
 Global population 
(n = 99) 
Group 1 
(n = 56) 
Group 2 
(n = 43) 
USG < 1.035 15 6 (10.7%) 9 (20.9%) 
USG 1.035 – 1.040 8 7 (12.5%) 1 (2.3%) 
USG > 1.040 76 43 (76.8%) 33 (76.7%) 
(Group 1 = Middle-aged cats (6 to 10 years); Group 2 = Old cats (older 
than 10 years); n = Number of cats; USG = Urine specific gravity) 
 
 
 
Table 3.5. Distribution of the complete population and age groups across the three proteinuria 
categories according to the ACVIM consensus statement (Lees et al 2005). 
 Global population 
(n = 99) 
Group 1 
(n = 56) 
Group 2 
(n = 43) 
UPC < 0.2 72 50  (89.3%) 22 (51.2%) 
UPC 0.2 – 0.4 25 6  (10.7%) 19 (44.2%) 
UPC > 0.4 2 0  (0%) 2 (4.7%) 
(Group 1 = Middle-aged cats (6 to 10 years); Group 2 = Old cats 
(older than 10 years); n = Number of cats; UPC = Urine protein: 
creatinine ratio; UPC < 0.2 = No proteinuria; UPC 0.2 – 0.4 = 
Borderline proteinuria; UPC > 0.4 = Proteinuria) 
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Age group comparison 
Old cats had a significantly higher SBP (P = 0.0049), heart rate (P = 0.014), murmur 
frequency (P = 0.026), platelet count (P = 0.035), urea concentration (P = 0.042), bilirubin 
concentration (P = 0.025) and UPC (P < 0.001) and a significantly lower BCS (P = 0.031), 
hematocrit (P = 0.009), albumin concentration (P = 0.002) and calcium concentration (P = 
0.049) than middle-aged cats. The other parameters did not differ significantly between the 
two age groups.  
 
Underweight cats 
 Of the 11 underweight cats, one was diagnosed with CKD IRIS stage 3, one with 
hyperthyroidism, and one was FIV seropositive. The serum creatinine, urea, TT4 
concentrations and UPC did not significantly differ between the three BCS categories 
(underweight, ideal and overweight). However, underweight cats had significantly lower USG 
(mean 1.038 ± 0.016) compared to cats with an ideal BCS (mean 1.045 ± 0.011; P = 0.037) 
and to overweight cats (mean 1.048 ± 0.008; P = 0.007).  
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Discussion 
 
This study is the first to describe health screening results of an apparently healthy cat 
population. The study population was balanced for sex and age and the breed distribution 
reflected the general cat population in Belgium. Domestic short- or longhair cats were the 
predominant breed also in other clinical studies performed in Belgium (Defauw et al 2011).  
 
The mean SBP of our population was 133.6 ± 21.5 mmHg which is very similar to two 
recent reports (mean SBP 133.6 ± 16 mmHg and 131.1 ± 17.8 mmHg). These studies also 
evaluated healthy conscious client-owned cats with the indirect Doppler technique, but 
contained cats with a wider age distribution (Lin et al 2006, Paige et al 2009). Eight cats had 
a mean SBP that exceeded the cut-off value above which further diagnostics are advised (160 
mmHg) (Lin et al 2006, Stepien 2010, Stepien 2011). We tried to limit the white-coat effect 
by measuring the SBP in presence of the owner after acclimatization in a quiet room and 
before performing the physical examination (Belew et al 1999).
 
However, white-coat 
hypertension cannot be excluded in our cats because the SBP was only measured on a single 
occasion (Brown et al 2007). Values of SBP above 180 mmHg, as recorded in four of our 
cats, are less likely to reflect white-coat hypertension (Belew et al 1999, Stepien 2011). Also, 
the SBP did not correlate with other physical and laboratory parameters that can be influenced 
by stress. An obvious underlying cause for the hypertension in our cats was not found. Further 
work-up was advised but declined by the owners. Several cats were borderline proteinuric or 
had moderately concentrated urine which can be consequences of the hypertension or 
indicative of early renal insufficiency (Brown et al 2007, Jepson 2011). Assessment of the 
glomerular filtration rate (GFR) could be helpful in such cats to diagnose non-azotemic 
kidney disease (Jepson 2011), but this was outside the scope of the present study. Several of 
our hypertensive cats were FIV seropositive and these cats had a significantly higher SBP 
than FIV negative cats. In human medicine, seropositivity for human immunodeficiency virus 
is a known risk factor for hypertension, cardiovascular disease and nephropathy (Weiner et al 
2003, Jung et al 2004, Bloomfield et al 2011). To the best of our knowledge, an association 
between hypertension and FIV infection is not reported and further studies are needed to 
elucidate if this is an incidental finding or if FIV seropositive cats are at risk for hypertension.  
Chapter 3. Aged cats 
 
82 
 
According to the BCS, which is useful for assessing the body fat percentage of pet cats 
(Bjornvad et al 2011), less than half of this apparently healthy cat population had an ideal 
body condition. This indicates that cat owners do not appreciate under- or overweight as a 
problem (Courcier et al 2010). Improved owner awareness of normal feline body condition 
and regular nutritional assessments by veterinarians is important to increase the proportion of 
cats with an optimal body condition (Freeman et al 2011).
 
Forty percent of our cats were too 
heavy, which is comparable to a recent UK study (39%) (Courcier et al 2010) and somewhat 
higher than in a recent French study (27%) (Colliard et al 2009). However, all three studies 
confirm that overweight and obesity is common in pet cats. As in another study (Courcier et 
al 2010), underweight cats were significantly older than cats with an ideal or overweight body 
condition. This may be explained by reduced fat and protein digestion with age in cats 
(Laflamme 2005). Only a few of our underweight cats were diagnosed with a condition that 
could explain weight loss. However, we must also consider that our underweight cats could 
have had occult systemic disease. The significantly lower USG might indicate decreased renal 
function at least in some underweight cats. Assessment of the GFR in underweight cats with 
poorly concentrated urine would have helped identifying cats with non-azotemic kidney 
disease.  
 
The most common abnormalities on physical examination were gingivitis, 
submandibular lymphadenopathy and a cardiac murmur. The majority of our cats (72%) 
showed gingivitis which is very similar to the 73.2% of gingivitis found by Verhaert and Van 
Wetter (2004) in a large cat population. Both studies took place in the same geographic area 
(Flanders, Belgium) and in both studies most owners (in the present study none) did not brush 
their cats’ teeth. Because we only performed visual oral inspection on conscious cats, we 
cannot comment on the number of cats with periodontitis, stomatitis or odontoclastic 
resorptive lesions. The presence of gingivitis was associated with mild submandibular 
lymphadenopathy in many cats.  
A heart murmur was auscultated in 11% of our cats which is lower than the 21% 
murmur prevalence in a young to middle-aged healthy domestic cat population (Côté et al 
2004). In both studies, all murmurs were systolic with intensity between 1/6 and 4/6. 
Differences in murmur prevalence between studies may be the result of differences in study 
populations (e.g. age), interobserver variation or geographic differences (Côté et al 2004). 
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One of our cats with a murmur was hyperthyroid, but in 10 cats there was no evidence of a 
systemic condition that could explain the murmur. In these cats the murmur could be caused 
by subclinical structural heart disease, which was a common finding in other studies that 
evaluated apparently healthy cats with a murmur (Côté et al 2004, Dirven et al 2010, 
Nakamura et al 2011). Although echocardiography is strongly recommended in healthy cats 
with a murmur (Côté et al 2004, Dirven et al 2010, Nakamura et al 2011), auscultation of a 
heart murmur had only poor sensitivity but moderate specificity to detect cardiomyopathy 
(Paige et al 2009).  
Several euthyroid cats had a palpable goiter. The maximum score of 3 is in line with 
other recent studies in which euthyroid cats mostly had small thyroid gland nodules 
(Norsworthy et al 2002, Paepe et al 2008, Boretti et al 2009). The mean STT results of the 
present study are very comparable to the STT results reported for young adult and middle-
aged normal cats (Margadant et al 2003, Cullen et al 2005, Ghaffari et al 2010). In contrast to 
dogs (Hartley et al 2006), we did not detect decreased tear production with increasing age. 
Only two cats had a STT < 5 mm/min in one or both eyes, which could be consistent with 
keratoconjunctivitis sicca (Moore 2000).  
 
Major findings on blood examination were leukocytosis, thrombocytopenia, increased 
serum urea concentration, increased serum creatinine concentration, hyperproteinemia, 
hyperglycemia, hypernatremia and hypophosphatemia. The leukocytosis and hyperglycemia 
were probably stress-related and the thrombocytopenia was probably 
pseudothrombocytopenia in the majority of cases. The 25% of cats with hyperglycemia is 
lower than recently published percentages for ill cats at admission to an emergency service 
(40%) (Chan et al 2002) or during hospitalization (64%) (Ray et al 2009). For the other 
laboratory parameters where many cats were outside the RI (Table 3.2), some of the abnormal 
values could truly be the result of occult disease, but we should also bear in mind that the RI 
may not be appropriate.  
One of the most striking findings was the increased serum creatinine concentration in 
almost one third of cats. Although some cats could have had early CKD, the increase was 
probably not clinically relevant in the majority of cases because most cats only had a mildly 
increased serum creatinine and hypersthenuric urine. The most likely explanation for the high 
proportion of cats with an increased serum creatinine concentration is the laboratory RI. For 
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serum creatinine, RIs can vary markedly between laboratories influencing the classification of 
samples as normal or abnormal (Boozer et al 2002, Ulleberg et al 2011). Finally, some cats 
could have had an increased creatinine production rate, resulting in mild azotemia despite 
normal renal function (Le Garreres et al 2007).  
Also many cats had mild hyperproteinemia, hypophosphatemia or hypernatremia 
which questions the appropriateness of these RIs. To avoid misinterpretation of clinical data, 
RIs need to reflect the population for which it is used (Friedrichs 2010). The laboratory that 
analyzed our samples used healthy young cats to calculate RIs which is not representative for 
our study population. An obvious example of an inappropriate RI in our study is the serum 
phosphorus concentration. In veterinary literature, typically the RI for serum phosphorus 
concentration in cats is between 0.81 and 1.94 mmol/L (Bates 2008, Kidder and Chew 2009). 
In contrast, the lower limit of our RI was 1.35 mmol/L, which resulted in a high proportion 
(40%) of cats with hypophosphatemia. The fact that young cats (6 months – 1 year) were used 
to determine the RI might explain this inappropriately high low reference limit. Indeed, 
enhanced renal tubular phosphate reabsorption results in increased serum phosphorus 
concentrations in growing animals (Corvilain and Abramow 1964). All but two of our cats 
had serum phosphorus within the RI if the published RI is used (Table 3.3). In addition, the 
majority of our cats had a serum phosphorus concentration in the lower half of the published 
RI and many of these cats were incorrectly classified as hypophosphatemic. This indicates the 
need to calculate age-dependent RIs to improve the interpretation of laboratory parameters in 
all age categories. 
 
We found a 14% FIV seroprevalence. Recent FIV seroprevalences vary greatly (2.5 – 
33.9%), depending on area and the cat population studied (Levy et al 2006, Norris et al 2007, 
Gleich et al 2009, Little et al 2009, Duarte et al 2010, Nakamura et al 2010, Al-Kappany et al 
2011). Our cats were all client-owned cats living in and around Ghent. Urban stray cats of the 
same area had a seroprevalence of 11.2% (Dorny et al 2002). This means that the FIV 
seroprevalence has not decreased despite stray cat programs have been running for years in 
this area. In contrast, FeLV antigen was detected in 3.8% of stray cats (Dorny et al 2002), but 
not in our cats. Possible explanations are different study populations (stray versus client-
owned cats) and different ages as FeLV mainly affects young cats (Gleich et al 2009). 
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On urinalysis, borderline proteinuria and crystalluria were common. The majority of 
cats with borderline proteinuria (except one with a positive culture) had an inactive sediment, 
and the amount of crystals was similar in cats with a normal (< 0.2) versus abnormal (≥ 0.2) 
UPC. Therefore and because the urine was taken by cystocentesis, this borderline proteinuria 
was probably of renal origin (Lees et al 2005). Although none of these cats showed overt 
renal failure, early CKD cannot be ruled out. Secondly, borderline proteinuria could be 
associated with occult or subclinical systemic disease because further diagnostics were not 
performed in any of the cats (Mardell and Sparkes 2006, Whittemore et al 2007). Finally, 
because the UPC was measured only once, we cannot determine if these cats were transiently 
or persistently borderline proteinuric (Lees et al 2005). As in Whittemore et al (2007), an age 
effect on the degree of urinary protein excretion was found with a significantly higher UPC in 
old versus middle-aged cats. Although older cats may be more prone for early CKD or occult 
systemic disease, the 0.2 cut-off value may also not be appropriate for UPC evaluation in old 
cats. Further research to explain borderline proteinuria in old cats is definitively warranted.  
Crystalluria was detected in almost half of our cats and was mostly mild and caused 
by amorphous crystals. All types of crystals that we detected (amorphous, struvite, calcium 
oxalate) can occur in normal urine samples. Although it is generally accepted that crystals are 
commonly present in feline urine (DiBartola 2010), we are not aware of scientific studies 
assessing how often crystalluria affects client-owned healthy cats. Although we cannot rule 
out urolithiasis, the crystalluria was probably non-pathogenic in the majority because none of 
our cats had lower urinary tract signs. Veterinarians should be aware that crystalluria is 
common in healthy cats and not sufficient to start feeding a calculolytic diet. In a previous 
study in specific pathogen free (SPF) cats, struvite crystals were found more commonly in 
cats fed a mixed diet compared to cats fed solely canned food (Sturgess et al 2001). This 
contrasts with the lack of association between diet type and presence or type of urinary 
crystals in our study. However, the absence of an association must be interpreted cautiously 
because diet information was not available in several of our cats and because we only found 
low number of cats with anything other than amorphous crystals.  
Another remarkable finding on urinalysis was the positive leukocyte-esterase dipstick 
test in all but one cats. This confirms that this test is nonspecific and cannot replace 
microscopic urine sediment examination (Holan et al 1997).
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One cat was diagnosed with an occult bacterial urinary tract infection (UTI). In cats, 
spontaneous bacterial UTIs occur most frequently in older cats (Lekcharoensuk et al 2001, 
Mayer-Roenne et al 2007, Bailiff et al 2008), mainly because common metabolic diseases 
such as CKD, diabetes mellitus, and hyperthyroidism predispose to UTIs (Mayer-Roenne et al 
2007, Bailiff et al 2008). However, a recent study found that cats of all ages were equally 
affected by UTIs (Martinez-Ruzafa et al 2012). Cats with UTIs often do not show lower 
urinary tract signs (= occult bacterial UTI) (Bailiff et al 2006, Mayer-Roenne et al 2007, 
Bailiff et al 2008, Martinez-Ruzafa et al 2012). A recent study revealed that occult bacterial 
UTIs particularly affect older female cats, mostly have Enterococcus faecalis isolated and can 
occur in cats without a history or clinical signs of a predisposing disease, as was the case in 
our cat (Litster et al 2009). Decreased USG, which was present in our cat, was recently found 
to be associated with UTI in cats (Martinez-Ruzafa et al 2012). 
 
Comparison of age groups resulted in significant differences for several parameters. A 
larger spread of UPC values in old versus middle-aged cats was obvious. For the other 
parameters, there was moderate to severe overlap between both groups which limits the 
clinical relevance for these differences. The significantly higher SBP, heart rate and murmur 
frequency in the old cats may be consequences of cardiovascular changes that occur with 
aging (Carpenter et al 2005).  
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Conclusion 
 
Based on the screening we performed in 100 cats, we diagnosed FIV infection in 14 
cats, CKD in two cats, hyperthyroidism in one cat and a UTI in one cat. In addition, several 
cats had a suboptimal SBP or BCS, gingivitis, heart murmur or laboratory abnormalities (e.g. 
increased serum creatinine, increased bilirubin, increased ALT, increased TT4, borderline 
proteinuria, glucosuria) for which further diagnostic investigation, treatment and/or follow-up 
were indicated. A minor limitation was that our cats were only evaluated at a single time 
point. Also further diagnostic tests to explain abnormal SBP, abnormal physical examination 
and laboratory findings were not always performed, although advised to the owners. 
However, this study clearly indicates the need and value of regular health checks of 
apparently healthy cats to improve early disease detection and allow early therapeutic 
intervention. This health screening should contain comprehensive history and thorough 
physical examination, including BCS assessment and oral inspection. Because most relevant 
abnormal laboratory findings were observed in group 2 cats – except FIV seropositivity –, we 
advise to perform FIV/FeLV testing in middle-aged cats with outdoor access and complete 
blood and urine examinations in old cats (above 10 years). Our findings support the widely 
accepted advice to measure the BP of cats that are ≥ 10 years of age (Brown et al 2007). To 
improve the interpretation of geriatric screening, small animal laboratories should make 
efforts to develop age depended RIs for certain parameters and further research is warranted 
to reveal the clinical importance of proteinuria in the borderline range.  
 
In conclusion, physical examination and laboratory abnormalities are common in 
apparently healthy older cats which emphasizes the need for regular health checks and age 
dependent laboratory RIs.  
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Introduction 
 
 In some countries, Ragdoll cats are routinely screened for kidney disease prior to 
breeding, based on recommendations of Ragdoll breed clubs. As explained in the general 
introduction of this thesis (Chapter 1), there is a need to gain scientific information on the 
occurrence of kidney disease within this breed and to evaluate the results of this screening.  
In Belgium and the Netherlands, many Ragdoll breeders perform pre-breeding 
screening on a voluntary basis. Although this screening is not obligatory to obtain a pedigree, 
it is highly recommended by breed clubs and there exists a strong social pressure between 
Ragdoll breeders to perform this screening.  
In our institution, this screening starts with controlling the cats’ identity by scanning 
the microchip and comparing this scanned microchip number with the original pedigree. A 
photocopy of the original pedigree is kept in the patient file. History and physical examination 
are performed to assess general health of the cats. Depending on the wishes of the breeder, 
pre-breeding screening consists of various combinations of echocardiography, assessment of 
feline immunodeficiency virus and feline leukemia virus status, measurement of serum urea 
and creatinine concentrations, blood typing, genetic testing for hypertrophic cardiomyopathy 
and/or polycystic kidney disease (PKD) and performing ultrasonography of the liver and 
kidneys. Most breeders perform all these tests in all their breeding cats. In cats that undergo 
screening, the results for hypertrophic cardiomyopathy and PKD are printed on the pedigree. 
Results of abdominal ultrasonography to evaluate for chronic kidney disease or chronic 
interstitial nephritis are not mentioned on the pedigree. 
 At first (Section §4.1), we performed a retrospective study in which we evaluated the 
data of Ragdolls that were presented at our institution for screening between September 2001 
and November 2009. Because of limitations that were inherent to the retrospective nature of 
this first study, we also performed a prospective study (Section §4.2) in which the results of 
screening tests of Ragdoll cats were compared with those of age-matched non-Ragdoll cats. 
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Summary 
 
This study aimed to assess the prevalence of renal abnormalities in Ragdoll cats. 
Ragdoll breeders often warn clients to watch for future renal problems, mainly due to chronic 
interstitial nephritis (CIN) and polycystic kidney disease (PKD). Therefore, Ragdoll screening 
by abdominal ultrasonography, measurement of serum creatinine and urea concentrations and 
genetic testing is often performed without documented scientific evidence of increased risk of 
renal disease.  
Data of Ragdoll screening for renal disease at one institution over an 8 year period 
were retrospectively evaluated.  
Renal ultrasonography was performed in 244 healthy Ragdoll cats. Seven cats were 
positive for PKD, 21 were suspected to have chronic kidney disease (CKD), 8 had 
abnormalities of unknown significance, and 2 cats had only one visible kidney. Cats 
suspected to have CKD were significantly older and had significantly higher serum urea and 
creatinine concentrations than cats with normal renal ultrasonography. All 125 genetically 
tested cats were negative for PKD. However, only one of the seven ultrasonographically 
positive cats underwent genetic testing for PKD.  
In conclusion, ultrasonographic findings compatible with CKD were observed in 
almost 10% of cats, and PKD occurred at a low prevalence (< 3%) in this Ragdoll population. 
Further studies are required to elucidate if Ragdoll cats are predisposed to CKD. 
  
Section §4.1 Retrospective 
103 
 
Introduction 
 
According to the Cat Fanciers’ Association, the Ragdoll is one of the most popular cat 
breeds worldwide (CFA 2010). Several Ragdoll breeder organizations such as the 
Scandinavian Ragdoll Club (SRC) and the Ragdoll Club Benelux (RCB) forewarn owners that 
renal problems may develop due to PKD, CIN, familial renal dysplasia or nephrocalcinosis 
(RCB 2003, SRC 2004). Based on recommendations of these breed clubs, Ragdoll cats are 
screened for PKD and CIN prior to breeding in several European countries such as Belgium, 
the Netherlands, Sweden and Finland (RCB 2003, SRC 2004). Several tests are part of this 
screening program, including abdominal ultrasonography to identify renal and/or hepatic cysts 
and evidence of CIN, measurement of serum urea and creatinine concentrations, and genetic 
testing for the PKD-1 mutation. The results of these screening tests can be found on the 
Ragdoll Health Database on the internet (RHD 2011). 
Although these screening tests have been performed for many years, there is only 
minimal scientific evidence of a specific increased risk for kidney disease within this breed. In 
Ragdoll cats, PKD and the PKD-1 nonsense mutation have been identified
 
(Lyons et al 2004), 
but information about the prevalence of PKD in this breed is lacking. Furthermore, there is no 
evidence that Ragdoll cats are predisposed to CIN, CKD, or renal dysplasia. For that reason, it 
is important to elucidate whether the concerns of the breed organizations are justified or not. 
If Ragdoll cats are indeed at risk for renal disease, adequate and regular monitoring of renal 
function may allow early disease detection and intervention. In addition, screening of 
breeding cats may then be warranted.  
Scientific evidence on the occurrence of renal disease in Ragdoll cats would appear 
beneficial to provide breeders with sound recommendations. Therefore, this study was 
undertaken to retrospectively evaluate the results of the screening tests performed on Ragdoll 
cats.  
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Materials and Methods 
 
The medical records of Ragdoll cats that were presented to the companion animal 
clinic at the Faculty of Veterinary Medicine of Ghent University (Belgium) between 
September 2001 and November 2009 were retrospectively evaluated. Healthy Ragdoll cats 
presented for CIN or PKD screening and evaluated by renal ultrasonography were included. 
Health was defined as clinically healthy for their owner and without significant abnormalities 
on physical examination. In addition to ultrasound, some Ragdoll owners also requested 
measurement of serum urea and creatinine concentrations or a genetic PKD test to complete 
their cat’s data in the ‘Ragdoll Health Database’. These blood results were also evaluated 
retrospectively. Cats that were only evaluated by renal ultrasonography, without a concurrent 
genetic PKD test, needed to be at least 10 months old to be included as PKD negative to avoid 
false negative results.  
Abdominal ultrasonography was performed by a Diplomate of the European College 
of Veterinary Diagnostic Imaging (ECVDI) or supervised ECVDI Resident. The cats were 
manually restrained in dorsal recumbency, and the hair was not or only minimally clipped. In 
the region of the kidneys and the liver, the hair was parted to expose the skin. To improve 
skin contact and conduction of ultrasound waves, the hair was soaked with alcohol and water 
before ultrasound coupling gel was applied. The kidneys and liver were evaluated with a 7.5 
MHz convex or sectorial transducer (Logic 7 GD Medical Systems, USA) using a 
ventrolateral and ventral approach.  
Serum creatinine and urea concentrations were measured with a colorimetric assay 
(Spotchem
®
, Menarini, Belgium). The reference intervals (RIs) (80 – 164 µmol/L for 
creatinine; 4.9 – 11.9 mmol/L for urea) were determined by the machine manufacturer by 
evaluating over 100 healthy cats of different ages and weights. At our institution, the PKD 
genetic test was completed as described by identifying the C > A transversion in exon 29 of 
the PKD-1 gene (Helps et al 2007). Owners of cats not genetically tested at our institution, 
were asked for the result of genetic PKD testing at other laboratories.  
A cat was defined as PKD positive if one or more clearly defined spherical anechoic 
cavities were detected in at least one kidney or the liver
 
(Beck and Lavelle 2001, Cannon et al 
2001) or if the cat was heterozygous for the PKD-1 nonsense mutation. A cat was suspected 
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of being affected by CKD if the kidneys showed ultrasonographic changes compatible with 
CKD, such as small kidneys (< 3.2 cm), irregular or undulating kidney shape or surface, 
reduced corticomedullary distinction, heterogeneous renal parenchyma, focal or diffuse 
cortical hyperechogenicity, focal or diffuse medullar hyperechogenicity, medullary rim sign, 
renal infarct and/or renal parenchymal mineralization. The presence of a single infarct, 
medullary rim sign, hyperechoic cortex or medulla, renal parenchymal mineralization or 
heterogeneity, as the only abnormality, was not sufficient to classify a cat as suspected of 
having CKD (Grooters and Biller 1995, Widmer et al 2004, d’Anjou 2008). These cats were 
classified as having ultrasonographic abnormalities of unknown significance. The serum urea 
and creatinine concentrations were not used to classify cats as having CKD or not because of 
the lack of urinalysis.  
Owners were contacted by telephone to follow up on cats suspected of having CKD. 
Owners were asked to complete a questionnaire evaluating the cat’s health, eating and 
drinking behavior, body weight and the cause of death when relevant. They were also asked if 
serum creatinine and urea concentrations and/or a urinalysis had been repeated since the time 
of inclusion in the study.  
All statistical analyses were performed with statistical software (PASW
®
 Statistics 18, 
USA). Cats without ultrasonographic abnormalities were compared to cats suspected of 
having CKD for age (nonparametric Mann-Whitney U rank sum test) and for serum urea and 
creatinine concentrations (independent two-samples t-test). All statistical tests were 
performed at the 0.05 significance level.  
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Results 
 
The study population consisted of 244 Ragdoll cats: 172 females (5 neutered) and 72 
males (4 neutered). The population characteristics are presented in Table 4.1. Only 4 cats 
were younger than 10 months, and these cats were all PKD positive based on the presence of 
renal cysts on ultrasonography. Renal ultrasonography was performed in all cats, serum urea 
and serum creatinine were measured in 141 cats, and the in-house genetic PKD-test was 
performed in 21 cats. Fifty-five cats were not genetically PKD tested, 104 cats were tested in 
various laboratories and for 64 cats there was no information if they underwent genetic PKD 
testing. The descriptive statistics for serum urea and serum creatinine concentrations are 
presented in Table 4.1. Four cats had an increase of both serum urea and creatinine 
concentrations, 11 only had a serum creatinine and two only a serum urea concentration 
exceeding the RI. All genetically tested cats were homozygous for the wild-type PKD-1 
allele, which is consistent with a PKD-negative status. 
 
Table 4.1. Descriptive statistics for the age, body weight, serum urea concentration and serum 
creatinine concentration of the included Ragdoll cats.  
 N Mean  ± SD Median Range RI 
Age (years) 244 2.2 ± 1.4 1.8 0.3  – 8.7 / 
Body weight (kg) 45 4.2 ± 1.2 4.2 1.8  – 7.9 / 
Urea (mmol/L) 141 8.5 ± 2.0 8.2 4.9  – 18.9 4.9 – 11.9 
Creatinine (µmol/L) 141 127.3 ± 30.8 124.0 70.0  – 222.0 80 – 164 
(N = Number of cats for which the parameter was found in the medical record; SD = 
Standard deviation; RI = Reference interval) 
 
Renal ultrasonography showed abnormalities in 38 cats (Table 4.2). Seven cats were 
diagnosed with PKD based on the presence of renal cysts on ultrasound. Hepatic cysts were 
not detected in any of the cats. One of the cats with renal cysts was genetically PKD negative. 
On repeat examination of this cat 5 years after inclusion, cysts were not observed on 
ultrasound, and blood and urine examinations were normal. In two cats, the right kidney could 
not be visualized, suggesting unilateral renal agenesis or aplasia. In one of these cats, the right 
kidney was also not visible on a ventrodorsal abdominal radiograph and on recheck 
ultrasound (4.5 years after inclusion). At this recheck, blood and urine examinations did not 
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reveal renal azotemia. Ultrasonographic abnormalities that could be compatible with CKD 
were observed in 21 cats and eight cats showed other renal ultrasonographic abnormalities. 
The significance of these other lesions is unknown. The CKD suspected cats were 
significantly older (median 2.7 (range 1 – 8.7) versus 1.7 (0.9 – 7.7) years; P = 0.002) and had 
significantly higher serum urea (mean ± SD 11.1 ± 3.6 versus 8.2 ± 1.3 mmol/L; P = 0.006) 
and creatinine concentrations (mean ± SD 155.9 ± 30.9 versus 124.7 ± 29.2 μmol/L; P < 
0.001) compared to cats without ultrasonographic abnormalities. In the CKD suspected cats, 
both serum urea and creatinine concentrations were normal in eight cats, increased in three 
cats and not measured in five cats. Four cats only had a serum creatinine and one cat only a 
serum urea concentration that exceeded the RI.  
 
Table 4.2. Overview of the observed ultrasonographic abnormalities and the frequency 
of their observation in Ragdoll cats with ultrasonographic abnormalities.  
The Ragdoll cats with ultrasonographic abnormalities (n = 38) are subdivided into cats that 
showed abnormalities suggestive of chronic kidney disease (CKD), cats that were diagnosed 
with polycystic kidney disease (PKD), cats with unilateral renal agenesis or aplasia and cats 
with ultrasonographic abnormalities for which the significance was uncertain. The majority 
(18/21) of CKD suspected cats had more than one ultrasonographic abnormality, which 
explains why the total number of ultrasonographic abnormalities exceeds the number of cats 
suspected of CKD (n = 21). 
Ultrasonographic 
conclusion 
N Age (years) Ultrasonographic abnormalities and 
frequency of occurrence 
Suspected of CKD 21 Median 2.7  
(range 1.1 – 8.7) 
Small kidney(s)  10/21 
Reduced corticomedullary distinction 7/21 
Undulating or bumpy cortical surface 6/21 
Renal mineralizations 5/21 
Hyperechoic renal cortex 4/21 
Renal infarct(s) 4/21 
Heterogeneous cortex  4/21 
Other findings 7/21 
PKD 7 Median 0.4 
(range 0.3 – 2.9) 
Renal cysts 7/7 
Unilateral renal 
agenesis/aplasia 
2 1.4 and 1.9 Absent right kidney 2/2 
Unknown 
significance 
 
8 Median 2.5  
(range 0.9 – 7.2) 
Hyperechoic renal cortex 3/8 
Corticomedullary rim sign 2/8 
Cortical hyperechoic triangle/spots 2/8 
Slight undulation of cortical surface 1/8 
(CKD = Chronic kidney disease; N = Number of cats; PKD = Polycystic kidney disease)  
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Follow-up was only available for 14 of 21 CKD suspected Ragdoll cats. Three 
developed clinical signs and laboratory abnormalities consistent with chronic renal failure. 
Two are still alive and were in IRIS stage 3 CKD at the last follow-up (14 months and 5 years 
after inclusion). The third cat was euthanized at 12 years of age (4 years after inclusion) after 
being treated for several years with a renal diet and benazepril. According to the owners, ten 
CKD suspected cats were still healthy at the time of writing (mean follow-up 3.4 ± 1.1 years), 
with normal eating and drinking behavior and stable body weight. Repeated measurements of 
serum urea and creatinine were only performed in one of these 10 cats (1 year after inclusion), 
and the results were within the RI. Two months after inclusion, a wedge-biopsy of the left 
kidney of one non-azotemic cat was taken during ovariohysterectomy. This cat had a small 
left kidney with an undulating cortical surface and an abnormal rounded shape. Routine 
histology indicated only very mild degeneration in the distal renal tubules, without glomerular 
or interstitial changes. The owner of one cat noted polydipsia. A recheck evaluation (6 years 
after inclusion) revealed mildly increased serum creatinine, hypersthenuric urine and 
microscopic renal hematuria. On ultrasonography, a small (3 cm) and irregularly shaped right 
kidney, infarcts in the left kidney and left ureteral dilation were detected.  
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Discussion 
 
In the popular European literature, there is a strong belief that Ragdoll cats are 
predisposed to renal disease, mainly due to CIN and PKD (RCB 2003, SRC 2004). 
CIN is a nonspecific inflammatory condition that is classified among the 
tubulointerstitial renal diseases. CIN can be primary or secondary to glomerular or systemic 
diseases, but the underlying cause is often unclear. It results in fibrosis, tubular atrophy and 
loss of healthy renal tissue. The consequence is progressive renal disease and it is considered 
to be a common cause of azotemic CKD in cats (DiBartola et al 1987, Lulich et al 1992, 
Minkus et al 1994, Maxie and Newman 2007). The definitive diagnosis of CIN is not possible 
without taking kidney biopsies and renal histology often does not reveal the underlying cause 
of the nephritis (DiBartola et al 1987, Lulich et al 1992, Polzin 2010). Ragdoll breed 
organizations recommend measuring serum urea and creatinine and performing renal 
ultrasonography to screen for the presence of CIN. The usefulness of ultrasonography in the 
diagnosis of CIN is limited, because CIN is a histological diagnosis and there are no 
pathognomonic ultrasonographic features for feline CIN (Grooters and Biller 1995, d’Anjou 
2008, DiBartola 2010). Therefore, in this study, cats were only evaluated for ultrasonographic 
features of CKD and not of CIN. Another limitation is that kidneys of cats with CIN 
occasionally have a normal ultrasonographic appearance (Grooters and Biller 1995, d’Anjou 
2008, DiBartola 2010). Finally, ultrasonography only provides information on organ 
structure, without evaluating organ function (Grooters and Biller 1995). An important 
limitation of measuring serum urea and creatinine to evaluate renal function is that these 
parameters are difficult to interpret without concurrent urinalysis. In addition, they only 
provide a rough estimate of kidney function and do not allow detection of early kidney 
dysfunction (DiBartola 2010).  
In this study, 8.6% of the screened Ragdoll cats showed ultrasonographic 
abnormalities that could be compatible with CKD. These CKD suspected cats were 
significantly older and had significantly higher urea and creatinine concentrations compared 
to cats without ultrasonographic abnormalities. It is important to recognize that the 
ultrasonographic findings do not imply that these cats were affected by CIN because several 
other diseases, such as glomerulonephritis, glomerulosclerosis, amyloidosis and 
nephrocalcinosis, can result in similar ultrasonographic abnormalities (Widmer et al 2004). 
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Although 8.6% appears to be a fairly high percentage of structural renal abnormalities for this 
population of young healthy cats, it is difficult to draw strong conclusions because the 
prevalence of renal ultrasonographic abnormalities in healthy cats of other breeds is currently 
unknown. The significantly higher age of the CKD suspected cats could be expected because 
CKD is a slowly progressive disease. However, the age difference between both groups was 
rather small, and the ages overlapped significantly. The significantly higher serum urea and 
creatinine concentrations of CKD suspected cats may indicate decreased renal function. 
However, because urinalysis was not performed in our cats, we cannot determine how many 
cats actually suffered from renal azotemia. Also, it is widely accepted, despite a lack of 
evidence, that ultrasonography is not a useful tool to predict which cats will develop azotemic 
kidney disease (Grooters and Biller 1995). Further studies will need to determine if the 
observed ultrasonographic abnormalities are clinically relevant. Urinalysis and renal function 
tests will help to identify cats with decreased renal function (DiBartola 2010). Renal biopsies 
may reveal the underlying cause of the ultrasonographic abnormalities. It is important to 
consider that kidney biopsies are not recommended in most cats with advanced or end-stage 
CKD. However, at an early CKD stage, renal biopsies can help to identify the underlying 
cause of CKD, mainly to evaluate if specific therapy directed at a primary cause makes sense 
(Polzin 2010). In this study, only one non-azotemic CKD suspected cat underwent a kidney 
biopsy which makes valid conclusions difficult. 
A small number of the cats had ultrasonographic abnormalities for which the clinical 
significance was unclear. Most had diffuse or focal hyperechoic renal cortices as a single 
abnormality. It has been shown that the cortical echogenicity of normal cat kidneys increases 
with the amount of fat present in the proximal tubular epithelial cells, which can result in 
cortical hyperechogenicity, especially in intact male cats (Yeager and Anderson 1989). On the 
other hand, hyperechogenicity of the renal cortex is the most common ultrasonographic 
finding in diffuse parenchymal renal diseases (Grooters and Biller 1995). A corticomedullary 
rim sign was present in two cats. Previous studies indicated that rim signs can occur in 
healthy and renal-diseased cats and dogs. Currently, it is still unknown if cortical 
hyperechogenicity or medullary rim signs can be early indicators of renal disease (Yeager and 
Anderson 1989, Biller et al 1992, Widmer et al 2004, d’Anjou 2008). 
PKD is an inherited condition that results in the formation of fluid-filled renal and, 
occasionally, hepatic cysts. This condition mainly affects Persian and Persian-related cats 
(Biller and DiBartola 1995). Because the Ragdoll is one of the breeds that have been 
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outcrossed with Persians, Ragdoll cats could be at risk for PKD (Beck and Lavelle 2001). 
Affected cats are heterozygous for a stop mutation in the PKD-1 gene that is inherited in an 
autosomal dominant manner (Biller et al 1996, Lyons et al 2004, Helps et al 2007). This 
mutation has been identified in a limited number of Ragdoll cats (Lyons et al 2004). The 
present study is the first to evaluate PKD prevalence in a large number of Ragdoll cats. A 
prevalence of less than 3% was found, which is considerably lower than the 31% to 42% 
prevalence of PKD described in recent European studies in Persian and related cats (Barthez 
et al 2003, Bonazzi et al 2007, Domanjko-Petrič et al 2008, Wills et al 2009). Five of the 
seven PKD-positive cats were presented in 2001 or 2002, which means that only one PKD-
positive and one doubtful PKD-positive (cysts on ultrasonography, negative genetic test) 
Ragdoll cat were observed at this institution during the last 7 years of the study. This may 
indicate that PKD screening prior to breeding is effective at eradicating PKD in this breed. 
However, the PKD prevalence found in this study is only an estimate of the true prevalence. 
A selection bias can have resulted in an underestimation of the actual prevalence because 
most Ragdoll breeders already screened their cats for PKD over several generations.  
All genetically tested cats tested negative for PKD, however, one was considered PKD 
positive on renal ultrasonography. In a previous study, several cats (5.7%) that showed renal 
cysts on ultrasonography were homozygous for the wild-type PKD-1 alleles (Bonazzi et al 
2009). There are several possible explanations for this discrepancy. The small cysts that were 
visualized by ultrasound could have been acquired instead of inherited. The cat could have 
also been affected by inherited PKD caused by another mutation, other than the one that is 
evaluated by the PKD test, or a technical error resulting in a false negative PKD test or a false 
positive ultrasonography could have occurred (Helps et al 2007, d’Anjou 2008, Bonazzi et al 
2009). As no cysts were observed five years later, a false positive ultrasonography is the most 
likely explanation in this case.  
In two cats, the ultrasonographer could not identify the right kidney. This can indicate 
unilateral renal agenesis or severe renal hypoplasia or dysplasia, resulting in a kidney-like 
remnant that is too small to be detected by routine medical imaging modalities (Toolan 1993, 
Greco 2001, Chang et al 2008). Further diagnostic tests to differentiate between these 
conditions were not performed. Both feline and canine unilateral renal agenesis are often 
associated with other developmental urogenital tract abnormalities or compensatory 
hypertrophy of the contralateral kidney (Greco 2001, Agut et al 2002, Taney et al 2003, 
Morita et al 2005, Chang et al 2008). The ultrasound reports of both cats, and abdominal 
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radiographs and recheck ultrasonography of one cat did not reveal other abnormalities besides 
the absent right kidney.  
Almost 11% of our Ragdoll cats had serum creatinine concentrations exceeding the 
RI. Because urinalysis or clearance tests to determine the glomerular filtration rate were not 
performed, it is not possible to determine how many cats actually had decreased renal 
function. At least three cats developed overt renal failure, but follow-up was not available for 
many cats or was limited to phone contact with the owner. Next to kidney dysfunction, other 
reasons may explain the increased serum creatinine concentration. One is misclassification 
due to an inappropriate RI. The issue of inappropriate RIs for small animal laboratory 
parameters has recently been emphasized in veterinary literature (Archer, 2010, Friedrichs 
2010). The fact that we used the RI of the machine manufacturer, instead of developing a 
laboratory-specific RI, was not ideal (Friedrichs 2010). Both in dogs and in cats, RIs are often 
not appropriate to assess serum or plasma creatinine concentrations, which can influence the 
classification of samples as normal or abnormal (Boozer et al 2002, Ulleberg et al 2011). The 
increased creatinine concentrations can be a breed-specific feature, as was reported for 
Birmans (Gunn-Moore et al 2002, Reynolds et al 2010). The Ragdoll was founded by cross-
bred cats, but has been outcrossed with Persians, Birmans, Balinese and maybe other breeds 
(Beck and Lavelle 2001, RFCI 2006). Although Gunn-Moore et al (2002) reported 
hypercreatinemia in one third of adult Birmans, Reynolds et al (2010) only described a small 
number of Birmans with a creatinine concentration that exceeded the RI. Further research is 
required to determine if a breed-specific RI is warranted for assessment of serum creatinine in 
Ragdoll cats. 
This study had several limitations, mainly due to its retrospective nature. First, several 
cats only underwent renal ultrasonography without a genetic PKD test or measurement of 
serum urea and creatinine concentrations. Therefore, the PKD-positive status of all but one cat 
that showed renal cysts at ultrasonography was not confirmed genetically. Second, renal 
ultrasonography was performed by different ultrasonographers with or without minimal 
clipping of the cats’ hair. Therefore, it is possible that mild ultrasonographic abnormalities 
were missed or not noted in the patient records or that the renal echogenicity was 
underestimated (Walter et al 1987). However, as in previous studies, adequate images could 
be obtained in most cases by preparing the skin and hair coat well before scanning (Cannon et 
al 2001, Wills et al 2009). Third, interpretation of the serum urea and creatinine 
concentrations was limited by the lack of urinalyses. Finally, disease prevalence is affected by 
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the specific characteristics of the studied population (Hahn and Overley 2010), such as 
geography. All Ragdoll cats included in this study resided in Belgium or the Netherlands and 
the majority was born in the same area. Only a minority of cats were imported from other 
European countries, the United States or Australia.  
 
Despite these limitations, this study has clear value because kidney disease screening 
results were evaluated for the first time in a large population of Ragdoll cats. It can be 
concluded that ultrasonographic findings compatible with CKD occurred in almost 10% of 
this healthy Ragdoll population. Further research is needed to elucidate if this is clinically 
relevant and whether these cats were affected by CIN. In addition, PKD occurs at a low 
prevalence in Ragdoll cats residing in Belgium and the Netherlands.  
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Summary 
 
Ragdoll breeder organizations often forewarn Ragdoll cat owners that renal problems 
may develop due to polycystic kidney disease (PKD), chronic interstitial nephritis (CIN), 
familial renal dysplasia or nephrocalcinosis.  
Healthy Ragdoll and non-Ragdoll cats were prospectively evaluated by measuring 
serum creatinine and urea concentrations, routine urinalysis and abdominal ultrasonography. 
All Ragdoll cats also underwent genetic PKD testing.  
One hundred and thirty-three Ragdoll and 62 control cats were included. Ragdoll cats 
had significantly lower serum urea concentrations and higher urine specific gravity (USG). 
However, median creatinine concentration, median urinary protein: creatinine ratio (UPC) and 
the proportion of cats with serum creatinine or urea concentration exceeding the reference 
interval (RI) did not differ. One or more renal ultrasonographic changes were detected in 
66/133 (49.6%) Ragdoll and in 25/62 (40%) control cats. Ragdoll cats showed significantly 
more frequent segmental cortical lesions (SCLs; 7.5% versus 0%), abnormal renal capsule 
(19.5% versus 8%) and echogenic urine (51.9% versus 25.8%). Chronic kidney disease 
(CKD) was ultrasonographically suspected in 7/133 (5.3%) Ragdoll and in none of the control 
cats, which approached significance. Laboratory parameters confirmed kidney dysfunction 
only in 1/7 of these Ragdoll cats. All Ragdoll cats were PKD negative.  
In conclusion, breed-specific serum creatinine RIs are not likely required for Ragdoll 
cats. Secondly, renal ultrasonographic abnormalities are common, both in Ragdoll and non-
Ragdoll cats. Thirdly, healthy young Ragdoll cats are uncommonly affected by PKD and 
CKD, but an increased susceptibility of Ragdoll cats to develop CKD cannot be excluded. 
Finally, Ragdoll cats are predisposed for SCLs, which may indicate renal infarction or cortical 
scarring.  
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Introduction 
 
According to the Cat Fanciers’ Association, the Ragdoll is one of the most popular cat 
breeds worldwide (CFA 2012). Several Ragdoll breeder organizations such as the Ragdoll 
Club Benelux and the Scandinavian Ragdoll Club forewarn owners that renal problems may 
develop due to PKD, CIN, familial renal dysplasia or nephrocalcinosis (RCB 2003, SRC 
2004). Based on recommendations of these breed clubs, Ragdoll cats are screened for PKD 
and CIN prior to breeding in several European countries such as Belgium, the Netherlands, 
Sweden and Finland (RCB 2003, SRC 2004). Several tests are part of this screening program, 
including abdominal ultrasonography to identify renal and/or hepatic cysts and evidence of 
CIN, measurement of serum urea and creatinine concentrations, and genetic testing for the 
PKD-1 mutation. The results of these screening tests can be found on the Ragdoll Health 
Database on the internet (RHD 2012). 
Recently our group retrospectively evaluated the results of these screening tests 
performed on Ragdoll cats at our institution. Ultrasonographic findings compatible with CKD 
were observed in 8.6% and PKD in 2.9% of included healthy Ragdoll cats. However, this 
study was limited by the lack of urinalysis, incomplete screening tests in many Ragdoll cats 
and the lack of information about the prevalence of renal ultrasonographic abnormalities in 
healthy non-Ragdoll cats (Paepe et al 2012).  
To further elucidate if the concerns of the Ragdoll breed organizations are justified or 
not, we performed a prospective study to compare serum creatinine and urea concentrations, 
routine urinalysis and renal ultrasonographic findings between Ragdoll cats and an age-
matched control group.  
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Materials and methods 
 
Study population 
Ragdoll cats that were presented by their owner for CIN or PKD screening were 
considered for inclusion. Age matched non-Ragdoll cats were actively recruited as control 
cats by contacting colleagues, friends and veterinary students. Both pure- and mixed-breed 
cats were considered for inclusion as control cats, but maximum five cats of each pure cat 
breed were allowed. Both Ragdoll and control cats needed to be 10 months or older to be 
included. To avoid bias towards kidney disease in the Ragdoll population, Ragdoll cats that 
were presented by their owner with an already diagnosed CKD were excluded from this study. 
Because cats presented for screening are usually healthy, only healthy Ragdoll and control 
cats were included. Health was defined as clinically healthy for their owner and without 
significant abnormalities on physical examination, complete blood count
a,b
 and serum 
biochemistry profile
a,c
, except for serum creatinine and urea concentrations. All cats were 
fasted for 12 hours, water was offered ad libitum.  
The study was completed at the Department of Medicine and Clinical Biology of 
Small Animals, Faculty of Veterinary Medicine, Ghent University between October 2010 and 
March 2012. All cats were privately owned, the owners were thoroughly informed about the 
study aims and protocol, and the study was approved by local and national ethical committees 
(EC2010/104). 
 
Procedures 
The cats underwent measurement of serum creatinine
d
 and urea
d
 concentrations, 
complete urinalysis and abdominal ultrasonography. Only the Ragdoll cats underwent a 
genetic PKD test
e
 that was completed as described by identifying the C > A transversion in 
exon 29 of the PKD-1 gene (Helps et al 2007). 
Urinalysis consisted of a urinary dipstick test; measurement of USG with a manual 
refractometer, urinary pH and UPC
a,f
; and sediment examination. The sediment was prepared 
as previously described (Meyer 2001, Paepe et al 2013) and evaluated under the microscope 
within 30 minutes of collection. Crystalluria was evaluated semi-quantitatively and expressed 
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per low-power field (LPF, 10x objective) as mild (< 1/LPF), moderate (1 – 3/LPF), or severe 
(> 3/LPF). Bacterial culture
a,g
 of the urine was only performed if considered necessary based 
on routine urinalysis or on the presence of sediment in the urinary bladder during 
ultrasonography. 
Abdominal ultrasonography was performed by a Diplomate of the European College 
of Veterinary Diagnostic Imaging (ECVDI) or supervised ECVDI Resident, using a 
multifrequency (6 – 10 MHz) microconvex or multifrequency (7.5 – 12 MHz) linear 
transducer
h
. The cats were manually restrained in dorsal recumbency. The hair was not or 
only minimally clipped and parted to expose the skin. To improve skin contact and 
conduction of ultrasound waves, the hair was soaked with alcohol and water before ultrasound 
coupling gel was applied. The kidneys, urinary bladder and liver were evaluated according to 
a standard protocol in longitudinal and transverse scanning planes (see Addendum). A 
ventrolateral and ventral approach was used for the kidneys and liver, a ventral approach for 
the urinary bladder. Parameters assessed at the level of the kidneys were the renal capsule 
(normal or abnormal), renal shape (regular, irregular or other), kidney length in a sagittal 
plane, cortical echogenicity (diffuse hypo-, iso- or hyperechogenic compared to the spleen or 
liver or focal abnormalities), medullar echogenicity (diffuse hypo-, iso- or hyperechogenic 
compared to the renal cortex or focal abnormalities), corticomedullary demarcation (well-
delineated or reduced), renal pelvis (normal, enlarged, or presence of uroliths), proximal 
ureter (normal, enlarged, or presence of uroliths) and the presence or absence of medullary 
rim sign, dystrophic mineralization, cavitary lesion, solid mass, nodule, segmental cortical 
lesion and retroperitoneal fluid. For the urinary bladder, bladder filling, echogenicity of the 
urine and presence or absence of uroliths was noted. The liver was carefully evaluated for the 
presence or absence of cysts or other parenchymal changes. Additional changes in the liver, 
kidneys, urinary bladder and the remainder of the abdomen were also noted. Because CIN is 
not an ultrasound diagnosis, the radiologist was asked to judge if the observed abnormalities 
could be indicative of CKD possibly caused by CIN. In addition, the radiologist was asked if 
the cat could be affected by renal agenesis, hypoplasia or dysplasia.  
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Statistical methods 
All statistical tests were performed with statistical software
i
 and at the 0.05 
significance level. To compare the Ragdoll and the control group, student’s t-test was used for 
continuous variables that approached normal distribution, Mann-Whitney U-test for non-
normally distributed continuous variables and the Fisher’s exact test or the Pearson Chi-
Square test for discrete variables.  
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Results 
 
Study population 
 In total, 133 Ragdoll and 62 control cats were included. Seven Ragdoll cats with 
known CKD and one Ragdoll cat for which it was already known that it only had one kidney 
were excluded. Two other Ragdoll cats were excluded, one because of dyspnea and muffled 
lung sounds due to pleural effusion and one because of ascites. Further diagnostic tests 
revealed feline infectious peritonitis in both cats. One control cat was excluded because of 
ulcerative and scaly swellings of the footpads consistent with plasma cell pododermatitis.  
 Age and body weight did not differ between groups (Table 4.3). The gender 
distribution differed significantly between groups (P < 0.001; Ragdoll: 80 intact female, 5 
neutered female, 40 intact male, 8 neutered males; control: 16 intact females, 20 neutered 
females, 0 intact males, 26 neutered males).  
 Ragdoll pedigrees indicated that 43 Ragdoll cats originated from Belgium, 37 from the 
Netherlands, 15 from other European countries, 28 from the United States of America, seven 
from Australia or New-Zealand, two from Canada and one from Israel.  
 
Laboratory parameters 
The results for serum creatinine and urea concentrations, USG and UPC for both 
groups are summarized in Table 4.3. Urine was not available in four Ragdoll cats because of 
empty bladder or pregnancy. Additionally, in nine Ragdoll and three control cats the amount 
of urine was insufficient to allow microscopic sediment examination.  
The median creatinine concentration and proportion of cats with serum creatinine 
(three Ragdoll, one control cat) or serum urea (two Ragdoll, one control cat) concentration 
exceeding the RI did not significantly differ between groups. However, control cats had 
significantly higher serum urea concentrations compared to Ragdoll cats (P = 0.010).  
Median USG was significantly lower in control cats (P < 0.001) and the number of 
cats that had USG below 1.035 was significantly higher in control (8/62) compared to Ragdoll 
(4/129) cats (P = 0.013). Median UPC and the proportion of cats with borderline proteinuria 
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(UPC = 0.2 – 0.4 (Lees et al 2005); 36/129 Ragdoll, 14/62 control cats) or overt proteinuria 
(UPC > 0.4
 
(Lees et al 2005); 14/129 Ragdoll, 4/62 control cats) did not significantly differ 
between groups. The urinary dipstick was positive for hemoglobin in 37/129 Ragdoll and 
17/62 control cats, for acetone in 9/129 Ragdoll and 1/62 control cats, for protein in 128/129 
Ragdoll and 56/62 control cats, for urobilinogen in 36/129 Ragdoll and 19/62 control cats and 
for glucose in 0/129 Ragdoll and 5/62 control cats. Bilirubin or nitrites positivity was not 
observed in any cat. Protein positivity was observed significantly more often in Ragdoll cats 
(P = 0.005) and glucose positivity more often in control cats (P = 0.003). Urinary crystals 
were observed in 61/121 Ragdoll (40 mild, 17 moderate, 4 severe crystalluria; 46 amorphous, 
14 struvite, 1 calcium oxalate crystalluria) and 29/58 control (17 mild, 7 moderate, 5 severe 
crystalluria; 19 amorphous, 10 struvite crystalluria) cats. Urinary casts were seen in 3/121 
Ragdoll and 2/58 control cats. All had rare (< 1 per high-power field) granular casts. A urine 
culture was performed in 70 Ragdoll and 45 control cats. Escherichia coli cystitis was 
diagnosed in one Ragdoll and one control cat. The amount and type of urinary crystals and the 
proportion of cats with casts or positive urine culture did not differ between groups. 
Based on the laboratory parameters, one Ragdoll cat was diagnosed with IRIS stage 2 
CKD. All Ragdoll cats were homozygous for the wild-type PKD-1 allele, which is consistent 
with a PKD-negative status. 
 
Ultrasonography  
A summary of the renal ultrasonographic findings is presented in Table 4.4. 
Descriptive statistics for the left and right kidney size and the absolute size difference 
between both kidneys is shown in Table 4.3. Only renal capsular abnormalities (P = 0.029), 
presence of SCL(s) (P = 0.019) and abnormal ultrasonographic appearance of the urine (P < 
0.001) were significantly different between groups and observed more frequently in Ragdoll 
cats. For the complete cat population, a significant influence of gender was seen on the 
presence of echogenic urine. Intact male cats were predisposed to have echogenic urine 
compared to the other genders (P < 0.001). Five of 10 Ragdoll cats with SCL only had one 
lesion (three right kidney, two left kidney), the other five had two lesions (1/5 had two in right 
kidney, 1/5 had two in left kidney, 3/5 had one in both kidneys). All 15 SCLs were positioned 
in the cortex, were triangular to wedge-shaped with peripheral broad base and hyperechoic 
compared to the surrounding cortex. These lesions were observed in the cranial (5/15) or 
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caudal pole (7/15) or in the middle (3/15) of the kidney. The presence of the lesion resulted in 
an irregular kidney shape and indentation of the renal capsule in all but one lesion. One of the 
Ragdoll cats with SCL(s) was the cat with IRIS stage 2 CKD. The other cats all had serum 
creatinine and urea concentrations within the RIs and USG above 1.035. Three of the cats 
with SCL(s) had borderline proteinuria and one overt proteinuria. Urinary sediment 
examination revealed hematuria in two, mild hematuria and rare granular casts in one, severe 
struvite crystalluria in one, mild amorphous crystalluria in two and no abnormalities in four 
cats. Urine culture was negative in all six cats in which it was assessed. Brief pedigree 
analysis of the Ragdoll cats with SCL(s) showed that one sire and his daughter and one dam 
and her son all had SCL(s). In addition, this dam and another cat with SCL(s) had two 
common grandparents. Furthermore, two other cats with SCL(s) had two common 
grandparents.  
The radiologist concluded that CKD was likely present in seven Ragdoll cats. The 
radiologist diagnosed PKD in one and suspected renal dysplasia in another control cat. One of 
these seven cats was the Ragdoll cat with IRIS stage 2 CKD. The other six cats that were 
suspected of CKD had hypersthenuric urine (USG > 1.035), three had borderline proteinuria 
and one had a serum urea concentration exceeding the RI. None of the control cats showed 
ultrasonographic abnormalities that were indicative for CKD. Although not significant, a 
trend towards a significantly different proportion of CKD suspected cats between groups was 
observed (P = 0.065). In two Ragdoll cats, PKD could not be ruled out based on the presence 
of a single anechoic cyst or a single cyst with echogenic debris. The control cat suspected of 
renal dysplasia was a one-year old cat with normally sized kidneys that showed a diffusely 
hypoechoic cortex with multiple small to large cortical hypoechoic areas that completely 
deformed the renal shape and contours. Fine-needle aspiration of the kidneys did not reveal 
significant abnormalities, so lymphoma was ruled out as a differential for this cat.  
The number of renal ultrasonographic abnormalities in Ragdoll and control cats is 
presented in Table 4.5 and does not differ between groups. Of the seven Ragdoll cats 
suspected of CKD all had five or more renal ultrasonographic abnormalities. The only 
Ragdoll with five renal ultrasonographic abnormalities not suspected of CKD was a Ragdoll 
with an abnormally shaped right kidney that was smaller than the left kidney due to the 
presence of two segmental cortical lesions. Both kidneys showed mildly increased cortical 
echogenicity and a medullary rim sign. The only control cat with five renal ultrasonographic 
abnormalities was suspected of renal dysplasia.  
Chapter 4. Ragdoll cats 
 
128 
 
 
Table 4.3. Descriptive statistics for continuous variables age, body weight, serum creatinine 
concentration, serum urea concentration, urine specific gravity (USG), urinary protein: 
creatinine ratio, size of the left kidney, size of the right kidney, difference in size between left 
and right kidney (in absolute values) for Ragdoll cats (group 1) and control cats (group 2).  
Parameter Group N Mean  ± SD Median Range 
Age (years) 1 133 2.7 ± 1.8 2.1 0.9 – 8.8 
2 62 2.7 ± 1.6 2.4 0.8 – 8.2 
Body weight (kg) 1 133 4.2 ± 0.9 4.1 2.8 – 7.5 
2 62 4.1 ± 0.8 4.2 2.5 – 6.2 
Creatinine (µmol/L) 1 133 145.5 ± 29.1 141 80 – 266 
2 62 139.6  ± 33.1 137.5 80 – 227 
Urea (mmol/L)* 1 133 7.6 ± 1.5 7.4 4.8 – 15.8 
2 62 8.0 ± 1.3 7.9 5.0 – 13.3 
USG* 1 129 1.056 ± 0.009 1.055 1.019 – 1.080 
2 61 1.049 ± 0.013 1.052 1.012 – 1.075 
UPC 1 129 0.21 ± 0.1 0.15 0.04 – 0.68 
2 62 0.18 ± 0.1 0.17 0.05 – 0.52 
Size left kidney (cm) 1 133 3.8 ± 0.5 3.7 2.8 – 5.7 
2 62 3.7 ± 0.3 3.7 3.0 – 4.5 
Size right kidney (cm) 1 133 3.9 ± 0.5 3.9 2.7 – 5.0 
2 62 3.8  ± 0.4 3.8 3.0 – 4.5 
Size difference (cm) 1 133 0.21 ± 0.22 0.15 0 – 1.28 
2 62 0.22 ± 0.18 0.17 0 – 0.76 
(N = Number of cats in each group for which the parameter was available; SD = 
Standard deviation; *Significant difference between group 1 and group 2 (P < 0.05)) 
Reference interval for serum creatinine concentration: 71 – 212 µmol/L.  
Reference interval for serum urea concentration: 5.7 – 12.9 mmol/L. 
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Table 4.4. Abnormalities observed during ultrasonographic evaluation of the kidneys, liver 
and urinary bladder in 133 Ragdoll and 62 control cats. For each evaluated ultrasonographic 
parameter, the proportion of cats that showed abnormalities (N) and a brief descript ion and 
localization of the abnormalities are presented in the table.  
 RAGDOLL CONTROL 
N Abnormalities N Abnormalities 
Renal capsule* 26/133 
(19.5%) 
Undulating or irregular (15 
bilateral, 9 only right, 2 
only left) 
5/62 
(8%) 
All bilateral undulating or 
irregular 
Renal shape 18/133 
(13.5%) 
Irregular or bumpy shape (8 
bilateral, 6 only right, 4 
only left) 
6/62 
(9.7%) 
5 bilateral irregular or 
bumpy shape, 1 more 
rounded but regular left 
kidney 
Cortical 
echogenicity 
20/133 
(15.0%) 
12 diffuse hyperechoic 
(1/12 hyperechoic striation 
radiating to the medulla), 7 
focal hyperechoic (5/7 focal 
triangular area due to 
segmental cortical lesion, 
1/7 hyperechoic spots, 1/7 
marbled appearance right 
kidney), 1 diffuse 
hypoechoic  
8/62 
(12.9%) 
5 diffuse hyperechoic, 2 
focal hyperechoic speckles, 
1 diffuse hypoechoic with 
focal round hypoechoic 
areas 
Medullar 
echogenicity 
7/133 
(5.3%) 
6 diffuse hyperechoic, 1 
medulla in two parts 
(echogenicity outer border 
between cortex and inner 
medulla) 
2/62 
(3.2%) 
2 diffuse hyperechoic 
Corticomedullary 
demarcation 
10/133 
(7.5%) 
8 bilateral reduced (1/8 also 
irregular), 1 only right 
reduced, 1 only left reduced 
5/62 
(8.1%) 
4 bilateral reduced, 1 
bilateral increased 
Medullary rim 
sign 
27/133 
(20.3%) 
21 bilateral present (1/21 
very thick and ill-defined), 
2 only right present, 4 only 
left 
11/62 
(17.7%) 
7 bilateral present (1/7 
thick and very echoic), 4 
only left present 
Dystrophic 
mineralization 
4/133 
(3.0%) 
3 focal in both kidneys (1/3 
in both pelvices and left 
diverticuli, 1/3 cortex, 1/3 
both pelvices), 1 focal only 
in right (corticomedullary 
junction) 
0/62 
(0.0%) 
/ 
Cavitary lesion 2/133 
(1.5%) 
1 with one (2.9 mm) cyst 
lesion with small echogenic 
structure in the cyst, 1 with 
one (4.5 mm) anechoic cyst 
cranial in left kidney  
1/62 
(1.6%) 
Several cysts in cortex of 
both kidneys (largest cyst 
right kidney: 16 mm; 
largest cyst left kidney: 6.9 
mm) 
*Significant difference between group 1 and group 2 (P < 0.05) 
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Table 4.4 Continued. 
 RAGDOLL CONTROL 
N Abnormalities N Abnormalities 
Solid mass/nodule 1/133 
(0.8%) 
1 cat with 1 small nodular 
lesion in left and 2 in right 
kidney  
1/62 
(1.6%) 
1 cat with 5 ill-defined 
round to oval hypoechoic 
areas in the cortex of both 
kidneys, deforming the 
renal contours  
Segmental 
cortical lesion* 
10/133 
(7.5%) 
3 bilateral, 4 only right, 3 
only left 
0/62 
(0.0%) 
/ 
Renal pelvis / 
proximal ureter 
3/133 
(2.3%) 
1 with 1.8 mm of right 
pelvis and hyperechoic 
spots in right proximal 
ureter, 2 focal 
mineralizations in both 
pelvices 
0/62 
(0.0%) 
/ 
Small kidney  
(< 3.2 cm) 
11/133 
(8.3%) 
2 bilateral, 2 only right, 7 
only left kidney 
6/62 
(9.7%) 
1 bilateral, 2 only right, 3 
only left kidney 
Large kidney size 
difference  
(> 0.7 cm) 
5/133 
(3.8%) 
2 right, 3 left kidney larger 1/62 
(1.6%) 
1 right kidney larger 
Urine* 69/133 
(51.9%) 
49 sediment, 17 speckles, 3 
other 
16/62 
(25.8%) 
3 sediment, 13 speckles 
Bladder uroliths 3/133 
(2.3%) 
1 sediment with acoustic 
shadow, 1 with one bladder 
urolith, 1 with three bladder 
uroliths 
1/62 
(1.6%) 
1 with one bladder urolith 
Retroperitoneal 
space 
0/133 
(0.0%) 
/ 0/62 
(0.0%) 
/ 
Liver: cysts 0/133 
(0.0%) 
/ 0/62 
(0.0%) 
/ 
Liver: 
parenchymal 
changes 
0/133 
(0.0%) 
/ 0/62 
(0.0%) 
/ 
Other findings 5/133 
(3.8%) 
3 pregnant, 1 small liver, 1 
enlarged uterus and 
possible metritis 
5/62 
(8%) 
3 pregnant, 1 pancreas cyst 
surrounded by hyperechoic 
parenchyma, 1 
splenomegaly 
*Significant difference between group 1 and group 2 (P < 0.05) 
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Table 4.5. The sum of abnormalities observed on ultrasonography of the kidneys in 133 
Ragdoll and 62 control cats. The parameters that were assessed to calculate this sum were 
abnormalities in renal capsule, renal shape, cortical echogenicity, medullar echogenicity, 
corticomedullary demarcation and renal pelvis; presence of small left kidney (< 3.2 cm), 
small right kidney (< 3.2 cm), large size difference between left and right kidney (absolute 
difference > 0.7 cm), medullary rim sign(s), dystrophic mineralization(s), cavitary lesion(s), 
solid mass(es)/nodule(s) and segmental cortical lesion(s). Multiple abnormalities of the same 
category (e.g. multiple segmental cortical lesions, multiple cavitary lesions) in the same cat 
were counted only once.  
N Ragdoll cats Control cats 
0 67 37 
1 35 13 
2 11 5 
3 8 5 
4 4 1 
5 3 1 
6 3 0 
7 0 0 
8 1 0 
9 1 0 
(N = number of abnormalities) 
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Discussion 
 
The main finding of this prospective study, in which serum creatinine and urea 
concentrations, urinalysis and renal ultrasonography were compared between healthy Ragdoll 
and age-matched non-Ragdoll control cats, was that SCLs occur more commonly in Ragdoll 
cats. Also, 5.3% of Ragdoll cats had ultrasonographic abnormalities suggestive of CKD and 
none of the Ragdoll cats was affected by PKD. Furthermore, the serum creatinine 
concentration and UPC did not differ between Ragdoll and control cats. In contrast, Ragdoll 
cats had lower serum urea concentrations and higher USG than control cats, but the clinical 
relevance of these findings is unknown.  
 
An important finding of this study is that serum creatinine concentrations did not 
differ between Ragdoll and control cats. In a retrospective study performed by our group, 
almost 11% of Ragdoll cats had serum creatinine concentrations exceeding the RI (Paepe et al 
2012). This raised the question if a breed-specific RI for serum creatinine should be 
developed for Ragdoll cats, as was reported for the Birman breed (Reynolds et al 2010). The 
low number of Ragdoll cats with serum creatinine concentration exceeding the RI in addition 
to similar serum creatinine concentrations in both cat populations in this study, suggest that 
this is not necessary for the Ragdoll breed.  
Crystalluria was observed in half of our Ragdoll and control cats, which is comparable 
to the 41% apparently healthy middle-aged and aged cats with crystalluria in a recent study 
(Paepe et al 2013). The low number of cats with urolithiasis in the present study confirms that 
crystalluria occurs commonly in healthy cats and that crystalluria per se is not a sufficient 
reason to start a calculolytic diet.  
The statistical differences in laboratory parameters between Ragdoll and control cats 
are probably not clinically relevant. The control cats had significantly higher serum urea 
concentrations, however all but one control cats had serum urea within RI. There were more 
control cats with poorly concentrated urine (USG < 1.035), resulting in significantly lower 
USG for control cats. However, none of the control cats with poorly concentrated urine had 
azotemia. Both in dogs and in cats, the USG can fluctuate over the day, many factors 
influence USG and a low USG without other indications for kidney disease does not 
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necessarily suggest decreased renal function (van Vonderen et al 1997, Stockham and Scott 
2008). It must be mentioned that USG in this study was measured with a traditional optical 
refractometer without separate scale for feline USG. Although it had been reported that these 
refractometers can overestimate the actual USG in feline urine (George 2001), a recent report 
has shown that this is not clinically relevant (Bennett et al 2011). Control cats were more 
likely to have glucosuria. However, none of the control cats with glucosuria showed or 
developed clinical signs of diabetes mellitus or showed other evidence (casts, mild 
proteinuria) for tubular dysfunction. Higher frequency of protein positivity on urinary dipstick 
in Ragdoll cats is probably not relevant because significant differences in UPC and in the 
proportion of cats with borderline and overt proteinuria were not observed between both 
populations. In addition, urinary dipstick tests are not very reliable to identify non-severe 
proteinuria, especially in cats with concentrated urine (Syme 2009).  
 
Segmental cortical lesions were seen more commonly in Ragdoll versus control cats. 
The ultrasonographic aspect of these lesions was in line with the ultrasonographic description 
of kidney infarcts in veterinary literature. Renal infarcts are described as linear or wedge-
shaped, well defined lesions in the renal cortex that are located perpendicular to the capsule, 
and may cause a dimple in the adjacent serosal surface. Initially, kidney infarcts are 
hypoechoic, but may become hyperechoic in the chronic state (Grooters and Biller 1995, 
Widmer et al 2004, d’Anjou 2008). 
Other pathogenic explanations besides renal infarction must be considered to explain 
the SCLs. Hyperechoic triangular to wedge-shaped cortical lesions, irregular kidney shape 
and cortical outline, as were seen in our cats with SCLs, also are ultrasonographic features of 
renal scarring in humans (Barry et al 1998). Segmental cortical scarring causing depression of 
the renal cortical surface has been described in humans and dogs with reflux nephropathy 
(Cargollo and Diamond 2007, Kolbjørnsen et al 2008). In humans, these renal scars mostly 
develop due to chronic nonobstructive pyelonephritis secondary to primary vesico-ureteral 
reflux (Cargollo and Diamond 2007). None of our cats with SCLs had a positive urine culture 
or a history of urinary tract infection. Whether sterile reflux results in renal damage remains 
controversial in humans (Cargollo and Diamond 2007). Renal scarring in humans occurs 
mostly in the polar segments of the kidney (Cargollo and Diamond 2007). In our study, cats 
were affected by single or double SCLs and the location varied from unilateral to bilateral and 
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from cranial to the caudal part of the kidney and most SCLs were observed in one of the 
kidney poles. 
Because SCLs were only observed in the Ragdoll and not in the control cat 
population, Ragdoll cats may have a breed-dependent increased susceptibility for SCL. 
Interestingly, brief pedigree analysis of the Ragdoll cats with SCLs showed two parent-
offspring combinations and several other cats that were related to each other. This may 
indicate a hereditary explanation for the SCLs.  
Major complications of renal scarring due to vesico-ureteral reflux and renal infarction 
in humans are hypertension and renal failure (Racusin and Pollack 2005, Cargollo and 
Diamond 2007, Tsai et al 2007). In addition, microscopic hematuria is commonly present in 
humans with acute renal infarction (Racusin and Pollack 2005, Tsai et al 2007). Indeed, some 
of our cats with SCLs showed mild to moderate urinary sediment abnormalities, such as 
microscopic hematuria. However, azotemic kidney disease and overt proteinuria was 
uncommon. Blood pressure was not evaluated in our cats, so hypertension cannot be excluded 
as underlying cause or consequence for SCLs in Ragdoll cats. Further studies will need to 
reveal the clinical significance and underlying cause for the SCLs observed in the Ragdoll 
cats. 
 
None of the control cats but 5.3% of the Ragdoll cats in this study showed 
ultrasonographic abnormalities suggestive of CKD. This percentage is mildly lower than the 
8.6% prevalence of CKD in Ragdoll cats in a recent retrospective study (Paepe et al 2012). 
Although we only found a trend towards significance (0.5 < P < 1), we cannot exclude that 
Ragdoll cats are predisposed to show ultrasonographic abnormalities compatible with CKD. 
However, it is important to remember that ultrasonography does not correlate with renal 
function and is not a useful tool to predict which cats will develop azotemic disease (Grooters 
and Biller 1995). In addition, the ultrasonographic findings do not imply that these cats were 
affected by CIN as several other diseases, such as glomerulonephritis, glomerulosclerosis, 
amyloidosis and nephrocalcinosis can result in similar ultrasonographic abnormalities 
(Widmer et al 2004). Follow-up of Ragdoll cats with ultrasonographic abnormalities 
suggestive of CKD is warranted to determine the clinical relevance of these findings. 
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In this study, PKD was only diagnosed in one Persian cat of the control group and in 
none of the included Ragdoll cats. In our retrospective study, PKD prevalence in Ragdoll cats 
of 2.9% was found (Paepe et al 2012). Although Ragdoll cats have been outcrossed with 
Persian cats in the past and could be at risk for PKD (Beck and Lavelle 2001), both studies 
indicate that PKD is uncommon in this population of Ragdoll cats.  
 
Ragdoll cats more frequently showed an undulating or irregular renal capsule and 
echogenic urine. The renal capsular abnormalities may in part be explained by the 
predisposition of Ragdoll cats for segmental cortical lesions or the presence of CKD in some 
cats. The predisposition for echogenic urine in Ragdoll cats may be explained by the different 
gender distribution of both populations. Intact male cats were predisposed for echogenic urine 
in this study, possibly because the presence of sperm, mucus or fat droplets resulted in turbid 
or cloudy urine (Stockham and Scott 2008).  
 
A remarkable finding of this study is that ultrasonographic abnormalities at the level 
of the kidney are very common in healthy cats, especially if the young age of our cat 
population is taken into account. To the authors’ knowledge, this is the first study that 
evaluated kidney ultrasonography in a large healthy cat population. Also, several commonly 
cited studies reporting ultrasonographic features of feline kidneys date from the eighties or 
early nineties (Walter et al 1987a, Walter et al 1987b, Walter et al 1988, Yeager and 
Anderson 1989, Biller et al 1992). Since then, the ultrasound devices and expertise have 
improved which may explain why minor changes nowadays are commonly detected. In half 
of the Ragdoll and 40% of the control cats at least one ultrasonographic abnormality was 
observed. Abnormalities that were seen in more than 10% of cats of both groups were the 
presence of a medullary rim sign and changes in cortical echogenicity, especially hyperechoic 
renal cortices. Although the significance of these abnormalities is still unknown (Yeager and 
Anderson 1989, Biller et al 1992, Widmer et al 2004, d’Anjou 2008), it is important that 
clinicians are aware that renal ultrasonographic abnormalities often occur in healthy cats. 
Further studies to evaluate which renal ultrasonographic abnormalities are clinically relevant 
are needed.  
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It is important to realize that disease prevalences are affected by the specific 
characteristics of the studied population (Hahn and Overley 2010), such as geography. All 
Ragdoll cats included in this study resided in Belgium or the Netherlands and the majority 
was born in the same area. However, 40% of Ragdoll cats were imported from different areas 
such as the United States, other European countries, Australia or New Zealand, Canada, or 
Israel. This means that the findings of this study are not just applicable for Ragdoll cats in the 
Benelux, but may be of interest for Ragdoll breeders all over the world. Secondly, a selection 
bias may have resulted in an underestimation of actual disease prevalence because most 
Ragdoll breeders that participated to this study had screened their cats over several 
generations. 
 
Although precise breeding recommendations cannot be made based on this study, it 
seems reasonable to discourage intensive breeding with Ragdoll cats with SCL(s) and obvious 
renal ultrasonographic changes. However, if Ragdoll breeders want to screen their Ragdoll 
cats for the presence of kidney disease, ultrasonography and measuring serum creatinine and 
urea concentrations must be combined with routine urinalysis. Concurrent urinalysis will 
facilitate the interpretation of serum urea and creatinine concentrations and is needed to detect 
kidney dysfunction (DiBartola 2010).  
 
 
Conclusion 
 
Based on this population, breed-specific serum creatinine RIs are not required for 
Ragdoll cats. Furthermore, renal ultrasonographic abnormalities are common in young 
healthy cats, both in Ragdoll and non-Ragdoll cats. Ragdoll cats are predisposed to segmental 
triangular to wedge-shaped cortical changes. Further studies are required to elucidate whether 
these lesions may represent renal infarction or cortical scarring and to determine the clinical 
implications of these SCLs. None of the Ragdoll cats was diagnosed with PKD, but 5.3% 
Ragdoll cats had clinically significant renal lesions based on ultrasonographic findings. 
Further studies are needed to identify if these cats are affected by CIN and whether they will 
develop azotemic kidney disease or not.   
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Addendum: Ultrasound protocol to evaluate the urinary system and liver 
 
Ultrasonographer:  
US parameters/lesions Patient number:                    Name:  
Renal capsule Smooth / irregular / undulating / thickened 
Renal shape Left kidney: regular / irregular 
Other:  
Right kidney: regular / irregular 
Other: 
Renal size (length in cm) Left kidney:                              
Right kidney:  
Renal echogenicity Cortex: 
*Diffuse: hypoechoic / normal / hyperechoic 
*Focal abnormalities: 
Medulla: 
*Diffuse: hypoechoic / normal / hyperechoic 
*Focal abnormalities: 
Corticomedullary 
distinction 
Good / reduced 
Medullary rim sign Absent / present 
Dystrophic mineralization Absent / present 
*linear / patchy / focal 
*location: 
Cavitary lesions Absent / cysts / abscess / hematoma 
*number:  
*size: 
*location: 
Solid mass / nodule Absent / present 
*number and size:  
*location: 
*description: 
 
Renal infarct Absent / present 
*number: 
*location: 
*description: 
 
Renal pelvis and proximal 
ureter 
Normal / enlarged 
*diameter: 
*remarks:   
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Bladder Filling: empty / moderately / severely distended 
Urine: anechoic / sediment / blood clot / other: 
Uroliths: absent / present 
*number: 
*size: 
*location: renal pelvis / ureter / bladder / urethra 
Retroperitoneal space Fluid: absent / present 
*anechoic / echoic 
Other:  
Liver Cysts: absent / present 
*number 
*size 
*location 
Parenchymal changes: absent / present 
*description: 
 
Additional findings not in 
the list 
*urinary tract:  
*other:  
 
 
After performing the US, the ultrasonographer must make conclusions.  
1) No abnormalities / abnormalities 
2) If abnormalities:  
o Are abnormalities clinically relevant? Yes / no / uncertain 
o Are abnormalities indicative of chronic kidney disease/chronic interstitial 
nephritis? Yes / no / uncertain 
o Is the cat affected by PKD? Yes / no 
o Comment why this is concluded:  
 
Renal agenesis or 
hypoplasia 
No / yes 
*left / right kidney 
*compensatory enlargement of other kidney? Yes / no 
Renal dysplasia No / yes 
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Summary 
 
Diabetic kidney disease (DKD) is a frequent and serious complication in human 
diabetic patients, but data are limited in cats. 
Kidney function was compared between cats with diabetes mellitus (DM), cats with 
chronic kidney disease (CKD) and age-matched healthy cats and between recently (< 1 
month) and not-recently diagnosed diabetic cats by measuring routine kidney variables (serum 
creatinine, serum urea, urine specific gravity (USG), urinary protein: creatinine ratio (UPC)), 
urinary Cystatin C: creatinine ratio (uCysC/uCreat) and glomerular filtration rate (GFR). 
Thirty-six diabetic cats (15 recently, 21 not-recently diagnosed), 10 cats with CKD 
and 10 healthy cats were prospectively recruited. Glomerular filtration rate was evaluated by 
exo-iohexol clearance in 17 diabetic cats, all cats with CKD and all healthy cats. In all cats 
but two diabetic cats, uCysC was measured with a human particle-enhanced nephelometric 
immunoassay, validated to measure feline Cystatin C (CysC). 
Diabetic cats had significantly lower serum creatinine (mean ± SD 123 ± 38 versus 
243 ± 80 µmol/L), serum urea (11 ± 3 versus 18 ± 7 mmol/L) and uCysC/uCreat (6 ± 31 
versus 173 ± 242 mg/mol) and significantly higher USG (1.033 ± 0.012 versus 1.018 ± 0.006) 
and GFR (2.0 ± 0.7 versus 0.8 ± 0.3 mL/min/kg) compared with cats with CKD. Compared 
with healthy cats, diabetic cats only had significantly lower USG (1.033 ± 0.012 versus 1.046 
± 0.008). None of these parameters significantly differed between recently and not-recently 
diagnosed diabetic cats. 
Based on evaluation of routine kidney variables, GFR and uCysC as a tubular marker 
at a single time point, a major impact of feline DM on kidney function could not be 
demonstrated. 
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Introduction 
 
 Both humans and cats are frequently affected by DM and the prevalence is rapidly 
increasing (Osto et al 2013, Reutens 2013). Diabetic kidney disease or diabetic nephropathy is 
a common and serious complication in human diabetics, particularly in type 2 DM. Diabetic 
nephropathy is characterized by glomerular alterations, resulting in altered GFR and micro- or 
macroalbuminuria, tubular damage and hypertension. In the prediabetic or early diabetic 
phase, GFR is often increased (glomerular hyperfiltration), whereas decreased GFR is a 
typical finding for patients with more prolonged diabetes (Reutens 2013, Ritz 2013, van 
Buren and Toto 2013). Although the detection of persistent renal (micro)albuminuria is often 
used as early marker for DKD, recent findings have revealed that renal impairment without 
albuminuria has become an increasingly common presentation of DKD in type 2 diabetic 
patients. Also, many patients with microalbuminuria never progress to renal dysfunction. 
Hence, more sensitive and specific markers for early detection of DKD are needed (Matheson 
et al 2010, Reutens 2013, Ritz 2013, Dwyer and Lewis 2013, Moresco et al 2013, Tramonti 
and Kanwar 2013). Many human patients with DKD have increased concentrations of urinary 
biomarkers indicating tubular damage, such as retinol-binding-protein (RBP), N-acetyl-β-D-
glucosaminidase, β-2 microglobulin, neutrophil-gelatinase associated lipocalin, kidney injury 
molecule 1 and liver-fatty acid-binding protein (Hong and Chia 1998, Matheson et al 2010, 
Moresco et al 2013, Tramonti and Kanwar 2013). Recent data show that uCysC, another 
marker of tubular dysfunction (Kim et al 2012, Togashi and Miyamoto 2013), might be a 
promising biomarker for early detection of DKD and for prediction of progression of renal 
impairment in type 2 diabetic patients (Kim et al 2011, Jeon et al 2011, Kim et al 2013, 
Togashi and Miyamoto 2013). 
As feline diabetic patients mostly suffer from type 2 DM, cats might be susceptible to 
develop DKD (Rand 2013, Bloom and Rand 2013). However, evidence whether or not feline 
diabetics are at risk for kidney disease is scarce. Nevertheless, a high prevalence of 
microalbuminuria and proteinuria has been described in diabetic cats (Al-Ghazlat et al 2011). 
On the other hand, hypertension is considered to be uncommon in diabetic cats (Norris et al 
1999, Sennello et al 2003, Al-Ghazlat et al 2011), in contrast to human diabetic patients. 
Additionally, histological lesions of the kidney were not more frequent in diabetic cats 
Chapter 5. Diabetic cats 
 
150 
 
compared with cats that died from other diseases (Zini et al 2012). To the authors’ 
knowledge, data on GFR and urinary biomarkers in cats with DM are currently lacking.  
Therefore, this study mainly aimed to evaluate GFR and uCysC in cats with DM. 
These parameters and routine kidney variables, i.e. serum creatinine and urea concentrations, 
USG and UPC, were prospectively compared between cats with DM, cats with CKD and 
healthy cats. The second objective was to evaluate the influence of duration of DM on kidney 
function, by comparing the same parameters between recently and not-recently diagnosed 
diabetic cats.  
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Materials and Methods 
 
Animals 
Cats with DM, cats with CKD and healthy cats were prospectively included. Diabetes 
mellitus was diagnosed based on compatible clinical signs, persistent hyperglycemia and 
glucosuria. Recently diagnosed DM cats were defined as cats that had received insulin 
therapy for less than 1 month. Not-recently diagnosed DM cats had received insulin for more 
than 1 month. Cats with intermittent episodes of diabetic remission (i.e. no insulin required to 
maintain normoglycemia for at least 4 weeks) and relapse of overt DM were included in the 
not-recently diagnosed DM group, also if the current insulin treatment duration was less than 
1 month. Glycemic control was evaluated based on the combination of history, bodyweight, 
blood glucose level, serum fructosamine concentration, and, if available, blood glucose curve 
in the hospital or at home. Glycemic control was considered good if all these parameters 
indicated good metabolic control (e.g. absence of polyphagia, polydipsia, polyuria; stable 
bodyweight; blood glucose level of 10 – 15 mmol/L with serum fructosamine < 470 µmol/L). 
Glycemic control was considered poor if all of these parameters indicated poor glycemic 
control (e.g. presence of polyphagia, polydipsia, polyuria, weight loss; blood glucose > 15 
mmol/L; serum fructosamine > 600 µmol/L). The diabetes was considered moderately 
controlled in cats with several (at least 2) parameters indicating poor glycemic control and the 
other parameters indicating good glycemic control. The diagnosis of CKD was based on 
compatible clinical signs and renal azotemia. Healthy was defined as absence of clinical signs 
and significant abnormalities on physical examination and routine laboratory analysis (see 
below). Efforts were taken to age-match the healthy cats to the diabetic cats.  
Routine physical examination (including thyroid gland palpation), complete blood 
count, serum biochemistry profile (including total thyroxin concentration in cats older than 6 
years), and urinalysis (including UPC and bacterial culture) were performed to assess the 
general health status of all included cats. Exclusion criteria for all groups were presence of 
hyperthyroidism or concurrent significant systemic disease and treatment with angiotensin-
converting enzyme inhibitors and antihypertensive drugs at the time of inclusion. The 
presence of azotemia was not an exclusion criterion for the DM group. Diabetic cats that were 
in diabetic remission and did not receive insulin therapy were not included. In the CKD 
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group, only cats with International Renal Interest Society (IRIS) stages 2 – 3 were included 
(IRIS 2009). 
The study was completed at the Department of Small Animal Medicine and Clinical 
Biology, Faculty of Veterinary Medicine, Ghent University. All cats were privately owned, 
the owners were thoroughly informed about the study aims and protocol, and the study was 
approved by local and national ethical committees (EC2010_029). 
 
Procedures 
Routine kidney variables were measured in all cats, namely serum creatinine 
(modified Jaffe assay
a
; reference interval (RI) 44 – 133 µmol/L), serum urea (enzymatic 
assay
a
; RI 6.2 – 11 mmol/L), USG (traditional hand-held optical refractometer) and UPCb. To 
evaluate if proteinuria was of renal origin, urine bacterial culture
c
 was performed and the 
urinary sediment was evaluated as previously described (Paepe et al 2013a, Paepe et al 
2013b). The tubular marker uCysC was determined in all cats. Urine was frozen at -80°C until 
batched analysis. The uCysC concentration was measured with a human particle-enhanced 
nephelometric immunoassay
d
, previously validated to measure feline CysC (Ghys et al In 
press), and expressed as uCysC: urinary creatinine ratio (uCysC/uCreat). Serum fructosamine 
concentration (colorimetric assay
a
; RI < 290 µmol/L) was measured only in diabetic cats.  
 A combined plasma exogenous creatinine-iohexol clearance test (PEC-ICT) was 
performed in cats of ≥ 3 kg bodyweight with easy, unstressed and nonaggressive behavior and 
for which the owner gave permission. Cats with CKD IRIS stage 4 were not eligible for GFR 
determination. The PEC-ICT was performed as previously reported (van Hoek et al 2007, van 
Hoek et al 2008a). Briefly, all cats received 40 mg/kg creatinine and 64.7 mg/kg iohexol 
intravenously. Blood samples were taken in tubes with ethylenediaminetetraacetic acid as 
anticoagulant before and 5, 15, 30, 60, 120, 180, 360, 480 and 600 minutes after injection. 
Plasma was frozen at -80°C until analyzed. For this study, the data of the exo-iohexol 
clearance test was used to compare GFR between the 3 groups of cats. Exo- and endo-iohexol 
concentrations were determined by a validated high-performance liquid chromatography 
method with ultraviolet detection (van Hoek et al 2007, De Baere et al 2012). 
Pharmacokinetic analyses were performed using WinNonlin
e
. The plasma data were subjected 
to noncompartmental analysis with a statistical moment approach. The area under the plasma 
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concentration-versus-time curve (AUC) was calculated by the trapezoidal rule with 
extrapolation to infinity, as described by Watson et al (2002). Plasma clearance of exo-
iohexol was determined by dividing exo-iohexol dose administered by AUC and indexed to 
bodyweight (mL/min/kg). 
 The study design included systolic blood pressure (SBP) measurement in all cats that 
underwent a clearance test for GFR determination. Whether or not SBP was measured in the 
other cats depended on the responsible clinicians’ decision. To measure SBP, the Doppler 
ultrasonic technique and a standardized procedure following the consensus statement of the 
American College of Veterinary Internal Medicine (ACVIM) (Brown et al 2007) were used. 
Hypertension was defined as SBP > 160 mmHg (Brown et al 2007, Stepien 2010). 
 
Statistical analysis 
All statistical tests were performed with statistical software
f
 and at the 0.05 
significance level. 
The effect of the disease (DM, CKD, healthy) on age, bodyweight, SBP, serum 
creatinine, serum urea, USG, UPC, uCysC/uCreat and GFR was tested by ANOVA. Within 
the DM group, ANOVA was also used to evaluate the effect of history (recently versus not-
recently diagnosed DM) on the same parameters and on serum fructosamine concentration. In 
case of a global significant difference, post-hoc pairwise comparisons were performed using 
the Tukey test. For cats with uCysC concentrations below the limit of quantification, the 
uCysC concentration was considered to be “zero” for the statistical analysis.   
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Results 
 
 In total, 56 cats were included, namely 36 diabetic cats (15 recently diagnosed, 21 not 
recently diagnosed), 10 cats with CKD and 10 healthy cats. Routine kidney variables (serum 
creatinine, serum urea, USG and UPC) and uCysC/uCreat were measured in all cats, except 
for serum urea in one diabetic cat and uCysC/uCreat in two diabetic cats because of 
insufficient sample volume. The exo-iohexol GFR was determined in 17 cats with DM (8 
recently diagnosed, 9 not recently diagnosed), all cats with CKD and all healthy cats. Because 
of technical problems SBP could not be measured in 3 of the diabetic and 1 healthy cat(s) that 
underwent a clearance test. In total, SBP was measured in 20 diabetic cats, all CKD cats and 9 
healthy cats. Serum fructosamine concentration was unavailable in 3 cats with DM. Eight of 
the 15 recently diagnosed diabetic cats were not yet treated with insulin at time of inclusion, 
the other 7 received insulin for a period between 2 and 4 weeks. The mean ± SD insulin 
treatment duration for the not recently diagnosed diabetic cats was 12.9 ± 15.3 months. Six 
cats were treated longer than 1.5 years, the others were treated between 1 month and 1 year. 
Four cats intermittently received insulin, but all of the not recently diagnosed diabetic cats 
were receiving insulin treatment at the time of inclusion. Of the 21 not recently diagnosed 
diabetic cats, glycemic control was good in 4, moderate in 6 and poor in 11 patients.  
Breed distribution consisted of 29 domestic short- or longhaired cats and 7 purebred 
cats (2 Burmese, 1 Siamese, 1 Russian Blue, 1 Oriental, 1 British shorthair, 1 Norwegian 
forest cat) in the diabetic group; 7 domestic short- or longhaired cats and 3 purebred cats (1 
British shorthair, 1 Persian, 1 Siamese cat) in the group of CKD cats and 10 domestic short- 
or longhaired cats in the group of healthy cats. The diabetic group involved 27 male (25 
neutered, 2 intact) and 9 female (7 neutered, 2 intact) cats and the CKD and healthy cat 
groups involved 3 male (all neutered) and 7 female (all neutered) cats.  
Because the available RI is inappropriate for interpretation of certain laboratory 
parameters in aged cats (Paepe et al 2013a), the mean concentration + 2 SD of the healthy 
cats was used as upper reference limit. Four diabetic cats had serum creatinine concentration 
> 160 µmol/L. Similarly, 5 diabetic cats had serum urea concentration > 14 mmol/L. Four 
diabetic, 8 CKD but no healthy cats had USG between 1.007 – 1.020; 17 diabetic, 2 CKD and 
1 healthy cat had USG between 1.021 – 1.035 and 15 diabetic, 0 CKD and 9 healthy cats had 
USG between 1.036 – 1.060. Glucosuria was detected in 29 diabetic cats but all other cats 
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were negative on urine dipstick for glucose. Ketonuria was not detected in any of the cats. 
According to the ACVIM Consensus Statement on proteinuria (Lees et al 2004), 23 cats did 
not have proteinuria (UPC < 0.2; 14 DM, 3 CKD, 6 healthy cats), 16 had borderline 
proteinuria (UPC 0.2 – 0.4; 8 DM, 4 CKD, 4 healthy cats) and 17 had overt proteinuria (UPC 
> 0.4; 14 DM, 3 CKD, 0 healthy cats). The urine bacterial culture was unavailable in one 
diabetic cat but was negative in all other cats. Urinary sediment analysis revealed microscopic 
hematuria in 2 cats (1 DM, 1 CKD) and a moderate amount of struvite crystals (6 per low 
power field) in 1 healthy cat. The urinary sediment of the other cats did not show significant 
abnormalities. 
Hypertension was present in 2 diabetic cats (SBP 165 and 220 mmHg), none of the 
cats with CKD and in 2 healthy cats (SBP 180 and 190 mmHg). All other cats were 
normotensive. The diabetic cat with SBP 165 mmHg also had mild proteinuria (UPC 0.5) but 
otherwise normal kidney parameters, including GFR. Although recommended, repeated SBP 
measurement was not performed. This cat was euthanized approximately 1 year after 
inclusion because of relapse of overt DM after a period of diabetic remission. Clinical signs of 
CKD were never noticed, but laboratory tests were not repeated after inclusion. The other 
hypertensive diabetic cat (SBP 220 mmHg) had mild azotemia with USG 1.020 and 
proteinuria (UPC 1.1), GFR was not measured in this cat. Repeated SBP measurements 
confirmed hypertension and further work-up revealed iatrogenic hypothyroidism. Both 
healthy cats with hypertension were very anxious during the examination which makes white-
coat hypertension most likely. 
The descriptive statistics for the parameters age, bodyweight, SBP, serum creatinine, 
serum urea, USG, UPC, uCysC/uCreat and GFR of the 3 groups are presented in Table 5.1. 
The box-plots for the GFR values of the 3 groups is shown in Fig 5.1. Between the 3 groups 
(DM, CKD, healthy) significant differences were not detected for the parameters age, 
bodyweight, SBP, and UPC. Cats with DM had significantly lower serum creatinine and 
serum urea (P < 0.001), higher USG (P = 0.001), lower uCysC/uCreat (P < 0.001) and higher 
GFR (P < 0.001) than cats with CKD. The same parameters also significantly differed 
between healthy cats and cats with CKD, which was expected based on our inclusion criteria. 
Diabetic cats only had significantly lower USG compared to healthy cats (P = 0.002).  
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Table 5.1. Mean ± SD [median (range)] age, bodyweight, systolic blood pressure (SBP), 
serum creatinine concentration (sCreat), serum urea concentration (sUrea), urine specific 
gravity (USG), urinary protein: creatinine ratio (UPC), urinary Cystatin C: creatinine ratio 
(uCysC/uCreat) and exo-iohexol glomerular filtration rate (GFR) for 36 cats with diabetes 
mellitus (DM), 10 cats with chronic kidney disease (CKD) and 10 healthy cats. Age, 
bodyweight, sCreat, USG and UPC were available in all cats, sUrea in all cats except for 1 
DM cat, uCysC/uCreat in all cats except for 2 DM cats, GFR in 17 diabetic cats and in all 
CKD and healthy cats and SBP in 20 diabetic cats, all CKD and 9 healthy cats.  
 DM CKD Healthy 
Age  
(years) 
10.7 ± 3.0 
[10.9 (5-17.4)] 
11.0 ± 6.0 
[9.9 (2.3-20)] 
10.5 ± 3.8 
[11.0 (3-14.6)] 
Bodyweight  
(kg) 
5.1 ± 1.4 
[4.9 (2.4-8.5)] 
4.4 ± 1.3 
[4.1 (3.0-7.5)] 
4.5 ± 1.1 
[4.5 (3-6.6)] 
SBP  
(mmHg) 
133 ± 28 
[130 (91-220)] 
133 ± 14 
[136 (106-150)] 
143 ± 28 
[132 (103-190)] 
sCreat 
(µmol/L)
*$
 
123 ± 38 
[114 (68-229)] 
243 ± 80 
[197 (158-383)] 
108 ± 26 
[98 (80-162)] 
sUrea  
(mmol/L)
*$
 
10.9 ± 3.3 
[10.3 (5.3-20.2)] 
18.3 ± 6.8 
[16.2 (8.2-28.3)] 
9.4 ± 2.3 
[9.0 (6.7-14.5)] 
USG
*§$
 1.033 ± 0.012 
[1.030 (1.010-1.060)] 
1.018 ± 0.006 
[1.017 (1.010-1.030)] 
1.046 ± 0.008 
[1.047 (1.030-1.060)] 
UPC 0.39 ± 0.28 
[0.33 (0.09-1.12)] 
0.41 ± 0.39 
[0.23 (0.07-1.21)] 
0.19 ± 0.06 
[0.19 (0.06-0.29)] 
uCysC/uCreat 
(mg/mol)
*$
 
6.2 ± 30.6 
[< LOQ (< LOQ-177.7)] 
172.7 ± 241.7 
[3.4 (< LOQ-585.6)] 
< LOQ 
 
GFR  
(mL/min/kg)
*$
 
2.0 ± 0.7 
[1.9 (1.0-3.8)] 
0.8 ± 0.3 
[0.7 (0.5-1.4)] 
2.1 ± 0.4 
[2.2 (1.4-2.6)] 
(< LOQ = uCysC below limit of quantification (0.049 mg/L) (Ghys et al In Press); 
*
Significant difference between cats with DM and CKD; 
§
Significant difference between cats 
with DM and healthy cats; 
$
Significant difference between cats with CKD and healthy cats)  
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Fig 5.1. Box-plots of exo-iohexol glomerular filtration rate (GFR; in mL/min/kg) for cats 
with diabetes mellitus (DM; n = 17), cats with chronic kidney disease (CKD; n = 10) and 
healthy cats (H; n = 10). 
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The descriptive statistics for the parameters age; bodyweight; SBP; serum creatinine; 
serum urea; serum fructosamine concentration; USG; UPC; uCysC/uCreat and GFR for 
recently and not recently diagnosed diabetic cats are presented in Table 5.2. Mean age was 
significantly lower in recently diagnosed than in not recently diagnosed diabetic cats (P = 
0.026). The other evaluated parameters did not significantly differ between both groups. 
 
Table 5.2. Mean ± SD [median (range)] age, bodyweight, systolic blood pressure (SBP), 
serum creatinine concentration (sCreat), serum urea concentration (sUrea), serum 
fructosamine concentration, urine specific gravity (USG), urinary protein: creatinine ratio 
(UPC), urinary Cystatin C: creatinine ratio (uCysC/uCreat) and exo-iohexol glomerular 
filtration rate (GFR) for 15 cats with recently diagnosed diabetes mellitus (DM) and 21 cats 
with not-recently diagnosed DM. Age, bodyweight, sCreat, USG and UPC were available in 
all cats. SBP was measured in 9 recently and 11 not-recently and GFR in 9 recently and 8 not-
recently diagnosed DM cats. sUrea was unavailable in 1 not-recently diagnosed DM cat, 
serum fructosamine in 1 recently and 2 not-recently diagnosed DM cats, uCysC/uCreat in 1 
recently and 1 not-recently diagnosed DM cat.  
 Recently diagnosed DM Not-recently diagnosed DM 
Age  
(years)
*
 
9.4 ± 3.6 
[9.0 (5.0-17.4)] 
11.6 ± 2.2 
[12.0 (6.0-14.3)] 
Bodyweight  
(kg) 
5.0 ± 1.5 
[4.9 (2.4-7.8)] 
5.2 ± 1.3 
[4.9 (3.1-8.5)] 
SBP  
(mmHg) 
128 ± 20 
[130 (100-165)] 
136 ± 33 
[130 (91-220)] 
sCreat  
(µmol/L) 
111 ± 34 
[95 (72-197)] 
131 ± 40 
[124 (68-229)] 
sUrea  
(mmol/L) 
10.0 ± 3.1 
[10.3 (5.7-17.7)] 
11.5 ± 3.4 
[10.5 (5.3-20.2)] 
Fructosamine  
(µmol/L) 
555 ± 130 
[544 (364-891)] 
487 ± 177 
[445 (262-914)] 
USG 1.032 ± 0.012 
[1.035 (1.010-1.050)] 
1.033 ± 0.013 
[1.030 (1.010-1.060)] 
UPC 0.37 ± 0.18 
[0.40 (0.14-0.80)] 
0.40 ± 0.33 
[0.26 (0.09-1.12)] 
uCysC/uCreat  
(mg/mol) 
13.3 ± 47.4 
[< LOQ (< LOQ-177.7)] 
1.1 ± 5.1 
[< LOQ (< LOQ-22.9)] 
GFR  
(mL/min/kg) 
2.2 ± 0.7 
[1.9 (1.7-3.8)] 
1.9 ± 0.6 
[1.8 (1-2.8)] 
(< LOQ = uCysC below limit of quantification (0.049 mg/L) (Ghys et al In Press); 
*
Significant difference between recently and not-recently diagnosed DM cats)  
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Discussion 
 
This study evaluated if DKD complicates feline DM as it does in human medicine. 
Therefore routine kidney variables, a tubular urinary marker and GFR of diabetic cats were 
compared with those of healthy cats and cats with CKD at a single time point. A major impact 
of feline DM on kidney function could not be demonstrated.  
Most parameters significantly differed between cats with DM and CKD, which 
indicates that our diabetic cats did not have obvious renal dysfunction. Compared to healthy 
cats, our diabetic cats only had significantly lower USG. As most of our diabetic cats had 
glucosuria, the lower USG is probably related to osmotic diuresis. This hypothesis is 
strengthened by the fact that most of our diabetic cats had USG > 1.020 which reflects renal 
concentrating ability in polyuric glucosuric animals. On the other hand, it should be kept in 
mind that marked glucosuria may falsely increase USG (Stockham and Scott 2008). 
In our diabetic group, an increased serum creatinine concentration and serum urea 
concentration was detected in 11.1% and in 14.3% of the cats, respectively. Our findings are 
somewhat lower compared to a recent study, where 17% of newly diagnosed cats with DM or 
diabetic ketoacidosis had an increased serum creatinine concentration (Callegari et al 2013). 
In the latter study, having a higher serum creatinine concentration at diagnosis appeared to be 
associated with decreased survival time, but whether the azotemia of these diabetic cats was 
pre-renal or renal in origin was not reported.  
Although the mean UPC was higher in diabetic cats than in healthy cats and 
approximately 40% of diabetic cats had proteinuria compared to none of the healthy cats, this 
did not result in a statistically significant different UPC between both groups. The prevalence 
of proteinuria in diabetic cats has been evaluated in 2 studies. Sennello et al (2003) did not 
detect proteinuria in 12 diabetic cats, but a cut-off for proteinuria of 1 was used, which is 
nowadays considered high based on the ACVIM Consensus on proteinuria (Lees et al 2005). 
In contrast, in a more recent study in 66 cats, 75% of feline diabetics had UPC > 0.4 and the 
UPC of diabetic cats was significantly higher compared to UPC of healthy and sick control 
cats (Al-Ghazlat et al 2011). Differences in proteinuria prevalence between the latter and our 
study might be explained either by technical or methodological differences in UPC 
measurement (Rossi et al 2012) or by differences in study population such as duration of DM 
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and degree of glycemic control. The conflicting results of studies evaluating proteinuria in 
diabetic cats might argue for further investigation, for instance by measuring urinary albumin: 
creatinine ratio (UAC). In human studies, proteinuria is more commonly quantified by 
measuring UAC than by UPC, both in diabetic as in non-diabetic patients. Although 
microalbuminuria is useful as early marker for DKD, there is no obvious evidence that UAC 
is superior to UPC once overt albuminuria is present (Reutens 2013, Fisher et al 2013). The 
effect of DM on UAC is poorly studied in veterinary medicine and data are currently 
unavailable in cats. In one study in diabetic dogs, an increase in UPC and UAC was 
commonly present and some diabetic dogs only had an increased UAC with normal UPC 
value. Thus UAC might have additional value to UPC for the detection of early renal damage 
in diabetic dogs (Mazzi et al 2008). An important remaining question is whether this low-
level proteinuria (UPC 0.4 – 1), that commonly affects feline diabetic patients, is an early 
marker for more severe renal dysfunction and whether these cats will develop DKD with 
more prolonged DM? Indeed, in cats with CKD, it is accepted that low-level proteinuria is a 
negative prognostic factor (Syme et al 2006, Kuwahara et al 2006, King et al 2007). On the 
other hand, the prognostic significance of low-level proteinuria in nonazotemic cats is less 
studied. However, preliminary data indicate that it might be associated with reduced survival 
times (Walker et al 2004). Borderline proteinuria was detected in 22% of diabetic cats and 
40% of healthy cats. A high prevalence of borderline proteinuria in apparently healthy cats 
has recently been reported by our group, but the clinical significance of this finding remains 
unknown (Paepe et al 2013a, Paepe et al 2013b).  
Altered GFR, initial glomerular hyperfiltration and in a later stage glomerular 
hypofiltration, is typical for DKD in humans (Mogensen et al 1983, Reutens 2013). In 
contrast, our diabetic cats did not show significant changes in GFR compared to healthy cats. 
Only one of the diabetic cats, diagnosed with DM the day before entering the study, was 
suspected of glomerular hyperfiltration (Fig 5.1). The GFR of this cat exceeded the GFR 
values for healthy cats of the current study and a previous study from our group (Paepe et al 
Submitted; see Chapter 6) and also exceeded the mean GFR value for hyperthyroid cats (3.3 
mL/min/kg; van Hoek et al 2009a). Only one diabetic cat had GFR below the low GFR cut-
off (1.2 mL/min/kg) for exo-iohexol clearance of the same previous study (Paepe et al 
Submitted; see Chapter 6). This indicates that almost all our diabetic cats had normal GFR.  
In contrast to human diabetic patients that frequently suffer from hypertension, 
particularly patients with type 2 DM (Van Buren and Toto 2013), only 10% of our diabetic 
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cats had hypertension. This is comparable to 15% previously found in cats (Al-Ghazlat et al 
2011). In two other reports, hypertension was not detected in any of the diabetic cats, but a 
cut-off of 180 mmHg was used to define hypertension (Norris et al 1999, Sennello et al 
2003). Although the latter two studies are limited by this inappropriately high cut-off to define 
hypertension (Brown et al 2007), the current veterinary literature suggests that hypertension is 
uncommon in feline diabetic patients.  
In our study, we could not detect significant differences in uCysC levels between 
diabetic and healthy cats. However, this parameter needs to be interpreted cautiously, because 
most diabetic cats (n = 31) had undetectable uCysC concentrations. Somewhat unexpected, 
uCysC also could not be found in several cats with CKD (n = 5). In contrast, in a previous 
study – using the same human nephelometric assay – all cats with CKD, but none of the 
healthy cats, had measurable uCysC concentrations (Ghys et al In Press). The urine samples 
of our study were stored up to 3 years at -80°C before CysC analysis, compared to maximum 
1.4 years in the study of Ghys et al. Cystatin C is considered to be a stable protein in human 
medicine and freezing or freeze/thaw cycles do not affect its concentrations (Herget-
Rosenthal et al 2004, Séronie-Vivien et al 2008, Gislefoss et al 2009). Therefore, stability of 
uCysC was assumed, but the stability of feline CysC in serum and urine is still under 
investigation. Although uCysC is a good marker for early detection of diabetic nephropathy in 
human medicine, it is possible that uCysC is a less ideal tubular marker in cats. Another 
tubular marker that has been studied in cats is retinol-binding protein (RBP) (van Hoek et al 
2008b, van Hoek et al 2009b). In an in-house pilot study, significant differences in exo-
iohexol GFR and urinary RBP: uCreat ratio were not detected between 7 diabetic and 5 age-
matched healthy cats (Paepe et al 2007). The combined results of both urinary markers might 
indicate that cats with DM are less sensitive to tubular damage compared to human diabetics.  
Humans with DKD may have variable structural changes of the kidneys, even before 
renal dysfunction occurs. The most typical structural renal changes of DKD are thickening of 
the glomerular and/or tubular basement membrane and mesangial expansion (Dalla Vestra 
and Fioretto 2003, Fioretto and Mauer 2007). Although a small study of cats with persistent 
hyperglycemia detected similar changes in some cats (Nakayama et al 1990), a recent study 
did not detect more frequent histological glomerular, tubulointerstitial and vascular lesions in 
the kidney of diabetic cats compared with cats that died from other diseases (Zini et al 2012). 
The latter study is in line with our findings suggesting that DKD does not seem to be of major 
importance in feline diabetic patients. Unfortunately, both veterinary studies only evaluated 
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the kidneys by light microscopy (Nakayama et al 1990, Zini et al 2012). Maximum 
information can only be obtained by evaluating kidney biopsies with a combination of light-, 
electron- and immunofluorescent microscopy (Segev 2010, Vaden 2010) as is routinely 
performed in human diabetic patients (Suzuki et al 2001, Penescu and Mandache 2010, Zhuo 
et al 2013). 
 
Our study was limited by not measuring GFR and SBP in all diabetic cats. Secondly, 
the patients were evaluated only at a single time point without performing follow-up. We 
were also not able to evaluate the influence of glycemic control on kidney function because 
only a small number of cats had good glycemic control at the time of inclusion. Finally, the 
different gender and breed distribution between groups may be potential confounding factors. 
 
Conclusion 
 
By evaluating routine kidney variables, GFR and uCysC as a tubular marker at a 
single time point, we could not demonstrate a major impact of feline DM on kidney function. 
In cats with concurrent DM and CKD, the question whether DM (partially) causes CKD or 
whether both diseases are unrelated cannot be fully answered. Still, current veterinary 
literature does not support a strong relationship between both diseases. However, follow-up 
studies, mainly to reveal the clinical significance of low-level proteinuria, are required in 
diabetic cats.  
  
Chapter 5. Diabetic cats 
163 
 
End notes 
 
a
Architect C16000, Abbott, Wiesbaden, Germany 
b
Iricell IQ, Instrumentation Laboratory, Zaventem, Belgium 
c
BioMerieux Media Square, Brussels, Belgium 
d
Behring Nephelometer (BN) ProSpec, Siemens Healthcare Diagnostics, Marburg, Germany 
e
WinNonlin Version 4.0.1, Scientific Consulting Inc Apex, NC, USA 
f
Systat 12, Systat Software Inc, San Jose, CA, USA 
 
Acknowledgements 
 
The authors wish to thank Ms. J. Lambrecht and Mrs. E. Lecocq for their laboratory 
assistance. 
 
  
Chapter 5. Diabetic cats 
 
164 
 
REFERENCES 
 
Al-Ghazlat SA, Langston CE, Greco DS, Reine NJ, May SN, Schofer FS. The prevalence of 
microalbuminuria and proteinuria in cats with diabetes mellitus. Top Companion Anim 
Med 2011; 26: 154-157. 
Bloom CA, Rand JS. Diabetes and the kidney in human and veterinary medicine. Vet Clin 
North Am Small Anim Pract 2013; 43: 351-365. 
Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, 
Labato M, Littman M, Polzin D, Ross L, Snyder P, Stepien R. Guidelines for the 
identification, evaluation, and management of systemic hypertension in dogs and cats. J 
Vet Intern Med 2007; 21: 542-558. 
Callegari C, Mercuriali E, Hafner M, Coppola LM, Guazzetti S, Lutz TA, Reusch CE, Zini E. 
Survival time and prognostic factors in cats with newly diagnosed diabetes mellitus: 114 
cases (2000-2009). J Am Vet Med Assoc 2013; 243: 91-95. 
Dalla Vestra M, Fioretto P. Diabetic nephropathy: renal structural studies in type 1 and type 2 
diabetic patients. Int Congr Ser 2003; 1253: 163-169. 
De Baere S, Smets P, Finch N, Heiene R, De Backer P, Daminet S, Croubels S. Quantitative 
determination of exo- and endo-iohexol in canine and feline samples using high 
performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 
2012; 61: 50-56. 
Dwyer JP, Lewis JB. Nonproteinuric diabetic nephropathy. Med Clin North Am 2013; 97: 53-
58. 
Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol 2007; 27: 195-
207. 
Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine 
protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a 
cross-sectional analysis. Am J Kidney Dis 2013; 62: 1102-1108. 
Ghys LFE, Meyer E, Paepe D, Delanghe J, Daminet S. Analytical validation of the particle-
enhanced nephelometer for cystatin C measurement in feline serum and urine. Vet Clin 
Pathol. In Press. DOI: 10.1111/vcp.12144. 
Gislefoss RE, Grimsrud TK, Mørkrid L. Stability of selected serum proteins after long-term 
storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47: 596-603. 
Herget-Rosenthal S, Feldkamp T, Volbracht L, Kribben A. Measurement of urinary Cystatin 
C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and 
reference range. Ann Clin Biochem 2004; 41: 111-118. 
Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998; 12: 
43-60. 
Chapter 5. Diabetic cats 
165 
 
International renal interest society (IRIS). IRIS staging of CKD. http://www.iris-
kidney.com/pdf/IRIS2009_Staging_CKD.pdf 2009. (Accessed 26 November 2013). 
Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ. 
Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean 
Med Sci 2011; 26: 258-263. 
Kim MR, Choi BG, Kang JH, Jeon YK, Kim SS, Kim BH, Lee CW, Kim YK, Kim IJ. 
Increased urinary excretion of Cystatin C predict renal impairment in type 2 diabetes 
[abstract]. Diabetologia 2011; 54 (Suppl): S441. 
Kim JS, Kim MK, Lee JY, Han BG, Choi SO, Yang JW. The effects of proteinuria on urinary 
Cystatin C and glomerular filtration rate calculated by serum Cystatin C. Renal Fail 2012; 
6: 676-684.  
Kim SS, Song SH, Kim IJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK. Urinary Cystatin 
C and tubular proteinuria predict progression of diabetic nephropathy. Diabetes Care 2013; 
36: 656-661. 
King JN, Tasker S, Gunn-Moore DA, Strehlau G, and the BENRIC (benazepril in renal 
insufficiency in cats) Study group. Prognostic factors in cats with chronic kidney disease. J 
Vet Intern Med 2007; 21: 906-916. 
Kuwahara Y, Ohba Y, Kitoh K, Kuwahara N, Kitagawa H. Association of laboratory data and 
death within one month in cats with chronic renal failure. J Small Anim Pract 2006; 47: 
446-450. 
Lees GE, Brown SA, Elliott J, Grauer GF, Vaden SL. Assessment and management of 
proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J 
Vet Intern Med 2005; 19: 377-385.  
Matheson A, Willcox MDP, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 
diabetes: a review. Diabetes Metab Res Rev 2010; 26: 150-171. 
Mazzi A, Fracassi F, Dondi F, Gentilini F, Bergamini PF. Ratio of urinary protein to 
creatinine and albumin to creatinine in dogs with diabetes mellitus and 
hyperadrenocorticism. Vet Res Commun 2008; 32 (Suppl 1): S299-S301. 
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with 
emphasis on the stages of incipient diabetic nephropathy. Diabetes 1983; 32 (Suppl 2): 
S64-S78.  
Moresco RN, Sangoi MB, De Carvalho JAM, Tatsch E, Bochi GV. Diabetic nephropathy: 
Traditional to proteomic markers. Clin Chim Acta 2013; 421: 17-30.  
Nakayama H, Uchida K, Ono K, Goto N. Pathological observation of six cases of feline 
diabetes mellitus. Jpn J Vet Sci 1990; 52: 819-822. 
Norris CR, Nelson RW, Christopher MM. Serum total and ionized magnesium concentrations 
and urinary fractional excretion of magnesium in cats with diabetes mellitus and diabetic 
ketoacidosis. J Am Vet Med Assoc 1999; 215: 1455-1459. 
Chapter 5. Diabetic cats 
 
166 
 
Osto M, Zini E, Reusch CE, Lutz TA. Diabetes from humans to cats. Gen Comp Endocrinol 
2013; 182: 48-53. 
Paepe D, van Hoek I, Vanden Broeck K, Croubels S, Lefebvre HP, Meyer E, Daminet S. 
Comparison of urinary protein-to-creatinine ratio, urinary retinol-binding-
protein/creatinine ratio and plasma exo-iohexol clearance between healthy and diabetic 
cats [abstract]. Meeting of the Society of Comparative Endocrinology, Vancouver, Canada, 
2007.  
Paepe D, Verjans G, Duchateau L, Piron K, Ghys L, Daminet S. Routine health screening. 
Findings in apparently healthy middle-aged and old cats. J Feline Med Surg 2013a; 15: 8-
19. 
Paepe D, Bavegems V, Combes A, Saunders JH, Daminet S. Prospective evaluation of 
healthy Ragdoll cats for chronic kidney disease by routine laboratory parameters and 
ultrasonography. J Feline Med Surg 2013b; 15: 849-857. 
Paepe D, Lefebvre HP, Concordet D, van Hoek I, Croubels S, Daminet S. Simplified methods 
for estimating glomerular filtration rate in cats and for detection of cats with low or 
borderline glomerular filtration rate. PLoS One. Submitted.  
Penescu M, Mandache E. The value of kidney biopsy in diabetes mellitus. Rom J Morphol 
Embryol 2010; 51: 13-19. 
Rand JS. Pathogenesis of feline diabetes. Vet Clin North Am Small Anim Pract 2013; 43: 351-
365.  
Reutens T. Epidemiology of diabetic kidney disease. Med Clin North Am 2013; 97: 1-18. 
Ritz E. Clinical manifestations and natural history of diabetic kidney disease. Med Clin North 
Am 2013; 97: 19-29. 
Rossi G, Giori L, Campagnola S, Zatelli A, Zini E, Paltrineiri S. Evaluation of factors that 
affect analytic variability of urine protein-to-creatinine ratio determination in dogs. Am J 
Vet Res 2012; 73: 779-788. 
Segev G. Proteinuria. In: Ettinger SJ, Feldman EC (eds). Textbook of Veterinary Internal 
Medicine. 7
th
 ed. St-Louis, Missouri, USA: Elsevier Saunders, 2010, pp. 168-171. 
Sennello KA, Schulman RL, Prosek R, Siegel AM. Systolic blood pressure in cats with 
diabetes mellitus. J Am Vet Med Assoc 2003; 223: 198-201. 
Séronie-Vivien S, Delanaye P, Piéroni L, Mariat C, Froissart M, Cristol JP. Cystatin C: 
current position and future prospects. Clin Chem Lab Med 2008; 46: 1664-1686. 
Stepien RL. Pathophysiology of systemic hypertension and blood pressure assessment. In: 
Ettinger SJ, Feldman EC (eds). Textbook of Veterinary Internal Medicine. 7
th
 ed. St-Louis, 
Missouri, USA: Elsevier Saunders, 2010, pp. 577-582. 
Stockham SL, Scott MA. Urinary system. In: Stockham SL, Scott MA (eds). Fundamentals of 
veterinary clinical pathology. 2
nd
 ed. Oxford, UK: Blackwell Publishing, 2008, pp. 415-
494. 
Chapter 5. Diabetic cats 
167 
 
Suzuki D, Takano H, Toyoda M, Umezono T, Uehara G, Sakai T, Zhang S, Mori Y, Yagame 
M, Endoh M, Sakai H. Evaluation of renal biopsy samples of patients with diabetic 
nephropathy. Intern Med 2001; 40: 1077-1084. 
Syme HM, Markwell PJ, Pfeiffer D, Elliott J. Survival of cats with naturally occurring 
chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006; 20: 528-
535. 
Togashi Y, Miyamoto Y. Urinary Cystatin C as a biomarker for diabetic nephropathy and its 
immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats. Exp 
Toxicol Pathol 2013; 65: 615-622. 
Tramonti G, Kanwar YS. Review and discussion of tubular biomarkers in the diagnosis and 
management of diabetic nephropathy. Endocrine 2013; 43: 494-503. 
Vaden SL. Glomerular diseases. In: Ettinger SJ, Feldman EC (eds). Textbook of Veterinary 
Internal Medicine. 7
th
 ed. St-Louis, Missouri, USA: Elsevier Saunders, 2010, pp. 2021-
2036. 
Van Buren PN, Toto RD. The pathogenesis and management of hypertension in diabetic 
kidney disease. Med Clin North Am 2013; 97: 31-51. 
van Hoek I, Vandermeulen E, Duchateau L, Lefebvre HP, Croubels S, Peremans K, Polis I, 
Daminet S. Comparison and reproducibility of plasma clearance of exogenous creatinine, 
exo-iohexol, endo-iohexol and 
51
Cr-EDTA in young adult and aged healthy cats. J Vet 
Intern Med 2007; 21: 950-958. 
van Hoek I, Lefebvre HP, Kooistra HS, Croubels S, Binst D, Peremans K, Daminet S. Plasma 
clearance of exogenous creatinine, exo-iohexol and endo-iohexol in hyperthyroid cats 
before and after treatment with radioiodine. J Vet Intern Med 2008a; 22: 879-885. 
van Hoek I, Daminet S, Notebaert S, Janssens I, Meyer E. Immunoassay of urinary retinol 
binding protein as a putative renal marker in cats. J Immunol Methods 2008b; 329: 208-
213.  
van Hoek I, Lefebvre HP, Peremans K, Meyer E, Croubels S, Vandermeulen E, Kooistra H, 
Saunders JH, Binst D, Daminet S. Short- and long-term follow-up of glomerular and 
tubular renal markers of kidney function in hyperthyroid cats after treatment with 
radioiodine. Domest Anim Endocrinol 2009a; 36: 45-56. 
van Hoek I, Meyer E, Duchateau L, Peremans K, Smets P, Daminet S. Retinol-binding 
protein in serum and urine of hyperthyroid cats before and after treatment with radioiodine. 
J Vet Intern Med 2009b; 23: 1031-1037. 
Walker D, Syme HM, Markwell P, Elliott J. Predictors of survival in healthy non-azotaemic 
cats [abstract]. J Vet Intern Med 2004; 18: 417. 
Watson AD, Lefebvre HP, Concordet D, Laroute V, Ferré JP, Braun JP, Conchou F, Toutain 
PL. Plasma exogenous creatinine clearance test in dogs: comparison with other methods 
and proposed limited sampling strategy. J Vet Intern Med 2002; 16: 22-33. 
Chapter 5. Diabetic cats 
 
168 
 
Zhuo L, Ren W, Li W, Zou G, Lu J. Evaluation of renal biopsies in type 2 diabetic patients 
with kidney disease: a clinicopathological study of 216 cases. Int Urol Nephrol 2013; 45: 
173-179. 
Zini E, Benali S, Coppola L, Guscetti F, Ackermann M, Lutz TA, Reusch CE, Aresu L. Renal 
morphology and function in cats with diabetes mellitus [abstract]. J Vet Intern Med 2012; 
26: 1537.  
  
 
  
 
  
 
 
 
 
 
 
 
 
 
CHAPTER 6 
 
SIMPLIFIED METHODS TO ESTIMATE 
GLOMERULAR FILTRATION RATE AND TO 
IDENTIFY CATS WITH DECREASED GLOMERULAR 
FILTRATION RATE 
 
 
 
 
 
 
 
  
 
  
 
SIMPLIFIED METHODS FOR ESTIMATING GLOMERULAR 
FILTRATION RATE IN CATS AND FOR DETECTION OF 
CATS WITH LOW OR BORDERLINE GLOMERULAR 
FILTRATION RATE 
 
 
 
 
Dominique Paepe
1
, Hervé P. Lefebvre
2
, Didier Concordet
3
, Ingrid van Hoek
1
, Siska Croubels
4
 
and Sylvie Daminet
1
 
 
1
 Department of Medicine and Clinical Biology of Small Animals, Faculty of Veterinary 
Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium 
2
 Université de Toulouse, INP, École Nationale de Vétérinaire de Toulouse, Unité de 
Recherche Clinique, 23 Chemin des Capelles, BP 87614, 31076 Toulouse Cedex 3, France 
3
 INRA, UMR 1331, Toxalim, École Nationale de Vétérinaire de Toulouse, 23 Chemin des 
Capelles, BP 87614, 31076 Toulouse Cedex 3, France 
4
 Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary 
Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium 
 
 
 
Adapted from:  
Paepe D, Lefebvre HP, Concordet D, van Hoek I, Croubels S and Daminet S. Simplified 
methods for estimating glomerular filtration rate in cats and for detection of cats with low or 
borderline glomerular filtration rate. In preparation for submission.  
Chapter 6. Simplified methods 
 
174 
 
Summary 
 
Simplified methods to detect patients with decreased glomerular filtration rate (GFR) 
are needed.  
Data of a 9-sample combined plasma exogenous creatinine-iohexol clearance test 
(PEC-ICT) of 73 cats were used. Limited sampling strategies (LSS) were developed by 
comparing all sampling time combinations to the entire 9 sampling times set and selecting the 
best sampling time combinations based on maximum relative error. By regression analysis, 
the ability of routine blood and urine parameters to predict GFR or identify cats with low or 
borderline GFR was examined. Cut-off clearance marker concentrations to predict low or 
borderline GFR were determined at three time points after marker injection. All procedures 
were analyzed for three clearance markers (exo-iohexol, creatinine, endo-iohexol).  
For reliable GFR estimation, at least 3 blood samples for clinical purpose and 5 blood 
samples for research purpose are required. Regression formulae based on routine variables did 
not reliably predict GFR, but accurately identified cats with low or borderline GFR. Clearance 
marker concentrations exceeding given marker cut-off concentrations also identified cats with 
low or borderline GFR with high sensitivities and specificities.  
These simplified methods will facilitate detection of early kidney dysfunction in cats. 
The methodology used might also be valuable for human medicine.  
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Introduction 
 
Chronic kidney disease (CKD) is a serious health problem in humans and early 
identification of kidney dysfunction is important to delay progression to end-stage renal 
disease (Stevens et al 2006, Salgado et al 2012). Glomerular filtration rate is considered the 
best overall measure of kidney function. However, GFR determination is cumbersome, time-
consuming and expensive and therefore difficult to do in routine clinical practice (de Jong and 
Gansevoort 2005, Stevens et al 2006). Equations based on serum creatinine concentration and 
demographic variables are routinely used to estimate GFR (de Jong and Gansevoort, Stevens 
et al 2006, Salgado et al 2010). Unfortunately, these equations provide a less accurate GFR 
estimate in certain patient groups, including patients at extremes of ages and body size, severe 
under- or overweight patients, patients without CKD and patients with rapidly changing 
kidney function. Measuring GFR using exogenous markers is recommended to assess kidney 
function in these patient groups (Stevens et al 2006, Stevens and Levey 2009, Salgado et al 
2010).  
Similarly, routine blood and urine variables namely serum creatinine concentration, 
serum urea concentration, urine specific gravity (USG) and urinary protein: creatinine ratio 
(UPC), do not allow detection of early kidney dysfunction in small animals. It is generally 
accepted that more than two-thirds of functional renal mass must be lost before kidneys lose 
their ability to concentrate urine, and more than three-fourths must be lost before an animal 
becomes azotemic (Braun and Lefebvre 2008, Stockham and Scott 2008). Plasma clearance of 
an intravenously administered marker is commonly used in cats to estimate GFR (DiBartola 
2010, Von Hendy-Willson and Pressler 2011). However, multi-sampling techniques to 
determine GFR are labor-intensive, time-consuming, expensive and may be stressful or even 
painful which limits their practical use, particularly in cats (Paepe and Daminet 2013). Several 
LSS have been described to estimate feline GFR (Barthez et al 2000, Barthez et al 2001, Goy-
Thollot et al 2006, Vandermeulen et al 2008, Heiene et al 2009, Miyagawa et al 2010, 
Vandermeulen et al 2010, Finch et al 2011, Katayama et al 2012, Finch et al 2013, Katayama 
et al 2013), but none of these methods is sufficiently validated in cats with CKD to be used in 
practice.  
Thus, reliable simplified methods to identify humans or cats with early kidney 
dysfunction are needed (Salgado et al 2010, Paepe and Daminet 2013). For research purpose, 
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estimating the true GFR value with an acceptable margin of error is important. Conversely, 
knowledge of the actual GFR value is often not needed in daily practice. More important, 
clinicians need to be able to predict which patients have a decreased GFR based on routine 
blood and urine variables or based on other methods, requiring only a minimal number of 
blood samples.  
In this study, a population of cats with wide GFR range was evaluated. At first, we aimed to 
develop LSS, both for daily practice as for research purposes for creatinine, exo-iohexol, and 
endo-iohexol clearances. Secondly, we aimed to evaluate if routine variables (serum urea, 
serum creatinine, USG, UPC, systolic blood pressure (SBP)) can predict the actual GFR value 
of a cat or can identify cats with low or borderline GFR. Finally, we aimed to develop cut-off 
concentrations for creatinine, exo-iohexol, and endo-iohexol at three time points after IV 
bolus of creatinine and iohexol to identify cats with low or borderline GFR. 
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Materials and Methods 
 
 Data of cats that underwent a combined PEC-ICT at the Department of Small Animal 
Medicine and Clinical Biology, Ghent University, Belgium were used. All animal work was 
conducted according to guidelines for animal care, with consent of the Ethical Committee of 
the Faculty of Veterinary Medicine from Ghent University, Belgium and with informed owner 
consent. Data of several cats were previously published (van Hoek et al 2007, van Hoek et al 
2008, van Hoek et al 2009). If cats underwent several clearance tests, only one clearance test 
was used for the present study. The PEC-ICT had been performed as previously reported (van 
Hoek et al 2007, van Hoek et al 2008). Briefly, all cats received 40 mg/kg creatinine and 64.7 
mg/kg iohexol intravenously. Blood samples were taken in tubes with 
ethylenediaminetetraacetic acid as anticoagulant before and 5, 15, 30, 60, 120, 180, 360, 480 
and 600 minutes after injection. Plasma creatinine was assayed by an in-house validated 
enzymatic method
a
 and exo-iohexol and endo-iohexol concentrations were determined by a 
validated high-performance liquid chromatography method with ultraviolet detection (van 
Hoek et al 2007, De Baere et al 2012). Pharmacokinetic analyses were performed using 
WinNonlin
b
. The plasma data were subjected to noncompartmental analysis with a statistical 
moment approach. The area under the plasma concentration-versus-time curve (AUC) was 
calculated by the trapezoidal rule with extrapolation to infinity, as described by Watson et al 
(2002). Plasma clearance of creatinine, exo- and endo-iohexol was determined by dividing 
dose administered by AUC and indexed to bodyweight (mL/min/kg).  
 Following information was retrieved from the medical records of these cats: health 
status, signalment, serum creatinine, serum urea, total thyroxine concentration (TT4), USG, 
UPC, and SBP. Healthy was defined as absence of clinical signs and significant abnormalities 
on physical examination, complete blood count, serum biochemistry profile (including TT4 in 
cats older than 6 years) and routine urinalysis (including UPC and bacterial culture). CKD 
was diagnosed based on compatible clinical signs and renal azotemia. Cats that had both CKD 
and diabetes mellitus (DM), both CKD and hyperthyroidism or cats that developed CKD after 
treatment for hyperthyroidism were included in the CKD group and excluded from the 
hyperthyroid or DM group. Hyperthyroidism was diagnosed based on compatible clinical 
signs and increased TT4. The diagnosis of DM was made based on compatible clinical signs, 
hyperglycemia, glucosuria and increased serum fructosamine concentrations. Cats without 
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DM or hyperthyroidism that were suspected of renal disease but with doubtful routine blood 
(serum urea, serum creatinine) and urine (USG, UPC) parameters were allocated to a separate 
group of cats with doubtful renal status.  
 
Statistical analysis 
 All statistical tests were performed with statistical software
c,d
 and at the 0.05 
significance level.  
 
Simplified methods for estimating GFR 
To develop LSS, a total of 510 sampling time combinations (i.e. all possible 
combinations) were compared to the entire 9 blood sampling times set for each clearance 
marker (creatinine, exo-, and endo-iohexol) by calculation of AUC values by the trapezoidal 
rule. The maximum relative error was calculated and used to select the best sampling time 
combination for each number of samples.  
Secondly, a general linear model was used to evaluate if routine variables (SBP, serum 
urea, serum creatinine, USG, UPC) could predict feline GFR values.  
 
Simplified methods to identify cats with borderline or low GFR 
Method 1: Logistic regression analysis was used to evaluate if routine parameters 
(SBP, serum urea, serum creatinine, USG, UPC) are able to differentiate cats with GFR below 
a certain threshold from cats with GFR equal to or above this threshold. By looking at the 
GFR data and health status of the cats, the range in which GFR results of cats with CKD 
overlapped with GFR results of other groups was identified for each clearance marker 
(creatinine, exo-, and endo-iohexol). Within these ranges of GFR values, several GFR cut-off 
values were evaluated by binary logit analysis. Clinically useful GFR cut-off values to 
discriminate between cats with GFR below and above these cut-off GFR values were 
determined based on sensitivity, specificity and receiver-operating-characteristic (ROC) curve 
analysis.  
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 Method 2: To develop cut-off concentrations for creatinine, exo-iohexol and endo-
iohexol after marker injection to identify cats with decreased GFR, borderline and low GFR 
cut-off values were selected for each clearance marker. The borderline GFR cut-off values 
were arbitrarily selected by looking at the serum creatinine-GFR relationship curves and 
selecting a cut-off value in the area where the curve started to bend (i.e. where decreasing 
GFR resulted in increasing serum creatinine concentrations) and where GFR values of CKD 
cats and cats with doubtful renal function overlapped with the other groups. We assured that 
GFR values of all CKD cats were below this cut-off (except the outlier for endo-iohexol 
clearance) (Fig 6.1). Borderline GFR cut-off values were defined as 1.7 mL/min/kg for exo-
iohexol and 1.9 mL/min/kg for creatinine and endo-iohexol clearances. The lower GFR cut-
off value was selected based on GFR results of CKD and healthy cats in a previous study 
using the same PEC-ICT (van Hoek et al 2009). A GFR cut-off value between GFR results of 
CKD and healthy cats was selected, resulting in low GFR cut-off values of 1.2 mL/min/kg for 
exo-iohexol and 1.4 mL/min/kg for creatinine and endo-iohexol clearances. Using these 
selected borderline and lower GFR cut-off values, sensitivities, specificities, positive (PPV) 
and negative (NPV) predictive values were calculated for various creatinine, exo-iohexol, and 
endo-iohexol concentrations 60 (t60), 120 (t120) and 180 (t180) minutes after marker 
injection. The sensitivities and specificities were used to draw ROC curves for each clearance 
marker at these three time points for both the borderline and low GFR cut-off value. For PPV 
and NPV calculation (Bourdaud’hui 2012), the pre-test probability that the animal is diseased 
was set between 40 and 60% because a veterinarian will only evaluate kidney function more 
thoroughly in cats for which routine blood and urine parameters give doubtful results. 
Clinically useful cut-off creatinine, exo-, and endo-iohexol concentrations at t60, t120 and 
t180 were identified based on their sensitivities, specificities, PPV and NPV.  
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Results 
 
Study population 
 Seventy-three cats were included, namely 16 healthy, 20 CKD (13 only CKD, 6 CKD 
after treatment for hyperthyroidism, 1 CKD and DM), 19 DM, 16 untreated hyperthyroid cats 
and 2 cats with doubtful renal status. None of the cats had combined DM and 
hyperthyroidism. According to the International Renal Interest Society (IRIS) staging system 
(IRIS 2009), 10 CKD cats were in IRIS stage 2 and 10 in IRIS stage 3. The study population 
involved 63 domestic short- or long-haired and 9 purebred (3 Siamese, 3 British shorthairs, 1 
Burmese, 1 Persian, 1 Oriental) cats and 34 female (1 intact, 33 neutered) and 38 male (3 
intact, 35 neutered) cats. For one cat, breed, gender and age were not recorded. The mean ± 
SD age was 10.4 ± 4.6 (range 1-20) years and mean ± SD bodyweight 4.6 ± 1.2 (range 2.3-
7.8) kg. The mean ± SD SBP was 137 ± 24 (range 91-210; n = 59) mmHg, mean ± SD serum 
urea 11.0 ± 4.7 (range 5.3-28.3; n = 68) mmol/L, mean ± SD serum creatinine 135.1 ± 70.9 
(range 40.7-382.8; n = 68) µmol/L, mean ± SD TT4 51.7 ± 60.6 (range < 6.5-200; n = 58) 
nmol/L, mean ± SD USG 1.034 ± 0.015 (range 1.008-1.060; n = 68) and mean ± SD UPC 
0.34 ± 0.30 (range 0.06-1.29; n = 69). For the 5 cats for which serum creatinine (modified 
Jaffe assay) was not recorded, the baseline creatinine concentration of the PEC-ICT was used 
to assess renal status. These cats were excluded from the general linear model to predict GFR 
and from the logistic regression analysis to identify cats with decreased GFR.  
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Clearance 
 The GFR values for the complete population, healthy cats, hyperthyroid cats, CKD 
cats, DM cats and cats with doubtful renal status are presented in Table 6.1. The GFR-versus-
serum creatinine relationship for the three clearance markers are shown in Fig 6.1. The mean 
± SD (range) extrapolated area of the AUC was 5.7 ± 5.5% (0.2-20.7%) for exo-iohexol, 6.3 ± 
4.9% (0.6-19.0%) for endo-iohexol and 14.9 ± 14.9% (0.2-61.4%) for creatinine clearance. 
This extrapolated area exceeded 20% for exo-iohexol clearance in 2 CKD cats and for 
creatinine clearance in 16 CKD cats, two diabetic cats, one healthy old cat and one of the cats 
with unknown renal status. The relationships between GFR versus serum urea, USG, UPC, 
SBP for exo-iohexol clearance are presented in Fig 6.2. For creatinine and endo-iohexol 
clearances, comparable relationships were found (data not shown).  
 
Table 6.1. Overview of glomerular filtration rates for the complete study population and 
the subgroups.  
Glomerular filtration rates (in mL/min/kg) for creatinine, exo-iohexol and endo-iohexol 
clearance for the complete population (n = 73) and subgroups of healthy cats (n = 16), 
untreated hyperthyroid cats (n = 16), cats with chronic kidney disease (CKD; n = 20), cats 
with diabetes mellitus (DM; n = 19), cats with doubtful renal status based on routine blood 
and urine parameters (n = 2). Results are presented as mean ± standard deviation (range), 
except for the cats with doubtful renal status where the actual GFR values are shown. 
Group Creatinine clearance Exo-iohexol clearance Endo-iohexol clearance 
Complete  2.33 ± 1.29 (0.4-6) 1.99 ± 1.16 (0.5-5.64) 2.55 ± 1.36 (0.52-6.2) 
Healthy 2.44 ± 0.78 (1.3-4.3) 1.82 ± 0.37 (1-2.5) 3.05  ± 0.76 (1.1-4.1) 
Hyperthyroid  3.95 ± 1.26 (2.1-6) 3.59 ± 1.12 (2-5.64) 3.69  ± 1.21 (1.94-6.2) 
CKD 1.02  ± 0.37 (0.4-1.6) 0.85 ± 0.22 (0.5-1.4) 1.02  ± 0.41 (0.52-2.4) 
DM  2.31 ± 0.61 (1.5-3.8) 2.05 ± 0.61 (1.2-3.6) 2.86  ± 1.16 (1-5) 
Doubtful 1.6 and 1.8 1.1 and 1.6 1.8 and 1.9 
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Fig 6.1. Relationship between 
glomerular filtration rate and 
serum creatinine concentration. 
The relationship between 
glomerular filtration rate (GFR) and 
serum creatinine concentration 
(sCreat) measured by a modified 
Jaffe assay for exo-iohexol, 
creatinine and endo-iohexol 
clearances for the complete study 
population (n = 73 cats). Each cat 
represents a dot on the figure. The 
cats with CKD are presented with a 
red dot, the cats of the other groups 
with a blue dot. The argyle-shaped 
dots represent cats for which sCreat 
was measured with a modified Jaffe 
assay (n = 68). For cats for which 
sCreat measured with this modified 
Jaffe assay was not recorded (n = 
5), the baseline creatinine 
concentration of the clearance test, 
measured with an enzymatic assay, 
was used. These cats are presented 
as circles on the figure. The GFR 
cut-off values that were selected 
based on these GFR-versus-sCreat 
curves (borderline GFR cut-off; 
dotted line) and based on the 
literature (low GFR cut-off; striped 
line) are also shown. 
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Simplified methods for estimating GFR 
The absolute value of maximum relative errors on the GFR calculation for all limited 
sampling time combinations compared with the GFR based on the complete 9 sample data set 
is shown in Fig 6.3. The best sampling time combinations and maximum relative errors for 
LSS with 1 – 8 blood samples for all three clearance markers are presented in Table 6.2.  
The best regression formulae to predict GFR values based on routine parameters (SBP, 
serum urea, serum creatinine, USG, UPC) and associated R² values are shown in Table 6.3.  
  
Fig 6.2. Relationship between glomerular filtration rate and other routine parameters. 
The relationship between glomerular filtration rate (GFR) and serum urea concentration 
(sUrea), urine specific gravity (USG), urinary protein: creatinine ratio (UPC) and systolic 
blood pressure (SBP) for exo-iohexol clearance for the complete study population (n = 73 
cats). Each cat represents a blue argyle-shaped dot on the graphs. Cats for which sUrea (n = 
5), USG (n = 5), UPC (n = 4) or SBP (n = 14) was not available, are not shown on these 
graphs. 
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Fig 6.3. Maximum errors for 
limited sampling strategies. 
Absolute value of maximum 
errors (%) on the calculation of 
plasma exo-iohexol, creatinine, 
and endo-iohexol clearances with 
a limited sampling strategy (LSS) 
compared with the clearances 
calculated based on the complete 
set of 9 blood samples. Each blue 
circle on the plots represents the 
maximum relative error for a 
given number of blood samples. 
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Table 6.2. The best sampling time combinations for the limited sampling strategies.  
The best sampling time combinations and maximum relative errors for limited sampling 
strategies (LSS) with 1-8 blood samples for three clearance markers (creatinine, exo-iohexol, 
endo-iohexol), compared with the entire 9 blood sampling times set of the plasma exogenous 
creatinine-iohexol clearance test of 73 cats. A negative maximum error indicates that the LSS 
underestimates the glomerular filtration rate (GFR), a positive maximum error indicates that 
the LSS overestimates the GFR compared with the entire 9 blood sampling times set. 
 Exo-iohexol clearance Creatinine clearance Endo-iohexol clearance 
N T (min) ME (%) T (min) ME (%) T (min) ME (%) 
1 60 -82.0% 180 -81.1% 60 -81.6% 
2 60, 480 33.8% 60, 480 -24.6% 60, 360 -36.9% 
3 30, 120, 480 -18.2% 60, 480, 600 -18.9% 30, 120, 480 -18.2% 
4 15, 60, 180, 
480 
-13.3% 30, 120, 480, 
600 
-15.7% 15, 60, 180, 
480 
-13.3% 
5 15, 30, 120, 
360, 600 
11.7% 15, 120, 180, 
360, 600 
7.5% 15, 60, 120, 
360, 600 
-10.5% 
6 15, 30, 120, 
360, 480, 600 
11.7% 15, 30, 180, 
360, 480, 600 
7.2% 15, 30, 120, 
360, 480, 600 
-9.6% 
7 5, 30, 60, 120, 
180, 360, 600 
5.0% 5, 30, 60, 120, 
180, 360, 600 
6.6% 5, 30, 60, 120, 
180, 360, 600 
4.6% 
8 5, 15, 30, 60, 
120, 180, 360, 
600 
2.5% 5, 15, 30, 60, 
120, 180, 360, 
600 
3.5% 5, 30, 60, 120, 
180, 360, 480, 
600 
4.3% 
(N = Number of samples; T = Optimal timing of the blood samples for this LSS; min = 
Minutes; ME = Maximum relative error) 
 
Table 6.3. Regression formulae to predict glomerular filtration rate. 
The best regression models to predict the glomerular filtration rate (GFR) based on the routine 
parameters systolic blood pressure, serum creatinine concentration (sCreat), serum urea 
concentration (sUrea ), urine specific gravity and urinary protein: creatinine ratio (UPC). The 
associated R-square values to judge the goodness of fit of the models are also shown. 
Clearance  Regression model  
R
2
 
Exo-iohexol GFR  = 3.141 – (0.011 * sCreat) + (0.961 * UPC)  0.582  
Creatinine GFR  = 3.817 – (0.071 * sUrea) – (0.007 * sCreat) + (1.085* UPC)  0.513 
Endo-iohexol GFR  = 4.338 – (0.013 * sCreat)  0.447  
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Simplified methods to identify cats with borderline or low GFR 
For prediction of borderline or low GFR based on routine parameters (serum urea, 
serum creatinine, USG, UPC), the regression formulae, the GFR range for which binary logit 
regression analysis was evaluated, the most appropriate cut-off values and associated 
sensitivities, specificities and area under ROC curve are shown in Table 6.4. Adding SBP to 
these routine parameters gave very similar results (data not shown).  
The sensitivities, specificities, PPV and NPV for clinically useful cut-off creatinine, 
exo-, and endo-iohexol concentrations at t60, t120 and t180 after marker injection to predict 
borderline or low GFR are presented in Table 6.5. The ROC curves to identify cats with 
borderline or low GFR for the evaluated exo-iohexol, creatinine, and endo-iohexol 
concentrations at t60, t120, and t180 are shown in Fig 6.4. The creatinine concentration for 
one cat at t60 and exo- and endo-iohexol concentrations for two cats at t180 were not 
available because of insufficient sample. Thus, the calculations of cut-off concentrations were 
based on the data set of 73 cats, except for t60 for creatinine clearance (n = 72) and for t180 
for exo- and endo-iohexol clearances (n = 71). 
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Table 6.4. Regression formulae to predict borderline or low glomerular filtration rate.  
The regression formulae for prediction of low glomerular filtration rate (GFR; mL/min/kg) for 
three clearance markers (creatinine, exo-iohexol, endo-iohexol) based on routine blood 
(serum urea concentration in mmol/L, sUrea; serum creatinine concentration in µmol/L, 
sCreat) and urine (urine specific gravity, USG; urinary protein: creatinine ratio, UPC) 
parameters in a population of cats (n = 67) for which all these parameters were available. The 
GFR range for which the logistic regression was performed and two clinically useful GFR 
cut-off values (low and borderline GFR cut-off) are presented. If e
u
/1+e
u
 < 0.5, the cat has a 
high probability to have a GFR below the given cut-off. The associated sensitivities (Sens; 
%), specificities (Spec; %) and area under receiver-operating-characteristic (ROC) curves (%) 
are also shown. 
Marker GFR 
range 
GFR 
Cut-
off 
Sens Spec Area 
under 
ROC 
curve 
Regression formula 
Exo-iohexol  0.9-1.6 
1.1 98.0 91.3 97.2 
u=-77.799 – 0.265 * sUrea – 0.040 * 
sCreat + 86 * USG – 0.162 * UPC 
1.5 91.1 81.8 96.5 
u=6.770 – 0.201 * sUrea – 0.065 * 
sCreat + 5 * USG – 0.928 * UPC 
Creatinine 1.0-2.0 
1.2 96.5 60.0 97.4 
u=-84.997 – 0.016 * sUrea – 0.033 * 
sCreat + 91 * USG – 3.241 * UPC 
1.7 93.3 81.8 95.8 
u=22.479 – 0.363 * sUrea – 0.05 * 
sCreat – 11 * USG + 1.009 * UPC 
Endo-
iohexol  
1.0-1.6 
1.1 98.2 90.0 98.8 
u=102.494 – 0.288 * sUrea – 0.073 * 
sCreat – 81 * USG – 0.251 * UPC 
1.5 96.0 76.5 97.2 
u=-21.674 – 0.396 * sUrea – 0.037 * 
sCreat + 31 * USG + 4.406 * UPC 
 
  
 
Table 6.5. Cut-off marker concentrations to predict borderline or low glomerular filtration rate. 
Sensitivities , specificities, PPV and NPV to identify cats with GFR above a certain threshold if marker concentrations are similar to or exceed 
the presented cut-off creatinine, exo-, and endo-iohexol concentrations 60, 120, and 180 minutes after marker injection. For the predictive values, 
the pre-test probability was set at 40-60% and the mean PPV and NPV for this range of pre-test probabilities is shown. In Table 6.5a low GFR 
cut-off values are used as GFR threshold and set at 1.2 mL/min/kg for exo-iohexol and at 1.4 mL/min/kg for creatinine and endo-iohexol 
clearances. In Table 6.5b borderline GFR cut –off values are used as GFR threshold and set at 1.7 mL/min/kg for exo-iohexol and at 1.9 
mL/min/kg for creatinine and endo-iohexol clearances. 
Table 6.5a. 
 Exo-iohexol clearance Creatinine clearance Endo-iohexol clearance 
Time Exo Sens Spec PPV NPV Creat Sens Spec PPV NPV Endo Sens Spec PPV NPV 
t60 
160 95.0 86.8 87.8 94.6 505 94.1 65.5 73.2 91.8 24 95.0 75.5 79.5 93.8 
180 95.0 92.5 92.6 94.9 555 94.1 85.5 86.6 93.6 27 90.0 81.1 82.7 89.0 
205 50.0 98.1 96.4 66.2 655 70.6 96.4 95.1 76.6 32 80.0 98.1 97.7 83.1 
t120 
100 100.0 88.7 89.8 100 340 94.1 76.8 80.2 92.9 15 100.0 84.9 86.9 100 
120 95.0 96.2 96.2 95.1 400 88.2 92.9 92.5 88.8 19 95.0 96.2 96.2 95.1 
135 80.0 98.1 97.7 83.1 460 70.6 94.6 93.0 76.3 22 80.0 98.1 97.7 83.1 
t180 
80 100.0 96.1 96.2 100 270 94.1 78.6 81.5 93.0 10 100.0 90.2 91.1 100 
85 95.0 98.0 98.0 95.2 315 94.1 89.3 89.8 93.8 14 90.0 98.0 97.9 90.7 
90 75.0 100.0 100 80.0 400 64.7 96.4 94.8 73.2 18 70.0 100.0 100 76.9 
(t60 = Blood sample 60 minutes after clearance marker injection; t120 = Blood sample 120 minutes after clearance 
marker injection; t180 = Blood sample 180 minutes after clearance marker injection; Creat = Creatinine concentration 
(µmol/L); Exo = Exo-iohexol concentration (µg/mL); Endo = Endo-iohexol concentration (µg/mL); Sens = Sensitivity 
(%); Spec = Specificity (%); PPV = Positive predictive value (%); NPV = Negative predictive value (%)) 
  
  
 
 
 
Table 6.5b. 
 Exo-iohexol clearance Creatinine clearance Endo-iohexol clearance 
Time Exo Sens Spec PPV NPV Creat Sens Spec PPV NPV Endo Sens Spec PPV NPV 
t60 
130 100.0 65.1 74.1 100 465 96.7 71.4 77.2 95.5 23 96.0 77.1 80.7 95.1 
143 93.3 83.7 85.2 92.6 505 90.0 81.0 82.5 89.0 27 88.0 87.5 87.6 87.9 
160 83.3 97.7 97.3 85.4 560 70.0 95.2 93.6 76.1 30 76.0 93.8 92.4 79.6 
t120 
80 96.7 86.1 87.4 96.3 290 100.0 67.4 75.4 100 10 100.0 75.0 80.0 100 
84 96.7 93.0 93.3 96.5 320 93.3 83.7 85.2 92.6 15 96.0 91.7 92.0 95.8 
90 86.7 97.7 97.4 88.0 350 80.0 93.0 92.0 82.3 19 80.0 97.9 97.5 83.0 
t180 
45 100.0 90.2 91.1 100 210 100.0 67.4 75.4 100 7 100 87.0 88.5 100 
50 96.7 95.1 95.2 96.6 250 96.7 90.7 91.2 96.5 10 92.0 95.7 95.5 92.3 
55 90.0 100.0 100 90.9 290 83.3 97.7 97.3 85.4 13 76.0 100.0 100 80.6 
(t60 = Blood sample 60 minutes after clearance marker injection; t120 = Blood sample 120 minutes after clearance 
marker injection; t180 = Blood sample 180 minutes after clearance marker injection; Creat = Creatinine concentration 
(µmol/L); Exo = Exo-iohexol concentration (µg/mL); Endo = Endo-iohexol concentration (µg/mL); Sens = Sensitivity 
(%); Spec = Specificity (%); PPV = Positive predictive value (%); NPV = Negative predictive value (%)) 
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Fig 6.4a. Cut-off marker concentrations to predict low glomerular filtration rate. 
The receiver-operating-characteristic (ROC) curves to identify cats with GFR below low GFR 
cut-off values for the evaluated concentrations of exo-iohexol, creatinine and endo-iohexol at 
60, 120, and 180 minutes after creatinine and iohexol injection. The GFR threshold is set at 
1.2 mL/min/kg for exo-iohexol and at 1.4 mL/min/kg for creatinine and endo-iohexol 
clearances. For all graphs, ‘1 – specificity’ (%) is shown at the X-axis and ‘sensitivity’ (%) at 
the Y-axis. 
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Fig 6.4b. Cut-off marker concentrations to predict borderline glomerular filtration rate. 
The receiver-operating-characteristic (ROC) curves to identify cats with GFR below 
borderline GFR cut-off values for the evaluated concentrations of exo-iohexol, creatinine and 
endo-iohexol at 60, 120, and 180 minutes after creatinine and iohexol injection. The GFR 
threshold is set at 1.7 mL/min/kg for exo-iohexol and at 1.9 mL/min/kg for creatinine and 
endo-iohexol clearances. For all graphs, ‘1 – specificity’ (%) is shown at the X-axis and 
‘sensitivity’ (%) at the Y-axis. 
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Discussion 
 
One of the major goals of this study was to develop LSS to estimate GFR with an 
acceptable margin of error. The present study has important advantages compared with other 
studies that have described feline LSS. Firstly, cats over a wide GFR range were involved, 
namely cats with glomerular hyperfiltration (hyperthyroid cats), normal GFR (healthy cats, 
most diabetic cats) and glomerular hypofiltration (CKD cats). Therefore, our study population 
is representative for the GFR range that can be encountered in practice. In other reports 
concerning simplified methods for GFR estimation, no or only few renal impaired or 
hyperfiltrating cats had been included (Barthez et al 2000, Barthez et al 2001, Goy-Thollot et 
al 2006, Vandermeulen et al 2008, Heiene et al 2009, Vandermeulen et al 2010, Finch et al 
2011, Katayama et al 2012, Katayama et al 2013). Secondly, all possible time combinations 
were evaluated. This contrasts with other studies evaluating LSS with blood sampling on 
arbitrarily selected time points, often without judging if the selected time points were the most 
appropriate ones for the GFR method used (Heiene et al 2009, Miyagawa et al 2010, 
Katayama et al 2012, Katayama et al 2013). However, our data clearly showed that, for a 
fixed number of samples, the maximum relative error can seriously differ based on the timing 
of blood sampling (Fig 6.3). Thirdly, LSS were compared with a GFR estimate that was 
calculated using a noncompartmental approach and based on multiple blood samples over a 
10-hour period, both in the distribution and elimination phases of the clearance marker. In 
several previous studies evaluating single or two-sample approaches, the reference GFR 
estimate was based on maximum five blood samples over a relatively short time period (4 – 5 
hours) and/or calculated using a one- or two-compartmental model (Heiene et al 2009, 
Miyagawa et al 2010, Vandermeulen et al 2010, Katayama et al 2012, Katayama et al 2013). 
Noncompartmental analysis is assumption free, unlike compartmental analysis. Both 
pharmacokinetic approaches are scarcely compared in cats, but it is known that a one-
compartmental model overestimates true feline GFR (Finch et al 2011). This means that in 
some of these studies, single- or two-sample approaches to estimate GFR have been compared 
with another GFR estimate that was prone to errors. To correct for these errors, correction 
formulae have been used (Heiene et al 2009, Miyagawa et al 2010, Katayama et al 2012). 
However, these formulae were based on human medicine or on dogs and their use in cats is 
not properly evaluated. Recently, a feline correction formula was reported to accurately 
predict multisample clearance in cats and with smaller errors than human- or dog-based 
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formulae. Unfortunately, only healthy cats were enrolled in that study (Finch et al 2011). 
Finally, LSS were developed for several clearance markers, which was previously reported 
only in one study and only in healthy cats (Heiene et al 2009).  
Our findings indicate that, based on a noncompartmental approach, GFR cannot be 
reliably estimated based on a single sample for all three markers. At least 3 or 4 blood  
samples after injection of the clearance marker are needed to estimate GFR with an acceptable 
margin of error (errors below 20%). For research purposes smaller margins of errors are 
required, preferably 10% or less, and 5 or more samples after marker injection are needed to 
maintain the error in the GFR estimate ≤ 10% in most cats. Our results also indicate that the 
optimal timing for blood sampling for LSS depends on the marker that is used for the 
clearance test. Also, a blood sample 10 hours after marker injection is almost always part of 
the optimal sampling time combination. This implies that, by performing LSS, the number of 
blood samples can be reduced but not the time needed to perform the clearance test. The same 
has been found in dogs (Watson et al 2002) and this may be explained because the timing of 
the last sample determines the percentage of AUC extrapolated. Also, the limit of 
quantification of the analytical method may influence the percentage of AUC extrapolated 
(Beal 2001, Fang et al 2011). The larger this proportion, the more inaccurate the GFR 
estimate and the extrapolated area should never exceed 20% of the total area (Watson et al 
2002). In our study, this criterion was met for almost all cats for exo- and endo-iohexol 
clearances, but not for creatinine clearance, particularly not in CKD cats. Prolonged sampling, 
between 10 and 24 hours after creatinine injection, may be required in cats with renal 
dysfunction for more accurate GFR estimation based on creatinine clearance, as has been 
reported for dogs with surgically induced renal impairment (Watson et al 2002). Similarly, 
late sampling is required for accurate GFR determination in humans with advanced renal 
failure or premature infants (Brion et al 1986, Bröchner-Mortensen and Freund 1981, Stake et 
al 1991, Schwartz et al 2010). 
Besides LSS, we evaluated the ability of routine blood and urine variables SBP, serum 
creatinine, serum urea, USG and UPC to predict GFR value. However, logistic regression 
analysis indicated that these parameters did not predict GFR values accurately. A possible 
explanation is the lack of strong relationships between GFR and these routine parameters (Fig 
6.1 and Fig 6.2). We found an inverse curvilinear relationship between GFR and serum 
creatinine and serum urea for each clearance marker with a stronger relationship for serum 
creatinine compared with serum urea. This is in agreement with the literature in dogs and cats 
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(Finco 1995, Miyamoto 2001). The GFR-versus-serum creatinine curves for our population 
indicated that up to a serum creatinine concentration of 200 µmol/L, minimal change in serum 
creatinine concentration can be associated with serious change in GFR. Above serum 
creatinine of 200 µmol/L, further decline of GFR results in concurrent increase of serum 
creatinine concentration. In this study, mildly positive correlations between GFR and USG 
were found. However, several cats with normal to high GFR values had poorly concentrated 
urine (USG < 1.035), which confirms that cats with normal renal function can have wide 
variations in USG (Finco 1995). Also in previous studies, several healthy cats had USG below 
1.035 (Paepe et al 2013a, Paepe et al 2013b). Conversely, some cats with decreased GFR had 
concentrated urine (USG ≥ 1.035). This is in line with the finding that some cats with severe 
experimental loss of renal functional mass retained their concentrating ability (Ross and Finco 
1981). Our data also indicated a mildly positive relationship between UPC and GFR. This was 
unexpected because we suspected more severe proteinuria with decreasing kidney function, as 
reported in humans (Regeniter et al 2009; Wu et al 2012) and in dogs (Wehner et al 2008). 
On the other hand, increased UPC could also result from increased filtration pressure 
associated with higher GFR values. Finally, no relationship between SBP and GFR was 
found. Also a previous study did not find an association between the severity of azotemia and 
the presence of hypertension (Syme et al 2002).  
Because, in daily practice, it is more important to detect cats with early renal 
dysfunction than knowing the exact GFR value, we also proposed two new methods to 
identify cats with low or borderline GFR. At first, with the regression formulae that we 
developed for each clearance marker (Method 1), veterinarians can determine if a cat has a 
high likelihood to have a GFR value below the proposed cut-off values based on routine 
parameters (serum urea, serum creatinine, USG, UPC). These regression formulae could 
predict, with very good sensitivity and moderate to good specificity, if a cat had a GFR value 
below the proposed GFR cut-offs. Adding SBP to these parameters did not have a major 
impact on these sensitivities and specificities, probably because there was no clear 
relationship between SBP and GFR. Also, because of more missing data for SBP than for the 
other parameters, adding SBP to these parameters reduced the number of cats available for the 
logistic regression analysis.  
The second simplified method (Method 2) to identify cats with borderline or low GFR 
requires clearance marker injection, one blood sample 60, 120 or 180 minutes after marker 
injection and determination of the clearance marker concentration in that blood sample. 
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Important advantages are that multiple sample analysis and mathematics for GFR calculation 
are not needed, which makes this method both simple and cost-effective. Based on the ROC 
curves, time points t120 and t180 minutes seem to be more appropriate than t60 for all three 
clearance markers. Depending on the clearance marker concentration, sensitivities, 
specificities, PPV and NPV vary. For each time point and for each clearance marker, three 
cut-off marker concentrations are given, which allows the veterinarian to choose a cut-off 
marker concentration depending if (s)he wants to predict borderline or low GFR with high 
sensitivity, high specificity or both. The higher the cut-off marker concentration at a certain 
time point, the more likely a cat with a value above this threshold has low to borderline GFR 
(higher specificity and PPV) because higher marker concentrations are associated with slower 
clearance rates. Important to remember is that predictive values change with disease 
prevalence or pre-test probability. For example, for disease prevalence lower than 40%, PPV 
will decrease and NPV will improve compared to the reported values in this study (Erb 2011).  
For both new simplified methods, we presented both low and borderline GFR cut-off 
values, so that veterinarians can choose which cut-off GFR value they will use, depending on 
the case. The low GFR cut-offs (Method 1: 1.2 mL/min/kg for creatinine clearance, 1.1 
mL/min/kg for exo- and endo-iohexol clearance; Method 2: 1.2 mL/min/kg for exo-iohexol 
clearance, 1.4 mL/min/kg for creatinine and endo-iohexol clearances) indicate renal 
dysfunction. Initiating treatment for renal disease may be indicated in these cats. The 
borderline GFR cut-offs (Method 1: 1.7 mL/min/kg for creatinine clearance, 1.5 mL/min/kg 
for exo- and endo-iohexol clearance; Method 2: 1.7 mL/min/kg for exo-iohexol clearance, 1.9 
mL/min/kg for creatinine and endo-iohexol clearances) indicate reduced to low-normal renal 
function. Several of these cats will have routine blood and urine parameters within reference 
intervals. Thus, both new methods may be additional tests to improve detection of cats with 
early kidney dysfunction. If these simplified methods suggest that a cat has a high likelihood 
to have GFR below this borderline cut-off value, more close monitoring of routine blood and 
urine parameters or additional tests to estimate GFR are warranted. The reason that the cut-off 
GFR concentrations differ for both methods to identify cats with borderline or low GFR is 
that these cut-offs were defined prior to statistical analysis only for Method 2, but not for 
Method 1. 
Possible strategies to identify renal dysfunction in cats with doubtful routine blood and 
urine variables are shown in Fig 6.5. A cost-effective approach is to combine the second 
simplified method to identify borderline or low GFR with GFR estimation based on LSS. The 
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veterinarian can perform a 3- or 4-sample clearance test on the time points presented in Table 
6.2 and initially analyze creatinine, exo- or endo-iohexol concentration only in one sample 
(t120 for 3-sample exo- and endo-iohexol clearance and for 4-sample creatinine clearance; 
t180 for 4-sample exo- and endo-iohexol clearance). If the marker concentration suggests that 
this cat likely has GFR below the cut-off value, clearance marker concentrations should be 
determined in the other 2 or 3 samples and GFR calculated. Currently, routine use of these 
methods is hampered because iohexol assays are expensive and not widely available and 
because injectable creatinine is not available for practitioners. As creatinine assays are 
inexpensive and easily accessible, a medical-grade formulation of creatinine should be 
commercialized for use in clearance tests. 
A study limitation is that the cut-offs were developed and evaluated in the same cat 
population which may result in overestimation of the ability to correctly predict new 
observations (Kutner et al 2005). An important further step is to evaluate the accuracy of 
these cut-offs in a different cat population.  
 
Conclusion 
 
In this cat population that is representative for the GFR range that can be encountered 
in practice, we developed simplified methods to estimate GFR or to identify cats with 
decreased GFR. These simplified methods will facilitate detection of cats with early kidney 
dysfunction allowing timely treatment and improved prognosis of CKD cats. The simplified 
methods to identify low or borderline GFR are a new and practical approach to identify 
kidney dysfunction. The methodology used might be valuable to detect early CKD in humans, 
particularly in patients in which equations to estimate GFR are less reliable and determination 
of GFR has practical limitations (e.g. pediatric patients). 
  
 
 
Fig 6.5. Tentative diagnosis 
algorithm to detect early 
kidney dysfunction 
Tentative diagnosis algorithm  
to screen for renal dysfunction 
in cats that need further 
assessment of kidney function. 
This scheme is designed for 
creatinine clearance. For exo- 
and endo-iohexol clearances, the 
cut-offs for the glomerular 
filtration rate and time points for 
sampling for limited sampling 
strategies need to be adjusted.  
(GFR = Glomerular filtration 
rate; CKD = Chronic kidney 
disease; IRIS = International 
Renal Interest Society; USG = 
Urine specific gravity; RP = 
Routine parameters, namely 
serum creatinine concentration, 
serum urea concentration, urine 
specific gravity and urine 
protein: creatinine ratio; LSS = 
Limited sampling strategy; T = 
Time point of blood sampling 
after clearance marker injection, 
in minutes) 
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7.1 INTRODUCTION 
 
Feline CKD is typically diagnosed based on the presence of combined renal azotemia 
and poorly concentrated urine (urine specific gravity (USG) ≤ 1.035), with compatible 
historical and/or physical examination findings (Grauer 1998, Bartges 2012). Unfortunately, 
diagnosing early feline CKD based on these criteria is challenging (Braun and Lefebvre 2008, 
Stockham and Scott 2008).  
Usually cats do not suffer from clinical signs of CKD until they have reached 
advanced disease stages. The most common clinical symptoms, namely polyuria, polydipsia, 
weight loss, partial anorexia and lethargy usually develop in cats with International Renal 
Interest Society (IRIS) stages 2 and 3. Further, polyuria/polydipsia – one of the earliest signs 
of CKD – is often not recognized by cat owners (Bartlett et al 2010, Polzin 2010). More 
severe and more frequent clinical signs, including vomiting and weakness, are seen in cats 
with IRIS stage 4 (i.e. end-stage) CKD (Elliott and Barber 1998, King et al 2007, Polzin 
2010).  
It is generally assumed that over two-thirds of functional renal mass must be lost 
before kidneys lose their urine concentrating ability and over three-quarters must be lost 
before azotemia develops. Thus, serum creatinine, urea concentrations and USG are often 
within reference intervals (RIs) in cats with early CKD (IRIS stages 1 and early 2) (Braun and 
Lefebvre 2008, Stockham and Scott 2008, DiBartola 2010). The limitations of these routine 
diagnostic tests can be overcome by measuring glomerular filtration rate (GFR), usually by 
performing a multi-sample clearance test (Braun and Lefebvre 2008). However, multi-sample 
clearance tests are labor-intensive, time-consuming and may be stressful or painful for the 
patient (Finch et al 2013). Although some simplified techniques to estimate GFR had been 
described at the start of this thesis (Barthez et al 2000, Barthez et al 2001, Goy-Thollot et al 
2006, Vandermeulen et al 2008, Heiene et al 2009), none of these simplified techniques had 
been sufficiently validated in cats with CKD to be routinely used in practice.  
Because clinical signs often develop late in the disease course and early clinical signs 
are often not recognized by cat owners, screening of at-risk populations for CKD is highly 
recommended in companion animal medicine (FAB 2008, Vogt et al 2010, Taylor and 
Sparkes 2013). However, prior to this thesis, scientific data to interpret this screening were 
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limited. Additionally there was a need for convenient diagnostic methods to detect mild feline 
kidney dysfunction. These may facilitate the diagnosis of early CKD, allowing timely 
therapeutic intervention and possibly an improved prognosis (Lees 2004, Grauer 2005).  
A more thorough summary of the diagnostic tests for cats with CKD and screening 
tests applicable to cats with increased risk for CKD can be found in Chapter 1 of this thesis. 
The final goal of this thesis (Chapter 2) was to evaluate limitations of currently 
performed screening practices for feline CKD and to develop possible solutions to improve 
detection of early CKD.  
Therefore, the actually used screening procedures were evaluated in two cat 
populations, namely middle-aged to old cats and Ragdoll cats. Also, we investigated if there 
is a need to routinely screen cats with diabetes mellitus (DM) for CKD. Finally, simple and 
cost-effective methods were developed to improve detection of early feline CKD. 
  
Chapter 7. General discussion 
209 
 
7.2 SCREENING FOR CHRONIC KIDNEY DISEASE IN AGED CATS 
 
In Chapter 3, we assessed the results of health screening, as it is currently performed, 
in a population of aging cats. The rationale to perform ‘geriatric health screening’ is the 
increased sensitivity of old cats to many chronic diseases and the assumption that early 
diagnosis and timely treatment might improve the prognosis (FAB 2008, Vogt et al 2010). 
Chronic kidney disease is a major point of attention for feline geriatric health screening as the 
prevalence of CKD is increasing with age and reaches up to 30% in cats over 15 years of age 
(Lulich et al 1992). Guidelines established by panels of experts in the veterinary field 
recommend that geriatric health screening should consist of a combination of clinical and 
laboratory variables (FAB 2008, Pittari et al 2009, Vogt et al 2010). However, studies 
evaluating the results of these screening procedures were not available before this thesis. 
Thus, it was unknown if age-specific RIs for clinical (e.g. systolic blood pressure (SBP), 
Schirmer tear test) or laboratory variables were required for aging cats.  
Therefore, general health screening was executed in 100 apparently healthy middle-
aged and old cats by fulfilling a complete history, SBP measurement, physical examination, 
ophthalmic examination, complete blood count, serum biochemistry profile and urinalysis. 
Physical and laboratory abnormalities were frequent and several physical clinical and 
laboratory variables significantly differed between middle-aged (6 – 10 years) and old cats (> 
10 years).  
Focusing on variables that are important for screening for CKD, we identified several 
potential problems. Mainly the findings on blood pressure, body condition and laboratory 
abnormalities warrant further discussion.  
Before the start of this study, the question remained whether normal blood pressure 
values in cats changed with aging because available reports yielded conflicting results (Bodey 
and Sansom 1998, Sparkes et al 1999, Sansom et al 2004, Lin et al 2006). The mean SBP of 
our population was 133.6 ± 21.5 mmHg, SBP exceeded 160 mmHg in 8% of our cats and old 
cats (> 10 years) had significantly higher SBP than middle-aged cats (6 – 10 years). No ocular 
lesions secondary to hypertension were detected in any of the cats. The mean SBP of our 
study corresponded well with two other reports that also evaluated healthy conscious client-
owned cats using the indirect Doppler technique (Lin et al 2006, Paige et al 2009). In the 
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latter two studies, the age-distribution of the included healthy cats was much wider (less than 
1 year to over 16 years) compared to our study. Sansom et al (2004) found that SBP increased 
with age if young (< 5 years), middle-aged (≥ 5 – < 10 years) and old (≥ 10 years) cats were 
compared, in contradiction to 2 other studies in which age did not correlate with SBP 
(Sparkes et al 1999, Lin et al 2006). Similar to Sansom et al (2004), we detected an age-effect 
on SBP as SBP was significantly higher in old cats (> 10 years) when compared to middle-
aged (6 – 10 years) cats. This age effect of SBP likely is a consequence of cardiovascular 
changes that occur with aging (Carpenter et al 2005), but an increased occurrence of 
undiagnosed conditions leading to hypertension in the older cat groups cannot be ruled out. 
Particularly subclinical CKD may be difficult to diagnose without measuring the GFR 
because increased blood pressure may induce polyuria and associated low USG (< 1.030) due 
to pressure diuresis (Brown et al 2007). Despite the observed age-effect on SBP, the vast 
majority of old cats of our study and the study of Sansom et al (2004) had SBP below 160 
mmHg. This means that only few healthy geriatric cats have SBP above the cut-off to pursue 
further diagnostic testing (Lin et al 2006, Stepien 2010, Stepien 2011).  
An important finding was that cat owners did not recognize some physical 
examination abnormalities, demonstrated by the high number of cats with non-ideal body 
condition (51%) or with gingivitis (72%). Particularly in aging pets, owners may appreciate 
clinical problems as a normal aging phenomenon (FAB 2008). The fact that cat owners do not 
appreciate under- or overweight as a problem had been reported previously (Courcier et al 
2010). Aging might affect the body condition because fat and protein digestion reduces with 
increasing age, potentially leading to age-related muscle wasting and decreased body weight 
(Laflamme 2005). Thus, it was unexpected to find such high proportion of overweight or 
obese cats (40%), similar or even worse to previous studies of healthy pet cats of various ages 
(Colliard et al 2009, Courcier et al 2010, Courcier et al 2012). However, our findings confirm 
that obesity is an important disease with growing incidence in pet cats, at it is in humans and 
pet dogs (Seidell 1999, Seidell 2000, WHO 2000, Corbee 2013). Overweight in dogs is 
related to overweight of their owners, but this is not true for cats (Nijland et al 2009). 
Recently, the common occurrence of overweight and obesity in purebred show cats was 
related to the standards of several cat breeds (Corbée 2014). Another potential reason why cat 
owners judge overweight as normal might be that cats are depicted as lazy fatty characters in 
popular cartoons or comics such as Garfield or Dikkie Dik. In one study, the probability of 
being obese peaked in the mature age group (7 – 10 years) (Courcier et al 2012). Also in our 
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study, middle-aged cats had significantly higher body condition score (BCS) compared to old 
cats.  
On the other hand, and more important in regard to screening for CKD, 11% of our 
study cats were underweight. Most underweight cats (n = 9/11) were over 10 years of age, 
which is in accordance with recent findings that the risk of being underweight increases with 
each life stage and that cats over 15 years of age have the highest risk (Courcier et al 2012). 
Weight loss and poor body condition are early clinical signs in companion animals with CKD 
and our findings indicate that these might be overlooked by pet owners (Hughes et al 2002, 
Pittari et al 2009, Bartlett et al 2010, Polzin 2010). One of our underweight cats had 
confirmed CKD, but the lower USG in underweight cats compared to cats with normal or 
overweight body condition might indicate that more underweight cats had early renal 
dysfunction. Studies that investigate kidney function in detail – preferably by assessing GFR 
– are needed in non-azotemic underweight cats with poorly concentrated urine. Our study 
described in Chapter 3 is limited by not assessing the muscle condition score, as 
recommended by the World Small Animal Veterinary Association (WSAVA) Nutritional 
Assessment Guidelines (Freeman et al 2011). However, the muscle condition scoring system 
proposed by WSAVA was not available at the time of our study. It is important to realize that 
muscle wasting might occur in cats of any body condition, thus also in overweight or obese 
cats. As the daily production rate of creatinine depends on the muscle mass, muscle wasting 
due to aging or concurrent conditions might affect serum creatinine concentrations (Lees 
2004, DiBartola 2010, Polzin 2010). Nevertheless, improved owner awareness of normal 
feline body condition, regular nutritional assessments (diet history, body weight, body and 
muscle condition score) by veterinarians and, if needed, nutritional support is mandatory to 
increase the proportion of aging cats with an optimal body condition (Hughes et al 2002, 
Freeman et al 2011, Freeman 2012). 
 As mentioned before, another clinical sign that feline owners do not always recognize 
as being abnormal is polyuria and polydipsia (Bartlett et al 2010). Inherent to the study 
design, none of our owners reported polyuria or polydipsia as a problem in their cat. 
However, 15% of the cats had poorly concentrated urine (USG < 1.035) and some of these 
might have had polyuria and/or polydipsia. Similarly, 13% of control cats in the study of 
Chapter 4 – Section §4.2 had poorly concentrated urine. Particularly in cats with outdoor 
access or in multi-cat households, the drinking and urination behavior might be difficult to 
judge for cat owners. As polyuria/polydipsia is one of the earliest clinical manifestations of 
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CKD and as patients with CKD show impaired urine concentrating ability prior to the 
inability to excrete metabolic waste, poorly concentrated urine might indicate early CKD 
(Lees 2004, Grauer 2005, Polzin 2010). However, it is important to keep in mind that many 
factors influence USG and daily USG fluctuations can be seen in healthy animals. So, low 
USG without other indications for CKD does not necessarily suggest kidney dysfunction 
(Lees 2004, Stockham and Scott 2008). However, USG consistently below 1.035 or USG 
below 1.035 found together with either azotemia or a physiologic state for which concentrated 
urine is expected (e.g. dehydration) may indicate impaired urine-concentrating ability and 
warrants further consideration (Lulich et al 1992, Lees 2004, Grauer 2005).  
The fact that owners might overlook clinical signs of CKD is confirmed by the two 
cases with confirmed CKD in this study and the single case with CKD in the prospective 
study of Ragdoll cats (Chapter 4, Section §4.2). One of these cats already had more advanced 
CKD (IRIS stage 3). Despite being a chronic disease, cats with CKD are often presented with 
an acute history of illness or in advanced diseases stages (DiBartola et al 1987, Elliott and 
Barber 1998, Kuwahara et al 2006, Boyd et al 2008). This also indicates that their owners 
probably missed the more subtle clinical signs of early CKD. Veterinarians should educate 
their cat owners properly in order to recognize early and subtle signs of CKD. An improved 
owner awareness might lead to earlier diagnosis and intervention and potentially better long-
term outcome (Hughes et al 2002, Bartlett et al 2010).  
For several laboratory variables, a high proportion of our apparently healthy middle-
aged and old cats had values outside the RI (e.g. 40% for serum phosphorus, 30% for total 
protein, 29% for serum creatinine). It is unlikely that all cats with one or more laboratory 
variables outside the RI had an occult pathologic condition explaining these abnormalities. 
Particularly the high number of cats with serum creatinine exceeding the upper reference limit 
and serum phosphorus below the lower reference limit are important to consider if cats are 
screened for CKD. For example, most of the cats with serum creatinine outside the RI only 
had a mild increase in combination with hypersthenuric urine, making early CKD in these cats 
less likely. Next to the high proportion of cats with laboratory variables outside the RI, we 
also found significant differences between middle-aged (6 – 10 years) and old (> 10 years) 
cats for several laboratory variables (serum urea, UPC, serum albumin, serum calcium, serum 
bilirubin, platelet count, hematocrit). This might be due to a higher prevalence of occult 
diseases in the older cat group, but an age-effect for several laboratory variables seems to be 
more plausible. If screening of cats for CKD is undertaken, it is important to keep in mind 
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that serum urea concentration and UPC are significantly higher in old cats (> 10 years) 
compared to middle-aged cats (6 – 10 years).  
The high proportion of cats with laboratory variables outside the RI and the potential 
age-effect for certain laboratory variables, confirm the need for age-specific RIs to improve 
the interpretation of blood and urine examinations of aging cats (Gunn and Alleman 2005). In 
general, the reference population to establish the RI should reflect the animal population for 
which the RI is used (Archer 2010, Friedrichs 2010, Friedrichs et al 2012). This was not true 
for the RIs that were used in our study as they were determined in young (6 months – 1 year) 
healthy cats. Growth hormone increases renal tubular phosphate reabsorption in dogs, 
explaining increased serum phosphorus concentrations in young, growing animals (Corvilain 
and Abramow 1964). For the other variables, it is more difficult to clarify the need for age-
specific laboratory RIs based on physiologic conditions. An important consequence of using 
inappropriate RIs is the misclassification of samples as normal or abnormal (Friedrichs 2010, 
Friedrichs et al 2012). A wide variation of laboratory RIs for serum creatinine leading to 
misclassification of samples had previously been reported, both in dogs and cats (Boozer et al 
2002, Ulleberg et al 2011). Adjacent to the variation in RIs, the variation in assay 
methodology must be taken into consideration as well (Friedrichs et al 2012). Both (modified) 
Jaffe and enzymatic assays for serum creatinine are still frequently used in commercial 
laboratories, as discussed in Chapter 1, and one should employ RIs established based on the 
same assay (Le Garreres et al 2007). Misclassification of samples may lead to misdiagnosis 
and/or improper treatment (Friedrichs et al 2012). For example, hyperphosphatemia might be 
overlooked if the phosphate RI is based on healthy young cats. This is a serious flaw as 
hyperphosphatemia commonly complicates feline CKD and is considered to be an important 
therapeutic target and prognostic factor (King et al 2007, Boyd et al 2008, Chakrabarti et al 
2012, Geddes et al 2013). Finally, technical or methodological factors must also be taken into 
consideration for comparing laboratory variables to generally accepted decision thresholds 
(Friedrichs et al 2012), as is done for UPC. Values of UPC can vary depending on the assay 
that is used (Fernandes et al 2005). In addition, other factors, such as storage conditions and 
sample dilution might lead to misclassification of UPC in dogs, mainly for UPC ratios close 
to the threshold limits 0.2 or 0.5 (Rossi et al 2012). These issues might be one reason for the 
high number of cats with borderline proteinuria in the studies of Chapter 3, Chapter 4 and 
Chapter 5, as discussed below (Section 7.4).  
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In conclusion, we encourage clinicians to consistently determine laboratory variables 
in a laboratory with good quality control and perform patient follow-up in a single laboratory 
(Lees 2004, Geffré et al 2009, Friedrichs et al 2012). Published guidelines to determine RIs 
for veterinary species should be followed (Geffré et al 2009, Friedrichs et al 2012) and 
veterinary laboratories should establish age-dependent RIs for certain laboratory variables. 
Partitioning the RIs for age will improve health screening of aged cats. However, a major 
challenge in the development of age-dependent RI is the selection of an appropriate reference 
population because older cats might suffer from subclinical diseases. To overcome the 
limitations of population-based RIs, subject-based RIs may be considered. These are referred 
to as reference change values or critical differences (i.e. a meaningful change between 2 
successive measurements) and are mainly useful for serial laboratory measurements during 
patient follow-up (Walton 2012, Baral et al 2014). For many biochemical analytes, subject-
based reference values are more sensitive than population-based reference values for detecting 
pathologic changes in an individual, both in humans and in dogs (Fraser 2004, Ruaux et al 
2012). Whether or not subject-based RIs are more suitable to assess biochemical analytes is 
determined by the analyte’s index of individuality which is based on biological (intra- and 
inter-individual) and analytical variation (Walton 2012, Baral et al 2014). Recent findings 
indicated that most feline plasma biochemistry variables have intermediate or high 
individuality (Baral et al 2014). For 5 variables with high individuality, amongst others 
plasma creatinine measured using an enzymatic assay, the use of subject-based reference 
change value or critical difference would be more appropriate than population based RI (Baral 
et al 2014). Calculation of reference change values is simple since laboratories should know 
the analytical variation and biological variation can be assessed based on a low number (e.g. 
as few as 8) of healthy reference individuals over a period of days to weeks (Fraser 2012, 
Walton 2012). To overcome calibration bias and measurement imprecision between and 
within laboratories, guidelines for standardization of creatinine measurements have been 
described in human medicine (Myers et al 2006). Similarly, standardization for measurement 
of urinary albumin in humans is under development (Miller et al 2009, Lieske et al 2013). 
Using subject-based reference values and standardization of laboratory tests in veterinary 
medicine will be important future steps to ameliorate the accuracy of laboratory 
measurements.  
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An important benefit of health screening is that it supports identifying conditions that 
remain unrecognized or that are regarded as normal aging consequences by cat owners (FAB 
2008, Pittari et al 2009). In our study, health screening allowed us to diagnose feline 
immunodeficiency virus (FIV) infection in 14 cats, CKD in two cats and hyperthyroidism and 
urinary tract infection in one cat. In addition, health screening may serve as baseline for future 
physical and laboratory examinations (FAB 2008, Pittari et al 2009). For example, increasing 
serum creatinine concentrations, even within RI, may indicate early kidney dysfunction, 
particularly in cats with weight loss or muscle wasting or USG consistently below 1.035 
(Lees 2004, Grauer 2005, Pittari et al 2009). By knowledge of reference change values, 
clinically meaningful changes will be more readily detected on regular laboratory assessments 
of mature and elderly patients (Ruaux et al 2012). The reference change value or critical 
difference for plasma creatinine measured with an enzymatic assay in healthy cats was 
determined to be 17.4%. In serial measurements in a feline patient, increases or decreases in 
plasma creatinine larger than 17.4% are clinically relevant, even if plasma creatinine remains 
within the RI (Baral et al 2014). Our study was not primarily designed to determine which 
tests should be part of health screening and at what age it should be initiated. However, based 
on our findings and current literature (FAB 2008, Vogt et al 2010), health screening of 
middle-aged cats should consist of a comprehensive history and thorough physical 
examination – including thyroid gland palpation, nutritional assessment and oral inspection – 
and finally FIV and feline leukemia virus (FeLV) testing for cats with outdoor access. For old 
cats (> 10 years), these tests should be added with blood pressure measurement and complete 
blood and urine examinations. Health screening is advised yearly in healthy senior cats (> 10 
years) and twice yearly in healthy geriatric cats (> 15 years) and more frequently in cats with 
signs of illness (FAB 2008, Vogt et al 2010). Also, a more frequent screening of cats infected 
with feline immunodeficiency virus (FIV) for CKD seems to be warranted because of 
significant relationships between FIV and azotemia or CKD and because proteinuria is 
common in FIV-infected cats (Thomas et al 1993, Avila et al 2010, White et al 2010, Baxter 
et al 2012). As we detected significantly higher SBP in FIV-infected cats, the association 
between hypertension and FIV should be investigated further.   
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7.3 SCREENING FOR CHRONIC KIDNEY DISEASE IN RAGDOLL CATS 
 
In Chapter 4 we evaluated the screening of Ragdoll cats for polycystic kidney disease 
(PKD) and chronic interstitial nephritis (CIN). For many years, this screening was performed 
at our institution based on recommendations of Ragdoll breeder organizations. According to 
these organizations, screening should include measuring serum creatinine and urea 
concentrations, ultrasonography of liver and kidneys and genetic testing for PKD (SRC 2012, 
RCB 2013). As mentioned in the general introduction of this thesis (Chapter 1), we already 
identified a problem prior to the start of our studies. The definitive diagnosis of CIN can only 
be made by kidney histology because pathognomonic ultrasonographic features for CIN do 
not exist (Grooters and Biller 1995, d’Anjou 2008, DiBartola 2010). Thus, using the 
screening tests that are recommended by Ragdoll breeder organizations, we could only 
evaluate Ragdoll cats for CKD and not for CIN.  
At first, we performed a retrospective evaluation of Ragdoll cats presented at our 
institution over an 8 year period (Section §4.1). Renal ultrasonography of 244 healthy Ragdoll 
cats revealed a PKD prevalence of 2.9%, a suspicion for CKD in 8.6%, unilateral renal 
agenesis or severe hypoplasia in 2 cats (0.1%) and abnormalities with unclear significance in 
8 cats (3.3%). All genetically tested cats (n = 125) were homozygous for the wild-type PKD-1 
alleles indicating a PKD negative state. Almost 11% of the Ragdoll cats for which serum 
creatinine was measured (n = 141) had serum creatinine concentration exceeding the RI, 
which raised the question whether a breed-specific creatinine RI for Ragdoll cats would be 
appropriate.  
Because our retrospective study was limited by the lack of urinalysis, incomplete 
screening tests in many Ragdoll cats and lack of information on the prevalence of renal 
ultrasonographic abnormalities in healthy non-Ragdoll cats, a prospective study was the next 
step. A prospective evaluation (Section §4.2) of serum creatinine and urea concentrations, 
routine urinalysis and abdominal ultrasonography in healthy Ragdoll and age-matched non-
Ragdoll cats was subsequently performed. Renal ultrasonographic abnormalities were 
frequent, in Ragdoll cats (49.6%) as well as in control cats (40%). Approaching significance, 
CKD was ultrasonographically suspected in 5.3% of Ragdoll cats but in none of the control 
cats. Ragdoll cats showed significantly more frequent segmental cortical lesions, abnormal 
renal capsule and echogenic urine and significantly lower serum urea concentration and 
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higher USG compared to the control cats. The other ultrasonographic and laboratory 
parameters did not significantly differ between both groups. Blood and urine examinations 
confirmed CKD in only 1 of the Ragdoll cats and all Ragdoll cats were PKD negative based 
on genetic testing.  
Both studies indicate that PKD is uncommon in the breeding population of healthy 
juvenile Ragdoll cats and that CKD is ultrasonographically suspected in 5 to almost 10% of 
the same population. However, these disease prevalences are only estimates of the true 
prevalence as they are affected by the characteristics of the studied population (Hahn and 
Overley 2010). Nevertheless, the majority (n = 5) of the PKD-positive cats were presented in 
2001 – 2002 and almost no (n = 2) PKD positive cats were seen at our faculty since then. This 
may indicate that PKD screening prior to breeding is effective at eradicating PKD in this 
breed. In both studies, predominantly young Ragdoll cats were included, indicated by the 
mean age of 2.2 years in the retrospective study and 2.7 years in the prospective study. Taking 
this into account, in addition to the fact that none of the control cats was ultrasonographically 
suspected of having CKD, the 5 – 9% Ragdoll cats with ultrasonographic suspicion of CKD is 
a rather large proportion. It is important to keep in mind that it is unknown whether the cats 
that were suspected of having CKD on ultrasonography will progress to azotemic CKD 
because ultrasonography does not correlate with renal function (Grooters and Biller 1995). 
The prevalence of ultrasonographic abnormalities might be underestimated in our 
retrospective study because no standardized protocol was used for kidney ultrasonography 
and many ultrasound reports were incomplete. On the other hand, the ultrasound report 
containing the most complete information regarding the kidneys was retained for inclusion if 
a cat underwent multiple ultrasonographic examinations. This might have created a bias 
towards an increased prevalence of abnormal ultrasonography because – if no standardized 
protocol is used – it is more likely that the radiologist gave detailed information if 
abnormalities are noticed. In comparison, a recent retrospective study described that 
ultrasonographic findings compatible with CKD are not uncommon in juvenile Maine Coons, 
with a prevalence of 5.3%. None of these CKD suspected cats underwent blood or urine 
testing. It was unclear if these authors used a standard ultrasound protocol and how they 
defined CKD. The most common findings in cats with ultrasonographic findings compatible 
with CKD were reduced corticomedullary distinction (60%), irregular kidney contours in 
addition to other changes compatible with CKD (60%) and mineral sand or reflectors in the 
renal pelvis (50%) (Gendron et al 2013). In our prospective study, all but one Ragdoll cats 
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suspected of CKD had 6 renal ultrasonographic abnormalities, indicating that our 
ultrasonographers were stringent in their diagnosis of CKD suspicion. The presence of single 
renal abnormalities (e.g. reduced corticomedullary demarcation, small kidney size, dystrophic 
mineralization) was not sufficient for a suspicion of CKD. Although the prospective study 
design did overcome many limitations of the retrospective study by including urinalysis and 
using a standard ultrasound protocol, the true prevalence of CKD in Ragdoll cats still remains 
unknown. Most Ragdoll cats of the prospective study belonged to breeders that had screened 
their cats over several generations, possibly underestimating the true disease prevalence. A 
similar influence on disease prevalence might be caused by exclusion of cats with an already 
diagnosed CKD because we did not only include Ragdoll cats that underwent screening for 
the first time in their lifetime. Both in Belgium and the Netherlands, many Ragdoll breeders 
screen their cats yearly prior to breeding and usually only cats without a suspicion of CKD on 
previous screenings are retained for future screenings. However, the exclusion of cats with an 
already diagnosed CKD was necessary to avoid bias towards CKD.  
 A large difference in proportion of Ragdoll cats with serum creatinine concentration 
exceeding the upper limit of the RI was noticed for both studies, namely almost 11% in the 
retrospective study versus 1% in the prospective study. The question whether the increased 
creatinine concentration could be a breed-specific feature for Ragdoll cats, as has been 
reported for Birmans (Gunn-Moore et al 2002, Reynolds et al 2010, Paltrineiri et al 2014), 
was rejected by the prospective study. Indeed, in the latter study, the serum creatinine 
concentration did not differ between Ragdoll and control cats, suggesting that a breed-specific 
serum creatinine RI is not required for Ragdoll cats. Possible reasons for the large discrepancy 
between both studies in the proportion of Ragdoll cats with increased serum creatinine 
concentration might be the assay used, variable RI, or more cats with kidney dysfunction in 
the retrospective study. Serum creatinine concentrations were measured with a modified Jaffe 
assay in the retrospective study and with an enzymatic assay in the prospective study. Both 
methods correlate well with a reference method, but the Jaffe assay may overestimate feline 
serum creatinine at low concentrations by also measuring noncreatinine chromogens (Le 
Garreres et al 2007, DiBartola 2010). However, this probably does not explain the high 
proportion of Ragdoll cats with serum creatinine exceeding the RI because the same error will 
occur when measuring creatinine in the reference population. How many cats of both studies 
had kidney dysfunction is unknown because serum urea and creatinine concentrations do not 
allow detection of early kidney dysfunction and GFR was not measured (DiBartola 2010). 
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The retrospective study was additionally limited by the lack of urinalysis, making 
interpretation of serum creatinine concentration difficult (DiBartola 2010). However, as most 
cats of the retrospective study with increased serum creatinine only had a mildly increased 
concentration and normal serum urea concentration, it is unlikely that many of these Ragdoll 
cats had kidney dysfunction. Thus, the remaining and most feasible explanation is an 
inappropriate RI resulting in misclassification of samples as abnormal in the retrospective 
study. The importance of appropriate RIs to prevent incorrect sample classification as normal 
or abnormal (Boozer et al 2002, Archer 2010, Friedrichs 2010, Ulleberg et al 2011, Friedrichs 
et al 2012) has been discussed earlier in this chapter (Section 7.2).  
 A notable finding of the prospective study was the high number of renal 
ultrasonographic abnormalities in young healthy cats, both in Ragdoll as in non-Ragdoll cats. 
In the retrospective study substantially fewer ultrasonographic abnormalities were observed, 
most likely due to incomplete recording. In that study, abnormalities were probably only 
noted if the radiologist presumed they could be clinical relevant. Although abdominal 
ultrasonography is performed daily in companion animal practice, scientific information on 
feline kidney ultrasonography was scarce prior to our studies. Knowledge on ultrasonographic 
appearance of kidneys of healthy cats was largely based on studies of the late eighties (Walter 
et al 1987a, Walter et al 1987b, Yeager and Anderson 1989). The substantial progress of 
ultrasound devices and expertise since then, emphasizes the need for updated scientific 
information. Although our prospective study was not primarily intended to serve this goal, we 
were able to describe the frequency and type of ultrasonographic renal findings in juvenile 
healthy cats. In one study based on a very limited number of cats (n = 10), the renal length of 
healthy cats has been reported to be 3.8 to 4.4 cm (Walter et al 1987a). However, other 
authors prefer normal values of 3.2 to 4.2 cm (Widmer et al 2004) or between 3.0 and 4.3 cm 
(d’Anjou 2008). To our knowledge, our study was the first to report renal length in a large 
group of healthy cats. The size of the left and right kidney of the control cats was comparable, 
with mean values of 3.7 ± 0.3 cm and 3.8 ± 0.4 cm respectively. Only three (5%) of our 
control cats had a kidney smaller than 3.2 cm with a minimum size of 3 cm. One or both 
kidneys were larger than 4.3 cm in more than 15% of our control cats, but only five (8%) of 
our control cats had one or both kidneys larger than 4.4 cm with a maximum size of 4.5 cm. 
Thus, cut-offs of 3.2 cm and 4.4 cm seem to be appropriate to evaluate renal length in healthy 
cats. Recently, in a study from our institution, no significant differences were found for renal 
length, cortical thickness, medullary thickness and corticomedullary ratio of healthy cats of 
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three cat breeds (Debruyn et al 2013a). Within the Ragdoll breed, renal length showed a 
positive correlation with age, bodyweight and male gender, indicating that it might be useful 
to keep age, bodyweight and gender in mind when evaluating renal length on ultrasonography 
(Debruyn et al 2013b). Renal ultrasonographic abnormalities that were frequently seen in both 
groups of cats were the presence of a medullary rim sign and changes in cortical echogenicity, 
particularly hyperechoic renal cortices. Medullary rim signs have been described in healthy 
and renal-diseased cats, but the question remained whether it could be an early indicator of 
renal disease (Yeager and Anderson 1998, Biller et al 1992, Widmer et al 2004, d’Anjou 
2008). In our study, a rim sign was identified in approximately one fifth of healthy young 
non-azotemic Ragdoll and control cats. Because it is unlikely that all these cats will develop 
CKD in the near future, our study suggests that medullary rim signs as sole abnormality are 
unlikely to be relevant, as was reported for dogs (Mantis and Lamb 2000). The cortical 
hyperechogenicity, noticed in approximately 10% of our healthy Ragdoll and control cats, is 
probably explicable by presence of fat in the proximal tubular epithelial cells (Yeager and 
Anderson 1989). For other single abnormalities (such as changes in renal capsule, renal shape, 
unilateral small kidney), the clinical relevance remains uncertain. In the study of Gendron et 
al (2013) four out of nine Maine Coons with irregular renal form without changes in renal 
echogenicity and available follow-up had died or been euthanized because of CKD at less 
than six years of age. Thus, longitudinal studies in order to monitor kidney function and renal 
ultrasonography in cats with ultrasonographic changes of unknown significance are needed to 
reveal the significance of these changes. Our finding that renal ultrasonographic abnormalities 
often occur in healthy cats will ameliorate the awareness of clinicians that ultrasonography is 
not sufficient to diagnose CKD. Consequently, current data do not support feeding a renal diet 
solely based on ultrasonographic findings. However, the ultrasonographic appearance of 
kidneys in healthy and diseased cats warrants further studies. Contrast-enhanced 
ultrasonography might be a valuable additional test for the evaluation of renal diseases in cats, 
as it is in humans. The pattern of contrast enhancement in normal feline kidneys has been 
described, but the diagnostic value of contrast-enhanced ultrasonography in ill cats still needs 
to be studied (Kinns et al 2010). 
The most important renal ultrasonographic parameter that significantly differed 
between Ragdoll and age-matched non-Ragdoll cats in the prospective study was the presence 
of segmental cortical lesion(s) (SCLs). Further studies will need to reveal whether these 
represent renal infarction or renal scarring due to vesico-ureteral reflux and what is the 
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underlying cause (Domanovits et al 1999, Cargollo and Diamond 2007, Kolbjørnsen et al 
2008). In humans, the most common causes or risk factors for kidney infarcts are 
embolization, hypertension, cardiovascular disease, renal trauma, neoplasia, renal artery 
dissection, renal vein thrombosis, hypercoagulable states, hyperviscosity syndromes, 
vasculitis or DM (Suzer et al 2002, Tsai et al 2007, Javaid et al 2009). Idiopathic renal 
infarcts have also been described (Racusin and Pollack 2005). There was no history of trauma 
or illness in any of the Ragdoll cats with SCLs. The young age, the healthy clinical condition 
and normal routine blood and urine examinations in our Ragdoll cats excluded DM and made 
neoplasia unlikely. Cardiac disease was unlikely because echocardiography for pre-breeding 
screening for hypertrophic cardiomyopathy did not show significant abnormalities in any of 
these cats. The blood pressure and coagulation profile warrants further investigation in cats 
with SCLs. Reflux nephropathy in humans is mostly associated with primary vesico-ureteral 
reflux (Cargollo and Diamond 2007) and it is unknown whether this occurs in Ragdoll cats 
with SCLs.  
In the retrospective study, only 1.6% of Ragdoll cats had SCLs versus 7.5% in the 
prospective study. As discussed earlier, it is possible that not all SCLs were recorded in the 
retrospective study, but a growing prevalence must also be considered. In the recent report on 
renal ultrasonography of healthy juvenile Maine Coons, no infarct-like lesions were 
described, also not in cats with an irregular shape of the kidney (Gendron et al 2013). This 
might be a further indication that SCLs typically occur in Ragdoll cats, but further studies are 
required to confirm this. 
The suspicion of CKD on ultrasonography in 5 – 9% of Ragdoll cats versus none of 
the control cats and the predisposition of Ragdoll cats for SCLs indicates that a predisposition 
of Ragdoll cats for CKD cannot be excluded. Therefore, there seems to be a rationale to 
continue pre-breeding screening of Ragdoll cats for CKD. However, further research is 
needed to define what is the optimal screening protocol (i.e. which screening tests and at what 
age), to elucidate the genetic basis of SCLs or suspicion of CKD on ultrasonography and to 
determine the clinical relevance of SCLs and whether these represent renal infarction or 
cortical scarring. Until more data are available, urinalysis should be added to the currently 
applied screening protocol and a standard protocol (see Addendum of Chapter 4, Section 
§4.2) should be followed for the abdominal ultrasonography. Based on our studies, it seems 
wise to avoid breeding with Ragdoll cats with SCLs and with an ultrasonographic suspicion 
of CKD.  
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Because PKD is rare in Ragdoll cats and most Ragdoll breeders already screen their 
cats for PKD over several generations, routine screening for PKD does not appear to be 
mandatory. Screening of Ragdoll breeding cats for PKD is advised if there is no or dubious 
information regarding the PKD status of the parents or if cysts are detected on 
ultrasonography. Since it is known that a small number of ultrasonographically PKD positive 
cats are homozygous for the wild-type PKD-1 allele, PKD testing should be established on a 
combination of ultrasonography and genetic testing (Bonazzi et al 2009). To avoid false 
negative results, cats should be at least 10 months to undergo the ultrasonography (Barrs et al 
2001, Cannon et al 2001).  
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7.4 EVALUATION OF DIABETIC CATS FOR ‘DIABETIC KIDNEY DISEASE’ 
 
In Chapter 5 we assessed whether cats with DM show evidence for diabetic kidney 
disease (DKD) or diabetic nephropathy (DN) which is defined as structural and/or functional 
abnormalities of the kidney as complication of DM (Bloom and Rand 2013). Diabetic kidney 
disease is a common complication in human diabetic patients and is characterized both by 
glomerular changes leading to altered GFR and proteinuria and by tubular damage (Reutens 
2013, Ritz 2013). Prior to this study, data on influence of feline DM on kidney function were 
scarce, especially data on GFR and urinary biomarkers were lacking.  
Therefore, a prospective study was performed to evaluate routine kidney variables 
(serum urea, serum creatinine, USG, UPC), SBP, GFR and urinary Cystatin C (uCysC) as 
tubular marker in cats with DM, cats with CKD and healthy cats that were age-matched to the 
diabetic cats. The same variables were compared between recently diagnosed diabetic cats 
(i.e. diagnosed less than 1 month ago) and cats that were not-recently diagnosed with DM (i.e. 
1 month or longer). Cats with DM only had significantly lower USG compared to healthy 
cats. In contrast, most variables significantly differed between cats with DM and cats with 
CKD: diabetic cats had significantly lower serum urea concentration, serum creatinine 
concentration and urinary Cystatin C: creatinine ratio (uCysC/uCreat) and significantly higher 
USG and GFR. In the diabetic group, 38% had proteinuria (UPC > 0.4) versus 30% in cats 
with CKD and none of the healthy cats. Despite this, UPC did not significantly differ between 
these groups. Also SBP did not differ between the 3 groups of cats. None of the variables 
evaluating kidney function or kidney damage differed significantly between recently and not-
recently diagnosed diabetic cats.  
 Thus, based on a single evaluation of routine kidney variables, GFR and uCysC, a 
major impact of feline DM on kidney function could not be demonstrated. Nevertheless, the 
high prevalence of proteinuria in the diabetic group might be important. An increased 
prevalence of proteinuria in diabetic cats had already been described by Al-Ghazlat et al 
(2011). Low-level proteinuria (UPC 0.4 – 1) is a negative prognostic factor for azotemic cats 
(Kuwahara et al 2006, Syme et al 2006, King et al 2007) and for hypertensive cats (Jepson et 
al 2007). In addition, proteinuria is a marker for progression of feline CKD (Chakrabarti et al 
2012). However, the significance in nonazotemic normotensive cats is not yet known. In 
hyperthyroid cats, proteinuria is not a mediator of progression of CKD, but correlates with all-
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cause mortality (Williams et al 2010) and the same may be true for diabetic cats. Follow-up 
studies of diabetic cats with and without proteinuria will need to reveal if it is a negative 
prognostic factor and whether proteinuric diabetic cats will progress to more severe renal 
dysfunction.  
 Several reasons might explain why cats are not as sensitive as humans to develop 
DKD. The shorter duration of DM in cats might be a major issue. In human patients with type 
2 DM, progression to overt nephropathy usually takes over 10 years and progression to end-
stage renal disease over 30 years (Ayodele et al 2004). In our study population only 6 of 36 
diabetic cats were treated for longer than 1.5 years with a maximum of over 5 years. Genetic 
predisposition, which is an initiator of DKD in humans (MacIsaac and Watts 2005), might be 
less important in cats, but studies are currently lacking. Several promoters of human DKD, 
such as hypertension and dyslipidemia, are less common in cats and others, such as smoking, 
are not relevant for cats (MacIsaac and Watts 2005). Although hypertension is a frequent 
complication in human diabetic patients (Van Buren and Toto 2013), this does not appear to 
be true in cats. In our study only 10% of diabetic cats had hypertension, which is comparable 
to 15% found by Al-Ghazlat et al (2011). Also, primary hypertension is a major problem in 
human medicine but not in feline medicine (Reusch et al 2010). Around 18 – 20% of 
hypertensive cats are reported to have primary hypertension (Maggio et al 2000, Elliott et al 
2001), but subclinical CKD and primary hyperaldosteronism may have been overlooked as 
underlying causes for hypertension in these studies (Reusch et al 2010). Dyslipidemia in 
humans is associated with atherosclerosis and microvascular dysfunction leading to renal and 
cardiovascular disease (MacIsaac and Watts 2005, Falk et al 2013, Moody et al 2013). 
Hypercholesterolemia has been described in diabetic cats (Crenshaw and Peterson 1996, 
Nelson et al 1999) and obese cats have dyslipidemia, characterized by abnormalities in 
lipoprotein particle number and size (Jordan et al 2008). In addition, atherosclerosis can be 
induced in cats by feeding a high-fat, cholesterol enriched diet (Ginzinger et al 1997). 
However, spontaneous cases of cats with atherosclerosis have not been described and 
atherosclerosis is not a feature of feline obesity or diabetes, which contrasts markedly with the 
situation in humans. The lack of an apparent systemic inflammatory reaction in response to 
increased fat mass in cats might explain why atherosclerosis and cardiovascular problems do 
not occur in obese cats (Hoenig et al 2013).  
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Based on our findings and data in literature, there is currently no rationale for more 
intense screening of cats with DM for kidney damage or dysfunction in comparison to non-
diabetic cats of similar age. For diabetic cats of 6 years or older, guidelines of middle-aged or 
old non-diabetic cats can be followed as mentioned in Chapter 3 and Section 7.2. For younger 
diabetic cats, it is advised to act upon guidelines as proposed by the Feline Advisory Bureau 
(FAB 2008) or the American Association of Feline Practitioners and American Animal 
Hospital Association (Vogt et al 2010). It might be prudent to assess UPC in all diabetic cats 
and monitor UPC in diabetic cats with proteinuria. This will not cause specific harm to 
diabetic cats as regular urine bacterial culture is advised in cats with DM, because of their 
predisposition for urinary tract infection (Bailiff et al 2006, Mayer-Roenne et al 2007).  
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7.5 JOINT FINDINGS IN DIFFERENT POPULATIONS OF HEALTHY CATS 
 
A remarkable finding in the studies described in Chapter 3, Chapter 4 and Chapter 
5 is the high prevalence of borderline proteinuria in healthy cats. A UPC between 0.2 and 0.4 
was detected in 25% of middle-aged and old cats (Chapter 3), in 27.9% of Ragdolls and in 
22.6% of control cats of Chapter 4 and in 40% of the healthy cats of Chapter 5. To evaluate if 
proteinuria is of renal origin, urine should be taken by cystocentesis, urine bacterial culture 
should be performed, urinary sediment should be analyzed and prerenal proteinuria must be 
ruled out by evaluating serum/plasma protein concentration (Lees et al 2005). This was 
achieved in all three studies. Urine bacterial culture was positive only in a minority of our cats 
(approximately 1%). Urinary sediment analysis revealed crystalluria in many cats, but was 
mostly mild, and evidence of inflammation or microscopic hematuria was uncommonly 
detected. Also, routine blood examination did not show abnormalities in the serum proteins. 
This indicates that borderline proteinuria was of renal origin in most cats. In case of 
proteinuria of renal origin it is important to evaluate persistence, preferably with 3 samples 
over a period of at least 2 weeks. If persistent borderline proteinuria is noted, re-evaluation 
and re-classification after 2 months is recommended (Lees et al 2005, IRIS 2009). These 
recommendations were not accomplished in our studies as our cats were only evaluated at a 
single time point, therefore, the number of cats with persistent borderline proteinuria is 
unknown. Because of the high number of cats with borderline proteinuria, re-evaluation 
would have been very impractical and expensive, which raises the question if these 
recommendations are practically feasible.  
A more important question is whether borderline proteinuria in healthy cats is 
clinically relevant. In azotemic cats, it is accepted that low-level proteinuria is a negative 
prognostic factor (Kuwahara et al 2006, Syme et al 2006, King et al 2007), but data in non-
azotemic cats are scarce. In one study, that was only published in the format of an abstract, 
the median UPC for apparently healthy cats that died due to any cause was 0.3, whereas 
median UPC in cats that were still alive at the end of the study was 0.11, indicating that 
borderline or mild proteinuria could be of prognostic significance (Walker et al 2004). As 
borderline proteinuria might be a sensitive indicator of renal or extrarenal diseases (Segev 
2010), the significantly higher UPC in old versus middle-aged cats (Chapter 3), might be 
explained by the fact that older cats are more prone to early CKD or occult systemic disease. 
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However, it is unlikely that early CKD was the cause of borderline proteinuria in 
approximately ¼ of juvenile healthy cats (Chapter 4). As mentioned above (Section 7.2), it is 
possible that at least some of our cats actually did not have borderline proteinuria, but were 
incorrectly classified as such. Misclassification might be a consequence of the assay used 
(Fernandes et al 2005) or due to inappropriate storage or dilution of urine samples (Rossi et al 
2012). Assessing borderline proteinuric cats for microalbuminuria could have been 
meaningful to decide whether renal damage was indeed present (Grauer 2007), but this was 
not done in our studies. Further research is needed to reveal the clinical relevance of 
borderline proteinuria in healthy cats of different ages. Hopefully, these future studies will 
result in precise and practical recommendations for the assessment and management of 
borderline proteinuria in non-azotemic cats.  
 Another mutual finding in the healthy cats investigated in Chapter 3 and Chapter 4 
was the frequent crystalluria, namely in 41% of the middle-aged to old cats (Chapter 3) and in 
50% of both cat groups of Chapter 4. Because we performed the urinary sediment analysis 
within 30 minutes of urine collection, in vitro crystal formation due to storage is unlikely 
(Albasan et al 2003). Although it is generally accepted that crystals are commonly present in 
feline urine (DiBartola 2010), we are not aware of scientific studies on the frequency of 
crystalluria in client-owned healthy cats prior to this thesis. Most of our cats had small 
amounts of amorphous crystals. Uroliths could not be ruled out in Chapter 3 because medical 
imaging studies were not performed in these cats, but were detected with ultrasonography 
only in approximately 2% of Ragdolls and control cats of Chapter 4. Almost all our cats with 
crystalluria had inactive urinary sediment and none had a history of lower urinary tract signs, 
indicating that these crystals usually do not cause discomfort to these cats. This indicates that 
amorphous crystals in small quantities do not necessarily explain clinical signs in cats that are 
presented with lower urinary tract signs. Also, the finding of crystalluria is not sufficient to 
recommend a calculolytic diet.   
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7.6 SIMPLIFIED METHODS TO DIAGNOSE EARLY KIDNEY DYSFUNCTION 
 
Finally, in Chapter 6 we aimed to develop simple methods to identify cats with early 
kidney dysfunction, because routine blood and urine variables can be within RIs in cats with 
early CKD (Braun and Lefebvre 2008, Stockham and Scott 2008, DiBartola 2010). These 
methods might be valuable mainly to screen feline populations at risk for CKD. In certain 
situations, such as for dosage adjustment of nephrotoxic drugs or in research situations, 
knowledge of the exact GFR value of the cat might be important (Lees 2004, Polzin 2010). 
Because multi-sample techniques for GFR estimation are too labor-intensive, time-consuming 
and stressful for use in practice (Finch et al 2013), there was a need for reliable, simple and 
cost-effective methods to estimate feline GFR. Conversely, identifying cats with decreased 
GFR is more important than knowledge of the exact GFR value in daily practice. Hence we 
also aimed to develop simple methods to identify cats with GFR below certain thresholds.  
 Data of a 9-sample combined plasma exogenous creatinine-iohexol clearance test of 
73 cats were used. Regression formulae based on routine variables (serum urea and creatinine 
concentrations, USG, UPC) could not reliably estimate the actual GFR value, but were 
trustworthy to identify cats with GFR below low or borderline thresholds. For reliable GFR 
estimation, at least 3 blood samples for clinical purpose and 5 blood samples for research 
purpose are required and optimal timing for these samples was determined. Finally, cut-off 
marker concentrations at three time points after marker injection were defined and these were 
able to identify cats with GFR below low and borderline thresholds with high sensitivities, 
specificities, positive and negative predictive values.  
Their relationship with GFR confirmed that routine variables might be within RIs in 
cats with low GFR (Fig 6.1 and 6.2). Several cats with low GFR had normal serum creatinine 
or urea concentration and USG ≥ 1.035. The fact that some cats with CKD retained their urine 
concentrating ability had already been described in cats with experimental loss of renal 
functional mass (Ross and Finco 1981). On the other hand, poorly concentrated urine or 
serum creatinine or urea concentrations exceeding the RI were seen in some cats with normal 
GFR. This is in line with the general opinion that USG below 1.035 – without other 
indications for CKD – does not necessarily suggest kidney dysfunction (Lees 2004, Stockham 
and Scott 2008). As discussed above (Section 7.2), poorly concentrated urine was found in 
15% of cats of Chapter 3 and in 3% of Ragdolls and 13% of control cats of Chapter 4. It is 
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unlikely that all these cats had early CKD. The same is true for cats of Chapter 3 and Chapter 
4 with increased serum creatinine and urea concentrations.  
Prior to this thesis, reported limited sampling strategies (LSS) in cats were 
insufficiently validated to be used in practice (Barthez et al 2000, Barthez et al 2001, Goy-
Thollot et al 2006, Vandermeulen et al 2008, Heiene et al 2009). Since the study of Chapter 6 
was finalized, other reports describing LSS in cats were published (Miyagawa et al 2010, 
Vandermeulen et al 2010, Finch et al 2011, Katayama et al 2012, Finch et al 2013, Katayama 
et al 2013). As mentioned in Chapter 6, many of these studies are predominantly limited by 
including no or only few renal-impaired cats (Barthez et al 2000, Barthez et al 2001, Goy-
Thollot et al 2006, Vandermeulen et al 2008, Heiene et al 2009, Vandermeulen et al 2010, 
Finch et al 2011, Katayama et al 2012, Katayama et al 2013). Other limitations are that the 
reference GFR, which is used to design LSS, is often computed using a clearance technique 
with less than 5 blood samples (Heiene et al 2009, Katayama et al 2012, Katayama et al 
2013) or total duration of 5 or less hours (Goy-Thollot et al 2006, Vandermeulen et al 2008, 
Heiene et al 2009, Miyagawa et al 2010, Vandermeulen et al 2010, Katayama et al 2012, 
Katayama et al 2013).  
Some authors report that feline GFR can be reliably estimated based on 1 or 2 blood 
samples (Barthez et al 2001, Goy-Thollot et al 2006, Vandermeulen et al 2008, Heiene et al 
2009, Miyagawa et al 2010, Vandermeulen et al 2010, Katayama et al 2012, Finch et al 2013, 
Katayama et al 2013) which contrasts markedly with our finding that for clinic situations at 
least 3 blood samples and for research purpose at least 5 blood samples after injection of the 
clearance marker are required to estimate GFR with an acceptable margin of error. This might 
be explained by different methodologies to estimate the reference GFR and to define LSS 
based on this reference. Other authors calculated the reference GFR using a one- or two-
compartmental model with or without a human- or dog-based correction formula to adjust for 
errors caused by the chosen model (Barthez et al 2001, Goy-Thollot et al 2006, 
Vandermeulen et al 2008, Heiene et al 2009, Miyagawa et al 2010, Vandermeulen et al 2010, 
Katayama et al 2012, Katayama et al 2013). However, because different pharmacokinetic 
approaches to estimate GFR are scarcely compared in cats and because human- or dog-
specific correction formulae are not properly evaluated for use in cats, the reliability of these 
reference GFR values is difficult to judge. In contrast, we compared LSS with a GFR estimate 
that was calculated using a noncompartmental approach, which is assumption free and thus 
avoids these downsides (Heiene and Moe 1998, Von Hendy-Willson and Pressler 2011). One 
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group recently developed a 3-sample iohexol clearance method using the slope-intercept 
method and a feline correction formula (Finch et al 2011). This was followed by development 
of a single-sample method starting from their 3-sample method, using a modified Jacobsson 
technique (Finch et al 2013). As a first step, a 3-sample clearance method was created in 20 
healthy cats using a one-compartmental model and compared to a multisampling method with 
blood samples taken over 6 hours after marker injection and using a two-compartmental 
model to calculate the reference GFR. These reference GFR values were shown to be in 
excellent agreement with GFR values reached by noncompartmental analysis of the same 
multisampling method (Finch et al 2011). A limitation was that these authors only used 
healthy cats to compare their two-compartmental model to noncompartmental analysis and the 
question remains whether the same level of agreement would have been reached in renal-
impaired cats. For accurate GFR estimation using a noncompartmental approach, the 
extrapolated area of the area under the plasma concentration-versus-time curve (AUC) should 
never exceed 20% of the total area (Watson et al 2002). Six hours after injection, most of the 
marker will probably be excreted by the kidneys in healthy cats, but not in renal-impaired 
cats. This was clearly shown in our study, as some of our cats with CKD had an extrapolated 
area of the AUC larger than 20% for exo-iohexol clearance, even though we sampled until 10 
hours after marker injection. Results were even more striking for creatinine clearance as the 
extrapolated area of the AUC exceeded 20% in most of our cats with CKD. The need for 
more prolonged sampling, between 10 and 24 hours after creatinine injection, for patients 
with renal dysfunction has previously been shown in dogs (Watson et al 2002). In a second 
step, a single-sample method was created using a group of nonazotemic (n = 73) and azotemic 
(n = 16) cats and compared to the previously developed 3-sample method (Finch et al 2013). 
To do so, the authors used a modification of the Jacobsson method that was originally 
designed for human patients. Other authors also used the Jacobsson formula to create single-
sample methods to estimate feline GFR (Katayama et al 2012, Katayama et al 2013). This 
Jacobsson method is based on a one-compartmental model and assumes immediate and 
uniform admixture of the clearance marker in the distribution volume after injection. Also, the 
timing of the blood sample should be based on renal function and distribution volumes 
(Jacobsson 1983). In the studies of Finch et al (2011, 2013) the time points of the blood 
samples for the 3-sample clearance were randomly chosen and not based on clearance values 
or distribution volumes. Whether the other assumptions inherent to the Jacobsson method are 
applicable to cats is currently unknown. In addition, the Jacobsson method requires multiple 
calculations which hampers its use in daily practice.  
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All these limitations indicate that there are many uncertainties to the published LSS. 
Although we did not primarily intend to compare our LSS with published LSS, we can 
summarize the advantages of our methodology as follows: our reference GFR was based on 
multiple blood samples over a 10 hour period, both in the distribution and elimination phases 
of the clearance marker, and computed using an assumption free noncompartmental approach. 
Additionally, LSS were designed for 3 different clearance markers in a cat population with 
wide range of GFR. So, based on current knowledge on feline GFR, our LSS are as reliable as 
possible.  
An important further step in veterinary medicine is to evaluate whether GFR can be 
reliably estimated based on serum creatinine and demographic variables. In humans, GFR is 
estimated from prediction equations that take into account the serum creatinine concentration 
and some or all of the following variables: age, gender, race, and body size. These equations 
are more reliable than estimates of GFR from measurement of serum creatinine alone, mainly 
because they compensate for the substantial variation in creatinine production across sex, age 
and ethnicity (NKF 2002). Similary, the endogenous creatinine production rate has a high 
inter-individual variability in cats (Le Garreres et al 2007), but which factors (e.g. age, breed, 
sex) are responsible for this variation is currently unknown. 
The methods to estimate GFR and identify cats with decreased GFR and the diagnostic 
algorithm (Fig 6.5) proposed in Chapter 6 can support veterinarians in the work-up of cats for 
early kidney disease. The methods to identify cats with GFR below borderline or low GFR 
thresholds are described for the first time. Remaining limitations are that iohexol assays are 
expensive and not widely available, that injectable creatinine is not yet commercialized and 
that the accuracy of these new methods was not evaluated in a separate cat population than the 
one they were designed in. However, these methods can give important additional information 
to the routine variables to evaluate kidney function in cats. Because these methods are easy to 
do, inexpensive and do not require difficult calculations, they are very suitable for daily use in 
practice. Main indications to apply these methods are cats with one or more risk factor(s) for 
CKD (e.g. age, breed, related condition, drug therapy), particularly if the routine blood and 
urine variables give doubtful results. These methods represent an important progress for 
detecting mild feline kidney dysfunction and these new tools can be employed in the 
screening for feline CKD. An improved opportunity to diagnose early feline CKD can lead to 
timely therapeutic intervention and possibly an improved prognosis.   
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7.7 GENERAL CONCLUSION 
 
In this thesis, commonly applied screening techniques for CKD were assessed in two 
at-risk populations, namely aged and Ragdoll cats. Health screening of middle-aged and old 
cats did lead to multiple diagnoses such as FIV infection, CKD, hyperthyroidism and urinary 
tract infection. In addition, many cats had a suboptimal SBP or BCS, gingivitis, heart murmur 
or laboratory abnormalities for which further diagnostic intervention, treatment or follow-up 
were indicated. This clearly indicates the need and value of regular health checks in aged cats 
to improve early disease detection – including CKD – and to allow timely therapeutic 
intervention. We found that Ragdoll cats are predisposed for segmental cortical lesions, but an 
increased susceptibility of Ragdoll cats for CKD could neither be confirmed nor excluded. 
Although further studies are required, the ultrasonographic suspicion for CKD in 5 – 9% 
Ragdoll cats versus none in the control group may support continued pre-breeding screening 
of Ragdoll cats for kidney disease.  
Because DM is an important risk factor for CKD in humans, we also evaluated if cats 
with DM were susceptible to develop DKD. By comparing diabetic cats with healthy and 
CKD cats, we could not demonstrate a major influence of feline DM on kidney function. 
Therefore, there is currently no rationale for more intense screening of diabetic cats for kidney 
disease than non-diabetic cats of similar age. 
Throughout this thesis, several limitations of the currently used screening tests for 
CKD were noticed and solutions were proposed. For some restrictions, no clear solution could 
be given and further study is needed. An overview is provided in Table 7.1. 
An important solution is the design of convenient and cost-effective methods and a 
diagnostic algorithm (Fig 6.5) that can be employed in the diagnosis of early feline CKD. 
Limited sampling strategies were developed allowing GFR estimation with a margin of error 
that is acceptable both for clinical and for research situations. Reliable new methods were 
created to identify cats with a GFR value below certain thresholds, using routine kidney 
variables or clearance marker concentrations at three time points after marker injection. These 
methods can be applied for screening of cats for CKD, particularly in cats with doubtful 
routine blood and urine variables, and will facilitate the diagnosis of early CKD. Future 
studies will need to elucidate whether early detection of kidney dysfunction and timely 
therapeutic intervention leads to an improved long-term outcome. 
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Table 7.1. Limitations of screening tests for chronic kidney disease and possible 
solutions. 
LIMITATION POSSIBLE SOLUTION 
Early clinical signs of CKD, such as poor 
body condition or polyuria/polydipsia, may 
be overlooked by cat owners. 
Veterinarians should educate cat owners to 
recognize early clinical signs of CKD.  
Routine health screening of cat populations 
at-risk for CKD is warranted.  
Many healthy cats have values outside the 
RI for certain laboratory variables (e.g. 
serum creatinine concentration, serum 
phosphorus concentration), questioning the 
validity of the RI.  
Secondly, an age-effect was found for 
certain laboratory variables. 
Veterinary laboratories should follow 
published guidelines to determine RIs.  
For age-dependent laboratory variables, 
partitioning the RIs for age will improve 
health screening of aged cats.  
Laboratories should calculate reference 
change values for laboratory variables with 
high individuality to facilitate detection of 
clinically relevant changes on serial 
laboratory results.  
Standardization of laboratory measurements 
is warranted in veterinary medicine.  
Many cats have doubtful routine kidney 
variables, namely increased serum urea or 
creatinine concentration or poorly 
concentrated urine as single abnormality. 
Routine blood and urine examinations 
cannot distinguish whether these 
abnormalities are irrelevant or might 
indicate early CKD. 
Simplified methods to estimate GFR (LSS) 
or to identify cats with decreased GFR 
(Chapter 6) can be applied to cats with 
doubtful routine kidney and urine variables.  
Approximately ¼ of healthy cats of various 
ages have borderline proteinuria. 
Longitudinal studies are needed to reveal 
the relevance of borderline proteinuria in 
healthy cats of different ages in order to 
ameliorate the recommendations for the 
management of borderline proteinuria in 
non-azotemic cats.  
Efforts should be taken to standardize UPC 
measurements in veterinary laboratories.  
(CIN = Chronic interstitial nephritis; CKD = Chronic kidney disease; GFR = Glomerular 
filtration rate; LSS = Limited sampling strategy; PKD = Polycystic kidney disease; RI = 
Reference interval; UPC = Urinary protein: creatinine ratio)  
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Table 7.1. Continued. 
LIMITATION POSSIBLE SOLUTION 
Chronic interstitial nephritis cannot be 
diagnosed using the current screening tests 
for Ragdoll cats, namely serum creatinine 
and urea concentrations, liver and kidney 
ultrasonography and genetic testing for 
PKD. 
Using these screening tests, Ragdoll cats 
can only be evaluated for CKD and PKD.  
Kidney histology is needed to determine if 
CIN is present in Ragdoll cats suspected of 
CKD or diagnosed with CKD.  
Interpretation of the current screening tests 
for Ragdoll cats is hampered by the lack of 
urinalysis and lack of knowledge of the 
frequency of renal ultrasonographic 
abnormalities in non-Ragdoll cats. 
Additional limitations revealed by the 
retrospective study were incomplete 
screening tests in many Ragdoll cats and 
many incomplete ultrasonography reports.  
We described the frequency and type of 
renal ultrasonographic abnormalities in 
young healthy non-Ragdoll cats. 
Urinalysis should be added to the currently 
applied screening tests. Secondly, a 
standardized protocol for abdominal 
ultrasonography should be followed and 
was proposed in this thesis. 
The retrospective study questioned whether 
a breed-specific RI was needed to interpret 
serum creatinine in Ragdoll cats. 
The prospective study rejected the need for 
a breed-specific serum creatinine RI for 
Ragdoll cats.  
As B-mode renal ultrasonography does not 
correlate with renal function and is not a 
useful tool to predict which cats will 
develop azotemic kidney disease, 
confirmation of CKD is not possible based 
on ultrasonographic findings. 
Simplified methods to estimate GFR (LSS) 
or to identify cats with decreased GFR 
(Chapter 6) can be applied to non-azotemic 
Ragdoll cats with an ultrasonographic 
suspicion of CKD. 
Long-term follow-up of kidney function is 
needed in these cats to help determine the 
clinical relevance of renal ultrasonographic 
changes. 
(CIN = Chronic interstitial nephritis; CKD = Chronic kidney disease; GFR = Glomerular 
filtration rate; LSS = Limited sampling strategy; PKD = Polycystic kidney disease; RI = 
Reference interval)  
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Chronic kidney disease (CKD) is a common condition in feline patients. The 
current knowledge on diagnosis, staging according to the International Renal Interest 
Society guidelines, and importance of screening for CKD is summarized in Chapter 1. 
This literature review underlines that CKD is mostly diagnosed late in the disease course, 
based on compatible clinical signs and renal azotemia. Detection of mild kidney 
dysfunction is difficult because azotemia and impaired urine concentrating ability can be 
absent. However, early detection of CKD is important to initiate appropriate therapy on 
time, aiming to slow down declining kidney function and to postpone disease 
complications. Determination of glomerular filtration rate (GFR) allows diagnosis of early 
CKD, but is too labor-intensive and time-consuming to perform in daily practice. Since 
early diagnosis of feline CKD is challenging, screening of at-risk populations is 
recommended.  
Because of their increased susceptibility for chronic diseases – including CKD – 
old cats are the first cat population for which health screening was already performed 
before the start of this thesis. Guidelines for routine health screening of senior and geriatric 
cats were created by the Feline Advisory Bureau, American Association of Feline 
Practitioners and American Animal Hospital Association. Unfortunately, scientific data on 
clinical and laboratory abnormalities of aging cats were scarce which limited the 
interpretation of this health screening. 
On the recommendation of breed clubs, Ragdoll cats are screened for years now in 
some countries for polycystic kidney disease (PKD) and chronic interstitial nephritis 
(CIN). For this screening, breed clubs advise measuring serum creatinine and urea 
concentrations and performing ultrasonography of liver and kidneys and a genetic test for 
PKD. However, scientific studies on the prevalence of Ragdoll cats for PKD and the 
predisposition of Ragdoll cats for CIN or CKD were not available prior to this thesis. 
Cats with diabetes mellitus (DM) are a third cat population for which screening for 
CKD might be recommended. Diabetic kidney disease (DKD) or diabetic nephropathy is a 
frequent and serious complication in human medicine, particularly in humans with type 2 
DM. Because cats mainly suffer from type 2 DM, the question did exist whether feline 
diabetics are susceptible for DKD? 
The final goal of this thesis (Chapter 2) was to demonstrate the limitations of 
currently performed screening practices for feline CKD and to develop possible solutions 
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to improve early CKD detection. Therefore, the screening of middle-aged and old cats and 
Ragdoll cats for CKD was evaluated and diabetic cats were evaluated for the occurrence of 
DKD. Finally, we aimed to develop convenient and cost-effective methods to estimate 
GFR and to identify cats with GFR values below certain thresholds.  
In Chapter 3 general health screening was executed in 100 apparently healthy 
middle-aged and old cats by fulfilling a complete history, systolic blood pressure (SBP) 
measurement, physical examination, ophthalmic examination, complete blood count, 
serum biochemistry profile and urinalysis. The cats were allocated to two groups, namely 
middle-aged (6 –10 years; n = 56) and old cats (> 10 years; n = 44). The mean SBP of our 
population was 133.6 ± 21.5 mmHg and SBP exceeded 160 mmHg in 8% of cats. 
Interesting findings on physical examination were gingivitis (72%), local 
lymphadenopathy (34%), palpable thyroid goiter (20%) and murmur (11%). The body 
condition score (BCS) was abnormal in 51% of cats: 40% were overweight and 11% 
underweight. Major findings on laboratory tests were increased creatinine concentration 
(29%), hypophosphatemia (40%), borderline proteinuria (25%) and crystalluria (41%). The 
tear production was similar for both eyes and ocular lesions secondary to hypertension 
were not detected. Cats over 10 years of age had significantly higher SBP, heart rate, 
murmur frequency, platelet count, serum urea concentration, serum bilirubin concentration 
and urinary protein: creatinine ratio (UPC) and a significantly lower BCS, hematocrit, 
serum albumin concentration and serum calcium concentration than middle-aged cats (6 – 
10 years). Health screening allowed us to diagnose feline immunodeficiency virus 
infection in 14 cats, CKD in 2 cats and hyperthyroidism and urinary tract infection in one 
cat. 
This study showed that physical and laboratory abnormalities are frequent in 
‘apparently healthy’ old cats. Our findings confirmed the importance of regular health 
screening – including nutritional assessment – and individualized nutritional support for 
aging cats. Further, this study emphasized the significance of reliable reference intervals 
(RIs) to allow an accurate interpretation of health screening. Finally, age-specific RIs are 
required, at least for some laboratory parameters (e.g. serum creatinine, serum phosphor).  
The occurrence of kidney diseases in Ragdoll cats was investigated in Chapter 4. 
At first, data of Ragdoll cats that were presented at our institution for PKD and CIN 
screening over an 8 years period were retrospectively evaluated (Section §4.1). Renal 
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ultrasonography of 244 healthy Ragdoll cats revealed a PKD prevalence of 2.9%, suspicion 
for CKD in 8.6%, abnormalities with unclear significance in 3.3% and unilateral renal 
agenesis or severe hypoplasia in 2 cats (0.1%). All genetically tested cats (n = 125) were 
homozygous for the wild-type PKD-1 alleles indicating a PKD negative state. Almost 11% 
of the 141 Ragdoll cats for which serum creatinine was measured had an increased 
concentration, which raised the question whether a breed-specific creatinine RI for Ragdoll 
cats would be appropriate? 
Given the limitations inherent to the retrospective study design, a prospective study 
was the logical next step (Section §4.2). Serum creatinine and urea concentrations, routine 
urinalysis and ultrasonography of the urinary tract and liver according to a standard 
protocol were compared between healthy Ragdoll and age-matched control cats. Ragdoll 
cats also underwent a genetic test for the PKD-1 mutation. In total, 133 Ragdoll cats and 
62 control cats were included. Renal ultrasonographic abnormalities were frequent, in 
Ragdoll cats (49.6%) as well as in control cats (40%). None of the control cats, but 5.3% of 
Ragdoll cats were suspected for CKD on ultrasonography, which approached significance. 
Ragdoll cats showed significantly more frequent segmental cortical lesions, abnormal renal 
capsule, echogenic urine, significantly lower serum urea concentration and higher urine 
specific gravity (USG) compared to the control cats. The other ultrasonographic and 
laboratory variables did not significantly differ between both groups. Blood and urine 
examinations confirmed CKD in only 1 of the Ragdoll cats and all Ragdoll cats were PKD 
negative based on genetic testing. Borderline proteinuria and crystalluria were frequent in 
both groups. 
Based on both studies of Chapter 4 we concluded that young, healthy Ragdoll cats 
are uncommonly affected by PKD, are suspected for CKD on ultrasonography in 5 – 9% of 
cases and are predisposed for segmental cortical lesions. A breed-specific serum creatinine 
RI does not seem required for Ragdoll cats. A remarkable finding of the prospective study 
was the high frequency of renal ultrasonographic abnormalities in juvenile healthy cats. 
However, none of the control cats showed segmental cortical lesions or was 
ultrasonographically suspected for CKD. Therefore, it appears wise to continue pre-
breeding screening of Ragdoll cats and to avoid breeding with Ragdoll cats with segmental 
cortical lesions and with an ultrasonographic suspicion of CKD.  
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In Chapter 5 routine kidney variables (serum urea, serum creatinine, USG, UPC), 
SBP, GFR and urinary Cystatin C (uCysC) as tubular marker were prospectively compared 
between cats with DM, cats with CKD and healthy cats that were age-matched to the 
diabetic cats. The same variables were compared between recently (i.e. less than 1 month) 
and not-recently diagnosed (i.e. 1 month or longer) diabetic cats. Cats with DM only had 
significantly lower USG compared to healthy cats. In contrast, most variables significantly 
differed between cats with DM and cats with CKD: diabetic cats had significantly lower 
serum urea concentration, serum creatinine concentration and uCysC: creatinine ratio and 
significantly higher USG and GFR. Systolic blood pressure and UPC did not significantly 
differ between the 3 groups of cats. None of the variables evaluating kidney function or 
kidney damage differed significantly between recently and not-recently diagnosed diabetic 
cats.  
Thus, based on the single evaluation of routine kidney variables, GFR and uCysC, a 
major impact of feline DM on kidney function could not be demonstrated. This indicates 
that there is currently no rationale to screen diabetic cats more frequently for CKD than 
non-diabetic cats of similar age.  
Finally, we aimed to develop simple methods to identify cats with early kidney 
dysfunction in Chapter 6. Data of 73 cats that underwent a 9-sample combined plasma 
exogenous creatinine-iohexol clearance test at our institution were used. Regression 
formulae based on routine variables (serum urea and creatinine concentrations, USG, UPC) 
could not reliably estimate the actual GFR value, but were trustworthy to identify cats with 
GFR below low or borderline thresholds. For reliable GFR estimation, at least 3 blood 
samples for clinical purpose and 5 blood samples for research purpose are required and 
optimal timing for these samples was determined. Finally, cut-off marker concentrations at 
three time points after marker injection were defined and these were able to identify cats 
with GFR below low and borderline thresholds with high sensitivities, specificities, 
positive and negative predictive values. Based on these new methods, we proposed a 
diagnostic algorithm to identify cats with early CKD.  
These convenient and cost-effective methods to estimate GFR and identify cats 
with decreased GFR can give crucial additional information to evaluate kidney function in 
cats. These methods represent an important progress for detecting mild kidney dysfunction 
and can be employed as part of the screening for feline CKD. 
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Throughout this thesis, we have gained important knowledge on the value and 
limitations of currently applied screening techniques for feline CKD and we have 
expanded the diagnostic tools for early detection of feline CKD. We can conclude that 
routine screening for CKD seems mandatory for aged cats and Ragdoll cats, but not for 
diabetic cats. To allow an accurate interpretation of this screening, a combination of blood 
and urine examinations is needed and well-designed reliable laboratory RIs are required. 
Additionally, a standardized protocol should be followed to screen Ragdoll cats using renal 
ultrasonography. In order to detect mild kidney dysfunction in case of doubtful routine 
laboratory results, methods to identify cats with GFR below certain thresholds were 
created. Also, limited sampling strategies were developed to estimate GFR in a convenient 
way. These techniques will facilitate the diagnosis of early feline CKD, aiming for more 
timely therapeutic intervention and possibly an improved prognosis.  
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Chronische nierziekte (CNZ) is een frequent voorkomende aandoening bij katten. 
De huidige kennis over de diagnose, de stagering volgens richtlijnen van de International 
Renal Interest Society en het belang van screening voor CNZ wordt samengevat in 
Hoofdstuk 1. Dit literatuuroverzicht benadrukt dat CNZ jammer genoeg vaak in een 
vergevorderd stadium wordt gediagnosticeerd, op basis van typische klinische symptomen 
en renale azotemie. Een milde afname van de nierfunctie is moeilijk vast te stellen omdat 
azotemie vaak niet aanwezig is en de nieren nog in staat zijn de urine te concentreren. 
Vroegtijdige detectie van CNZ is echter belangrijk om tijdig een gepaste therapie op te 
starten om zo verdere achteruitgang van de nierfunctie af te remmen en complicaties uit te 
stellen. Door bepaling van de glomerulaire filtratiesnelheid (GFS) kan milde CNZ 
gediagnosticeerd worden, maar dit is te arbeidsintensief en tijdrovend voor dagelijks 
gebruik. Feliene CNZ vroegtijdig opsporen is een uitdaging, daarom wordt screening van 
risicopopulaties aangeraden. 
Omdat oude katten vatbaar zijn voor verschillende chronische aandoeningen, 
waaronder CNZ, werd bij deze populatie gezondheidsscreening al toegepast vóór de start 
van deze thesis. Richtlijnen voor gezondheidscontroles van senior en geriatrische katten 
werden opgesteld door de Feline Advisory Bureau, American Association of Feline 
Practitioners en American Animal Hospital Association. Jammer genoeg was de 
interpretatie van dergelijke gezondheidscontroles moeilijk omdat wetenschappelijke 
informatie over klinische en laboratorium afwijkingen bij oude katten ontbrak. 
In sommige landen worden Ragdolls op aanraden van rasverenigingen al vele jaren 
gescreend voor polycystische nierziekte (‘polycystic kidney disease’; PKD) of chronische 
interstitiële nefritis (CIN). Voor deze screening adviseren rasverenigingen de bepaling van 
serum creatinine en ureum concentraties, echografie van lever en nieren en een genetische 
test voor PKD. Wetenschappelijke literatuur over de prevalentie van PKD en predispositie 
van Ragdolls voor CIN of CNZ was echter niet beschikbaar bij aanvang van deze thesis.  
Katten met diabetes mellitus (DM) zijn een derde kattenpopulatie waarvoor 
screenen van de nierfunctie belangrijk kan zijn. Diabetes nefropathie (= ‘Diabetic kidney 
disease’; DKD) is een frequente en ernstige complicatie in de humane geneeskunde, vooral 
bij mensen met type 2 DM. Aangezien katten meestal type 2 DM hebben, bestond de vraag 
of ze ook DKD kunnen ontwikkelen?  
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De algemene doelstelling van deze thesis (Hoofdstuk 2) was het aantonen van de 
beperkingen van huidige screeningmethodes voor feliene CNZ en mogelijke oplossingen te 
bieden om de detectie van vroegtijdige CNZ te verbeteren. Daarom werd de screening voor 
CNZ geëvalueerd bij katten van middelbare tot oude leeftijd en bij Ragdolls en werd 
onderzocht of DKD voorkomt bij suikerzieke katten. Tot slot wilden we 
gebruiksvriendelijke en betaalbare methodes ontwikkelen om de GFS in te schatten en om 
katten met een GFS onder een bepaalde grenswaarde te detecteren.  
In Hoofdstuk 3 ondergingen 100 schijnbaar gezonde katten van 6 jaar of ouder een 
algemene gezondheidscontrole door middel van een complete anamnese, bloeddrukmeting, 
grondig lichamelijk onderzoek, oogonderzoek, hematologisch en biochemisch 
bloedonderzoek en urineonderzoek. De katten werden verdeeld in 2 groepen, namelijk 
katten van middelbare leeftijd (6 – 10 jaar; n = 56) en oude katten (> 10 jaar; n = 44). De 
gemiddelde bloeddruk was 133,6 ± 21,5 mmHg en de systolische bloeddruk (SBD) was 
meer dan 160 mmHg bij 8% van onze katten. Interessante bevindingen op lichamelijk 
onderzoek waren gingivitis (72%), lokale lymfadenopathie (34%), een vergrote schildklier 
(20%) en een bijgeruis (11%). De lichaamsconditie score was abnormaal bij 51% van de 
katten: 40% had overgewicht en 11% ondergewicht. De belangrijkste bevindingen op 
laboratorium onderzoek waren gestegen creatinine concentratie (29%), hypofosfatemie 
(40%), borderline proteïnurie (25%) en kristallurie (41%). De traanproductie was 
gelijkaardig in beide ogen en geen enkele kat vertoonde oogletsels secundair aan 
hypertensie. Katten ouder dan 10 jaar hadden een significant hogere SBD, hartslag, 
frequentie van bijgeruis, aantal bloedplaatjes, serum ureum concentratie, serum bilirubine 
concentratie en urinaire eiwit/creatinine ratio (E/C) en een significant lagere 
lichaamsconditie score, hematocriet, serum albumine concentratie en serum calcium 
concentratie dan katten van middelbare leeftijd (6-10 jaar). De gezondheidsscreening 
leidde tot diagnoses zoals infectie met felien immunodeficiëntievirus (14%), CNZ (2%), 
hyperthyroïdie (1%) en urineweginfectie (1%).  
Deze studie toonde aan dat afwijkingen op lichamelijk en laboratorium onderzoek 
frequent voorkomen bij ‘schijnbaar gezonde’ oude katten. Onze bevindingen bevestigden 
het nut van regelmatige gezondheidscontroles – inclusief beoordelen van de nutritionele 
status – en geïndividualiseerde nutritionele ondersteuning voor oudere katten. Verder 
benadrukte deze studie het belang van betrouwbare referentie intervallen om de resultaten 
van de gezondheidsscreening correct in te schatten. Tot slot konden we stellen dat 
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leeftijdspecifieke referentie intervallen noodzakelijk zijn voor sommige laboratorium 
parameters (bv. serum creatinine, serum fosfor). 
Het voorkomen van nieraandoeningen bij Ragdolls werd in Hoofdstuk 4 
onderzocht. Eerst en vooral werden gegevens van Ragdolls die gedurende een periode van 
8 jaar aan onze instelling werden aangeboden voor PKD en CIN screening retrospectief 
geëvalueerd (Sectie §4.1). Renale echografie toonde een PKD prevalentie van 2,9%, een 
vermoeden van CNZ bij 8,6%, abnormaliteiten waarvan de betekenis onduidelijk was bij 
3,3% en unilaterale renale agenesie of ernstige hypoplasie bij 2 katten (0,1%). Alle 
genetisch geteste Ragdolls (n = 125) waren homozygoot voor de wild-type allelen, wat 
wijst op een PKD-negatieve status. Bijna 11% van de 141 Ragdolls waarbij serum 
creatinine gemeten werd vertoonde een verhoogde waarde waardoor de vraag rees of een 
rasspecifiek referentie interval voor serum creatinine noodzakelijk is voor Ragdolls? 
Omwille van de beperkingen van deze retrospectieve studie, was een prospectieve 
studie de logische volgende stap (Sectie §4.2). Serum creatinine en ureum concentraties, 
routine urineonderzoek en echografie van urinair stelsel en lever volgens een standaard 
protocol werden vergeleken tussen gezonde Ragdolls en controlekatten van dezelfde 
leeftijd. De Ragdolls werden ook genetisch getest voor de PKD-1 mutatie. In totaal werden 
133 Ragdolls en 62 controlekatten onderzocht. Echografische veranderingen ter hoogte van 
de nieren waren frequent, zowel bij Ragdolls (49,6%) als bij controlekatten (40%). Geen 
enkele controlekat, maar wel 5,3% van de Ragdolls was echografisch verdacht voor CNZ, 
wat significantie benaderde. Ragdolls vertoonden significant vaker segmentale corticale 
letsels, een abnormaal nierkapsel en echogene urine en hadden een significant lagere serum 
ureum concentratie en hoger urinair soortelijk gewicht (USG) dan de controlekatten. De 
andere echografische en laboratorium variabelen verschilden niet significant tussen beide 
groepen. Bloed- en urineonderzoek bevestigden CNZ bij slechts 1 van de Ragdolls en alle 
Ragdolls waren PKD negatief volgens de genetische test. Borderline proteïnurie en 
kristallurie waren frequent in beide groepen. 
Beide studies van Hoofdstuk 4 toonden aan dat jonge, gezonde Ragdolls zelden 
PKD hebben, verdacht zijn van CNZ op echografie in 5 – 9% van de gevallen en een 
verhoogde vatbaarheid hebben voor segmentale corticale letsels. Een rasspecifiek serum 
creatinine referentie interval voor Ragdolls blijkt niet noodzakelijk. Een opmerkelijke 
bevinding van de prospectieve studie was de hoge frequentie van echografische 
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veranderingen ter hoogte van de nier bij jonge gezonde katten. Segmentale corticale letsels 
werden echter niet opgemerkt bij controlekatten en geen enkele controlekat was 
echografisch verdacht voor CNZ. Daarom lijkt het verstandig om verder Ragdolls te 
screenen vóór het fokken en niet te fokken met Ragdolls met segmentale corticale letsels 
en met een echografisch vermoeden van CNZ.  
In Hoofdstuk 5 werden routine renale variabelen (serum ureum, serum creatinine, 
USG, E/C), SBD, GFS en urinair Cystatine C als tubulaire merker prospectief vergeleken 
tussen katten met DM, katten met CNZ en gezonde katten van vergelijkbare leeftijd als de 
suikerzieke katten. Dezelfde variabelen werden vergeleken tussen recent (i.e. minder dan 1 
maand) en niet-recent (i.e. 1 maand of langer) gediagnosticeerde katten met DM. 
Suikerzieke katten hadden enkel een lager USG in vergelijking met gezonde katten. In 
tegenstelling, de meeste variabelen verschilden tussen katten met DM en CNZ: suikerzieke 
katten hadden significant lagere serum ureum concentratie, serum creatinine concentratie 
en urinair Cystatine C/creatinine ratio en significant hoger USG en GFS. De SBD en E/C 
waren niet significant verschillend tussen de 3 groepen katten. Geen enkele renale 
variabele verschilde tussen recent en niet-recent gediagnosticeerde suikerzieke katten.  
Met andere woorden, een duidelijke impact van feliene DM op de nierfunctie kon 
niet aangetoond worden op basis van een eenmalige beoordeling van routine renale 
variabelen, GFS en urinair Cystatine C. Daaruit volgt dat er momenteel geen 
wetenschappelijke basis is om katten met DM meer intensief te screenen op het voorkomen 
van CNZ in vergelijking met niet-suikerzieke katten van dezelfde leeftijd.  
Tot slot wilden we in Hoofdstuk 6 eenvoudige methodes ontwikkelen om katten 
met milde afname van de nierfunctie te onderkennen. We gebruikten gegevens van 73 
katten die aan onze instelling een gecombineerde plasma exogene creatinine-iohexol 
klaringstest van 9 stalen ondergingen. Hieruit bleek dat regressie formules op basis van 
routine variabelen (serum ureum, serum creatinine, USG, E/C) de eigenlijke GFS van een 
kat niet betrouwbaar konden inschatten, maar wel konden bepalen of een kat een GFS had 
beneden lage en borderline grenswaardes. De GFS kon betrouwbaar geschat worden met 
behulp van ten minste 3 bloedstalen voor klinische doeleinden en 5 bloedstalen voor 
onderzoeksdoeleinden. Ook werden de optimale tijdstippen voor deze staalname bepaald. 
Als laatste stelden we vast dat bepaalde ‘cut-off’ concentraties op 3 tijdstippen na injectie 
van de klaringsmerker in staat zijn om katten met een GFS beneden een lage of borderline 
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grenswaarde te detecteren met hoge sensitiviteit, specificiteit, positief en negatief 
voorspellende waarde. Met behulp van deze nieuwe methodes stelden we een diagnostisch 
algoritme op om katten met vroegtijdige CNZ te detecteren.  
Deze gebruiksvriendelijke en betaalbare methodes om GFS te schatten en katten 
met verminderde GFS te detecteren kunnen waardevolle bijkomende informatie geven om 
de nierfunctie van katten te beoordelen. Deze methodes betekenen een belangrijke 
vooruitgang om milde nierdysfunctie vast te stellen en kunnen gebruikt worden als 
onderdeel van de screening voor feliene CNZ.  
Dankzij deze thesis hebben we belangrijke kennis bekomen over de waarde en 
beperkingen van huidige screeningsmethodes voor feliene CNZ en werden de 
diagnostische opties voor vroegtijdige detectie van feliene CNZ uitgebreid. We kunnen 
besluiten dat routinematig screenen van oudere katten en Ragdolls voor CNZ essentieel 
blijkt te zijn, in tegenstelling tot katten met DM. Om deze screening accuraat te 
interpreteren, is een combinatie van bloed- en urineonderzoeken noodzakelijk en zijn goed 
opgestelde, betrouwbare laboratorium referentiewaardes vereist. Bovendien moet een 
standaard protocol gevolgd worden om Ragdolls te screenen via renale echografie. Om 
milde nierdysfunctie vast te stellen in geval van twijfelachtige routine laboratorium 
resultaten werden methodes ontworpen om katten met een GFS beneden bepaalde 
grenswaarden te identificeren. Ook werden gebruiksvriendelijke methodes ontwikkeld om 
de GFS in te schatten op basis van een beperkt aantal bloedstalen. Deze technieken zullen 
de diagnose van beginnende feliene CNZ bevorderen, met als doel tijdig een therapie in te 
stellen en mogelijk de prognose te verbeteren.  
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Het einde is in zicht: tijd voor het meest gelezen deel van dit boekje! Ik heb het 
parcours uiteraard niet alleen afgelegd en heel wat mensen verdienen een woordje van 
dank.  
 
Mijn promotor, Prof. Dr. Sylvie Daminet 
Sylvie, jij verdient het om als allereerste in de bloemetjes gezet te worden. Ik wil je 
vooral bedanken voor de jarenlange aangename en boeiende samenwerking. Jij hebt me 
alle kansen gegeven om me te ontplooien als internist, zowel in de kliniek als in het 
onderzoek. Ik ben je erg dankbaar voor de vrijheid die je me tijdens mijn doctoraat hebt 
gegeven om mijn eigen ding te doen. Gelukkig was je er om me bij te sturen (en soms op te 
peppen) waar nodig. Heel erg bedankt voor alle – vaak supersnelle – opbouwende 
verbeteringen van artikels, interessante discussies, hulp bij het voorbereiden van abstracts, 
en uiteraard ook de “niet-werk-gerelateerde” babbels! 
 
Mijn co-promotor, Prof. Dr. Jimmy Saunders 
Beste Jimmy, heel erg bedankt voor alle hulp bij de Ragdoll studies, vooral bij de 
prospectieve studie. Ook een dikke merci om mijn artikels steeds snel en grondig na te 
lezen, voor de relevante commentaar en de leuke babbels. 
 
Prof. Dr. Hervé Lefebvre 
Dear Hervé, you are a walking GFR encyclopedia, many thanks for sharing all your 
knowledge! I am very grateful for the opportunity to work with you. Thanks for all your 
help with the statistics, for correcting my manuscripts and for your thorough explanations 
if something was not clear. Also many thanks to you and Prof. Dr. Didier Concordet for 
the hospitality and pleasant collaboration during my visits to Toulouse! 
 
Prof. Dr. Siska Croubels, Dr. Andrew Sparkes, Dr. Frédéric Billen, Dr. Pascale Smets 
Dear members of my examination committee, thank you very much for reading my 
PhD very thoroughly and being so enthusiastic on my work. Your relevant comments gave 
me the opportunity to further improve my PhD publication.  
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Dr. Valérie Bavegems 
Beste Valérie, jij bent de start geweest van een belangrijk deel van dit doctoraat. Op 
één van de voorstellingen van de internwerkjes, maakte je me bewust van het “CIN 
probleem” bij Ragdolls en van het één kwam het ander. Een dikke merci om me met al je 
trouwe Ragdoll-fokkers in contact te brengen en ze mee warm te maken voor het 
onderzoek.  
Ik apprecieer het ook heel erg dat ik altijd op je kon rekenen om als vampier op te 
treden. Ragdolls zijn fantastische katten, maar stilzitten om bloed te prikken, is echter niet 
hun beste kant! Ook al was het vaak druk, de Ragdoll-dagen waren altijd plezant en ik heb 
je nooit horen morren over de kostbare tijd die mijn onderzoek van jou gevraagd heeft.  
 
Alle katten en hun eigenaars 
 Ik wil alle Ragdoll-fokkers bedanken voor hun enthousiaste deelname aan ons 
onderzoek. Niemand van jullie moest overtuigd worden, in tegendeel, jullie stonden vaak 
te springen om te komen. Een nadeel van het onderzoek was dat jullie bezoekjes aan Gent 
wat langer duurden dan gewoonlijk: bedankt voor jullie geduld! 
Daisy verdient een speciaal woordje van dank voor de twee schatten die ze ons 
heeft gegeven: Pinky was een superlieve knuffelbeer die jammer genoeg te vroeg van ons 
is weggegaan. We zijn superblij met zijn dochter Kissa, ook al kan ze hem uiteraard niet 
vervangen. 
Ook bedankt aan alle vrienden, collega’s en studenten voor de bijdrage van hun kat 
aan de wetenschap.  
Uiteraard verdienen ook onze eigen katten een dikke knuffel om (onvrijwillig) deel 
te nemen aan het onderzoek van hun (kleine) baas: Piepiep (aka. Ispahan of Bombeer), als 
CKD kat had jij de pech om een GFR te moeten ondergaan. Gelukkig was het de 
gemakkelijkste GFR ooit:…prrr…ik blijf spinnen…prrr…, en gelukkig was jij ook de 
outlier in mijn CKD groep. Frans (aka. Dikke Babbie), met jou ben ik echter in schande 
gekomen op medische beeldvorming, dus dat is niet echt voor herhaling vatbaar… Jules 
(aka. Julio Iglesias van het Begijnhof) en José (aka. José Maria Gonzales van het 
Begijnhof), broer en zus, ook al zijn jullie geen helden, elk op je eigen manier hebben 
jullie zich super gedragen. Kissa (aka. Platvoet of Keppefrulle) en vooral Pinky (aka. 
Neuzenpakker en…, zijn andere bijnaam is niet voor publicatie vatbaar): als Ragdoll 
hebben jullie je naam als “wriemelkont” uiteraard waargemaakt, maar de moeilijke 
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bloednames waren snel vergeten! Lieve mannen, misschien is het wel Werelddierendag 
vanavond…? 
 
Gaëlle Verjans 
Gaëlle, zonder jou was er geen “geriatrische studie” aangezien jij alle werk deed 
om de katten te rekruteren en te onderzoeken. Weinig interns brengen zo’n zwaar intern 
project tot een goed einde en ik wil zeker niet met jouw pluimen gaan lopen! 
 
The girls of medical imaging 
Anaïs, Pascaline, Elke, Caroline, Laure, Olga, Veerle, Yseult and Virginie, thank 
you very much for all your ultrasonographies and for punctually completing my papers!  
 
Bieke Weyn en Saar Muylaert, de kattenfluisteraars 
Saar, en vooral Bieke, heel erg bedankt dat ik altijd op jullie kon rekenen om de 
poezelige viervoeters onder bedwang te houden. Jullie “magic hands” en gezellige babbels 
maakten van een GFR een aangename gebeurtenis… 
 
Mijn bureaugenoot en kersverse Dr., Sophie Vandenabeele 
Sophie, bedankt voor alle leuke bureaumomenten tijdens onze doctoraatsperiode, 
voor alle discussies over patiënten en voor het delen van frustraties. De “zuchten” zullen 
nu wel terug afnemen… 
 
Liesbeth Ghys en Elien Taffin 
Liesbeth, heel erg bedankt voor alle hulp bij de zoektocht naar CKD katten, bij de 
GFRs en het analyseren van stalen.  
Elien, super bedankt om mijn volledige doctoraat onder de loep te nemen op 
schrijffouten. Je talrijke taal- en lay-out tips waren zeer waardevol! Ook een dikke merci 
om Kissa te “photoshoppen”.  
Beiden heel erg bedankt voor jullie steun en ik wens jullie heel veel succes met je 
eigen doctoraat! 
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Filip Clompen 
Een computer-nerd zal ik nooit worden… Filip, gelukkig was jij er altijd om bij te 
springen en om problemen op te lossen. Telkens was ik verwonderd hoe jij de gebreken 
van een foto professioneel kon wegwerken.  
 
Alle laboranten en interns 
Tijdens de jaren van mijn doctoraat zijn er een aantal laboranten de revue 
gepasseerd. Vooral Hanne en Jolien wil ik van harte bedanken voor alle ureum/creatinine 
analyses! Als er geen laborant beschikbaar was, kon ik steeds op één van de interns 
rekenen om in te springen. Daarom en ook voor alle hulp op kliniek, een dikke merci aan 
alle interns van de voorbije jaren.  
 
Onze dames van het secretariaat 
 Bedankt om alle Ragdolls tijdig in te schrijven en zo de Ragdoll-dagen een stuk 
vlotter te laten verlopen. Dominique en Cindy wil ik bedanken voor alle papierwerk en het 
regelen van de financiën.  
 
“Cover-helpers” 
Het ontwikkelen van de cover was één van deze moeilijkste opdrachten van dit 
doctoraat: geen inspiratie en vooral geen creatieve genen. Bedankt aan iedereen die hierbij 
geholpen heeft: Kris, Geert, Kathy, Elien en Filip. Ik vind het resultaat in ieder geval 
fantastisch! 
 
Alle collega’s van KHD en MBV, maar vooral de internisten 
Iedereen van de dienst kleine huisdieren en medische beeldvorming verdient een 
woordje van dank voor de aangename samenwerking als ik ‘on-clinic’ was. Een extra 
dikke merci gaat naar de internisten om al mijn patiënten en eigenaars fantastisch op te 
vangen als ik niet beschikbaar was!! 
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Alle vrienden 
 Aan al onze vrienden, een dikke merci voor de plezante momenten tijdens etentjes, 
kwartaalbijeenkomsten, barbecues,… en voor alle steun! 
 De vrije tijd tijdens mijn doctoraatsperiode was grotendeels gekenmerkt door 
afbraakwerken en verbouwingen. Aan iedereen die hierbij geholpen heeft: Cindy en Wim, 
Nele en Wim, Roger en Lucien, merci voor jullie tijd! Vooral dankzij Wim ben ik een 
“volleerd afbreker” (hmm…?) geworden en zijn dakwerken, het afschieten van muren en 
het bedienen van een hoogtewerker nu ook kinderspel.  
 Vivi, jou ken ik nu al meer dan de helft van mijn leven. Ook al horen en zien we 
elkaar niet zo dikwijls, het voelt toch steeds als een beetje thuiskomen… 
 
Familie 
Ik wil mijn schoonouders Annemie en Leo bedanken voor de rustige 
werkomgeving en de steun. Annemie, ook bedankt om ons regelmatig van eten te voorzien 
en voor de zorg voor onze vijfling als wij op vakantie zijn! 
Bobonne, merci om er altijd te zijn en om altijd voor ons klaar te staan met een 
lekker maal. “Chez Bobonne” is nog altijd een 5-sterren restaurant! 
Kristof en Aurélie, Julie en Lou. Door de drukte van mijn doctoraat, bijscholingen 
en (ver)bouwperikelen ben ik de laatste tijd geen goede meter en tante geweest. Sorry 
hiervoor, ik beloof dat we wat meer gaan langskomen! 
Mama, jou wil ik bedanken voor de jarenlange steun, voor alle kansen die je me 
hebt gegeven, om altijd voor me klaar te staan en voor nog zoveel meer…  
 
Liefste Els 
Last but not least, Els, jij hebt geen idee wat jij voor mij betekent. De rollercoaster 
van deadlines van de laatste maanden was niet gemakkelijk, maar ondanks alles sta jij 
steeds voor me klaar. Jij bent mijn ‘missing link’, jij maakt me compleet, en ik zeg het niet 
genoeg, maar “ik zie je graag”. 
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